University of Wollongong

Research Online
University of Wollongong Thesis Collection
1954-2016

University of Wollongong Thesis Collections

2003

Development of a polymer-based, pro-apoptotic cancer therapeutic
Rachel A. Jones
University of Wollongong, rachelj@uow.edu.au

Follow this and additional works at: https://ro.uow.edu.au/theses
University of Wollongong
Copyright Warning
You may print or download ONE copy of this document for the purpose of your own research or study. The University
does not authorise you to copy, communicate or otherwise make available electronically to any other person any
copyright material contained on this site.
You are reminded of the following: This work is copyright. Apart from any use permitted under the Copyright Act
1968, no part of this work may be reproduced by any process, nor may any other exclusive right be exercised,
without the permission of the author. Copyright owners are entitled to take legal action against persons who infringe
their copyright. A reproduction of material that is protected by copyright may be a copyright infringement. A court
may impose penalties and award damages in relation to offences and infringements relating to copyright material.
Higher penalties may apply, and higher damages may be awarded, for offences and infringements involving the
conversion of material into digital or electronic form.
Unless otherwise indicated, the views expressed in this thesis are those of the author and do not necessarily
represent the views of the University of Wollongong.

Recommended Citation
Jones, Rachel A, Development of a polymer-based, pro-apoptotic cancer therapeutic, PhD thesis,
Department of Biological Sciences, University of Wollongong, 2003. http://ro.uow.edu.au/theses/199

Research Online is the open access institutional repository for the University of Wollongong. For further information
contact the UOW Library: research-pubs@uow.edu.au

DEVELOPMENT OF A POLYMERBASED, PRO-APOPTOTIC
CANCER THERAPEUTIC
A thesis submitted in fulfilment of the
requirements for the award of the degree of

Doctor of Philosophy
From

The University of Wollongong
By

Rachel Anne Jones (B. Biotech. Hons. Class 1)

Department of Biological Sciences

2003

Acknowledgments
This thesis would not have been possible without the support of many people.

Firstly, I would like to thank A ssociate Professor M ark W ilson for his continual support,
guidance, encouragem ent and know ledge over the past 4 years. He alw ays had tim e to
answ er all my questions and help me in every way possible. He has graciously put up with
my continual laughter and jokes. T hanks M ark fo r fighting my battles with Leica in
G ermany and letting me have sing-a-long Tuesdays. I feel privileged to have worked in
your lab and would certainly recommend you as a supervisor to future students.

Thankyou also to all the past and present students in Lab 110, 112 and 120: Kerry, Dave,
M att, M arc, Stevie, A lison, Juzzy, Elise, Kara, Helen, Carolyn, Leonie, Nicole, M aree,
Jovanka, Sarah, Fay, Tim ra and Cindy. The fond memories of this lab (e.g. Stewie, Leroy
and Tyson the Siam ese fighting fish, the lab gym nastics, and the never ending lab photos)
will stay with me fo r a long tim e to come. Thankyou especially to A lison Smail and
Christine Gillen who have made these last 4 years extrem ely entertaining and exciting. I
have no doubt that our friendship will last for many years.

Thankyou to Stephen Pine, A lison Ung and the many other students in the Pine Lab.
T hankyou fo r allow ing me to w ork into your lab. T hankyou for your patience and
w illingness to answ er all my questions, especially about the Rotovap! W orking in a
chemistry lab was like learning a new language!

Thankyou, also to the many friends that have supported me over the past 4 years. Thankyou
to Katie Jones and M arianne Rietveld for graciously proof reading my thesis. Thankyou
also to M arianne for ringing me on numerous occasions ju st to tell me to keep on going and
that I would finish.

Lastly, I w ould like to thank my fam ily, especially my Mum and Dad. W ithout their
continual support, guidance and 100% confidence that I would finish, this thesis would not
have been possible.

Abstract
This thesis docum ents work directed towards the developm ent of a novel cancer therapeutic
that uses a synthetic polym er to deliver a pro-apoptotic peptide into the cytosol of cancer
cells and in turn induce death by apoptosis. This was approached by (1) testing the ability
of a range o f synthetic polym ers (poly(2-alkyl acrylic acid)s (PA A A s) and p o ly [ 1(dim ethylam ino)ethyl m ethacrylate] (pD M A EM A )) to facilitate the release of m olecules
from endosomes to the cytosol, (2) conjugating a pro-apoptotic peptide (Bad(140-165)) to a
suitable endosom al-disruptive polym er, and (3) testing the ability of the polym er-peptide
conjugate to enter the cytosol following endocytosis and to trigger apoptosis.

PAAAs were shown to be endocytosed into cells and transported to late endosom es, where
acidification of the lumen by the membrane H+-ATPase triggered polym er-mediated vesicle
disruption and release o f endosom al contents to the cytosol. pDM AEM A was shown to
induce rapid necrosis and to be endocytosed into cells w here it induced m orphological
changes in late endosom es/lysosom es. H owever, pDM AEM A did not have the ability to
disrupt endosomes, and was thus not used in further experiments. In addition, the very high
toxicity of pD M A EM A could also pose a significant risk of bystander cell dam age in
cancer therapies. A hydrazide-linker (X) was synthesised and conjugated to PAAAs.
Results showed that (1) the membrane disruptive ability of PAAAs was retained following
conjugation with hydrazide linker, and (2) the carboxcyclic-hydrazide bond incorporated
within the linker was stable at pH 7 but not at pH 5. Finally, PAAA-X was conjugated to
Bad(140-165) to form PA A A -X -B ad(140-165). Im m unofluorescence assays showed that
PAAA-X-Bad( 140-165) partially co-localised with early endosomes and induced disruption

of endosom es and release of their contents into the cytosol in a tim e-dependent manner.
Surprisingly, cell viability was retained follow ing uptake of PAAA -X-Bad(140-165). The
reasons why apoptosis was not induced follow ing uptake of PA A A -X -B ad(140-165) are
currently unknown, how ever possibilities include incomplete cleavage of the linker and/or
insufficient release o f Bad( 140-165) into the cytosol. Future experim ents, such as
increasing the num ber o f linkers and/or Bad(140-165) m olecules attached to m olecules of
PAAA, may aid in the understanding of why apoptosis was not induced.

As an adjunct to studies of the effects of polym ers and PAA A -X-Bad(140-165) on cells, a
new technique was developed to measure m itochondrial perm eability transition (M PT) in
intact cells. In this method, calcein is introduced into cells by pinocytic loading. Polarised
m itochondria are visualised as darkened voids w ithin a bright green fluorescent cytosol.
MPT is m easured as an in-filling of calcein fluorescence into these darkened voids. This
m ethod is free of disadvantages associated with earlier developed techniques and will be
valuable in studies of MPT in intact cells. H owever, unfortunately, technical lim itations
prevent the use of this method to measure MPT in cells undergoing apoptosis.

Taken together, results presented in this thesis provide a firm foundation for the future
developm ent of a novel cancer therapeutic that (1) directly targets cancer cells, (2) induces
apoptotic death, and (3) avoids d isad v an tag es asso ciated w ith trad itio n al cancer
therapeutics.
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This chapter gives a review of the current understanding of apoptosis. Details of the
molecules and processes involved and the mechanisms of regulation are described. The
developm ent of pH -sensitive polymers and their use in cancer therapies are then
described. The final section of this chapter describes a novel cancer therapeutic,
involving pH-sensitive polymers that directly target cancer cells and induce death by
apoptosis.

1.1

Apoptosis

Apoptosis, or programmed cell death, represents a physiological form of cell death and
is thought to be involved in every homeostatic and pathological process in the body
(Gastman, 2001; Wilson, 1998). It is the dominant form of cell death especially in the
organs and tissues of the immune system and is genetically controlled by an internally
encoded suicide program (Steller, 1995; White, 1993).

The apoptotic pathway is divided into three functionally distinct phases: initiation,
execution and degradation. During the initiation phase the cell receives a death-inducing
signal, which can result from various chemical and biological agents (Gastman, 2001).
Examples of initiating signals include a shortage of nutrient supply or ligation of death
signal-transmitting receptors (Kroemer et al., 1997). Apoptosis can be initiated by many
different pathways but it is in the execution phase where these different signals are
translated into a common molecular pathway. During the execution phase a ‘point of no
return’ is passed and the cells become irreversibly programmed to die (Kroemer et al.,
1995; Kroemer et al., 1997). The final degradation phase is accompanied by a distinct
set of morphological and physiochemical changes including:
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1. Cellular and nuclear shrinkage, which is accompanied by internucleosomal DNA
fragmentation (Patel et al., 1996; Vander Heiden et al., 1997).
2. Protein degradation and blebbing of the membrane into apoptotic bodies (which
contain intact cytoplasm ic organelles and nuclear fragments). This occurs ju st
before phagocytosis by macrophages or adjacent cells (Shi, 2001; Villa et al., 1997),
preventing the leakage of noxious cellular contents into the surrounding tissue.
Figure 1.1 depicts major cytostructural changes that occur during apoptosis.
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Figure 1.1: The major cytostructural changes that occur during apoptosis. (1) Shows a
normal cell. In the early stages of apoptosis the cytoplasm starts to condense, the
chromatin becomes very dense and compact, forming uniform, fine granular masses on
the nuclear envelope, and the nuclear and cellular outlines become mildly ruffled and
convoluted (2). This is then followed by rapid chromatin condensation and convolution
of the nuclear and cellular outlines. The nucleus breaks up into discrete membrane
enclosed fragments, and the cell buds to produce membrane-bound apoptotic bodies
containing well-preserved organelles (3). The apoptotic bodies are phagocytosed by
adjacent cells (4) and degraded within lysosomal vacuoles (5) to form compact debris
(6) (Adapted from Kerr, 1995).
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Organelles Involved in Apoptosis

In the evolution o f eukaryotic cells, m itochondria have fo r a long tim e played a
prom inent role (Scheffler, 2001). They (1) are essential for cellular energy m etabolism
(R utter and Rizzoto, 2000), (2) reduce and detoxify free radicals, such as reactive
oxygen species (ROS) (M ignotte and V ayassiere, 1998), (3) serve as a cellular calcium
buffer (Orth and Schapira, 2001), and (4) are sites o f electron transport and generators
of cellular A TP (Harris and Thom pson, 2000). A growing body of evidence from many
independent research groups, now supports a role fo r m ito ch o n d ria as crucial
participants in the induction and execution phases of apoptosis (Finucane et al., 1999;
W ilson, 1998; G reen and Reed, 1998; K roem er et al., 1998; Bernardi et al., 2001;
Desager and M artinou, 2000, G ottlieb et al., 2000; Parone et al., 2002).

In recent years, several controversial reports have suggested that lysosom es may also
play a crucial role in apoptosis, particularly in the initiation phase. In a num ber o f cell
types, apoptosis is associated with an early destabilisation of lysosomal m em branes and
subsequent release of lysosom al enzym es into the cytosol (Term an et al., 1999; Neuzil
et al., 1999; R oberg et al., 1999). It w as suggested that rupture o f the lysosom al
m em brane may be an early upstream event in apoptosis (Antunes et al., 2001). Despite
these recent fin d in g s, the in v olvem ent o f lysosom es in apoptosis is still poorly
understood (see section 1.7), and probably because o f this, not generally accepted
(Hengartner, 2000).

It has also been suggested that the endoplasm ic reticulum may be involved in the
execution phase, independent of m itochondria (Ng et al., 1997). Ng et al. (1997)
suggested that caspase-m ediated generation of an N -term inal 20 kD a fragm ent o f the
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hum an protein p28 Bap31 in the endoplasm ic reticulum induces apoptotic nuclear
changes. It is also possible that other organelles may be involved. For exam ple, M ancini
and colleagues (2000) have suggested that the Golgi com plex may be involved in the
execution phase, while Li et al. (2000) suggest the involvem ent o f the nucleus in the
execution phase. H ow ever, to date, evidence is lim ited and further research will be
needed to confirm these suggestions.

1.3

Proteins Involved in Apoptosis

Extensive research has revealed many of the crucial com ponents involved in apoptosis,
how ever ongoing research indicates the potential for many more. Some of the vital
com ponents of the apoptotic pathway discovered to date include: (1) cytosolic-based
proteins such as caspases and inhibitor o f apoptosis (IA P) fam ily proteins and (2)
m itochond ria-asso ciated proteins such as B cl-2 fam ily p ro tein s, cytochrom e c,
Smac/DIABLO, apoptosis inducing factor (AIF) and Omi/HtrA2.

1.3.1

Cytosolic Proteins

1.3.1.1

Caspases

Caspases (cysteinyl aspartate-specific proteinases) are a fam ily of intracellular cysteine
proteases that cleave substrates ad jacen t to aspartic acid residues and that can
them selves be activated by cleavage at sim ilar sites (M ignotte and V ayssiere, 1998;
Green and Evan, 2002). They are produced in cells as catalytically inactive zym ogens
and are activated by either truncation or dim erization. Three general m echanism s of
caspase activation have been described thus far:
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1. Processing by an upstream caspase - This type of activation results from procaspases being exposed to a previously activated caspase. It is the simplest mechanism
of caspase activation and is used specifically for the activation of downstream caspases,
such as caspase-3, -6 and -7 .
2. Induced Proximity - Muzio et al. (1998) suggest that the formation of a deathinducing signalling complex (DISC), comprised of tightly clustered specific ligands
(e.g. Fas), receptor molecules, adaptor proteins (e.g. FADD) and pro-caspase-8, is
sufficient to allow the pro-enzyme molecules to mutually cleave and activate each other,
thereby producing active caspase-8.
3. Association with regulatory subunits - This activation process is the most complex.
The only known example involves the formation of a large complex, comprised of
Apaf-1, cytochrom e c, ATP and pro-caspase-9. The specific combination of these
proteins results in the activation of caspase-9, however, the exact mechanism of
activation remains unclear (Hengartner, 2000).

Over a dozen caspases have been identified and are divided into three subgroups, based
on their substrate preference, extent of sequence homology and structural similarities
(Hengartner, 2000). Table 1.1 shows the groupings of all known caspases. The cysteine
containing sequence glutam ine-alanine-cysteine-arginine-glycine (QACRG) is a
conserved motif common to all caspases; if the cysteine is mutated, then the proteases
are inactivated (Vaux and Strasser, 1996).
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Group

Caspase

I

Caspase-1, -4, -5

II

Caspase-2, -3, -7

III

Caspase-6, -8, -9,-10

Structurally related to group I

C aspase-11, -12,-13

Structurally related to group II

C aspase-14

Table 1.1: - Caspases and their subgroups (Gastman, 2001).

1.3.1.2

IAPS

The inhibitor of apoptosis (IAP) family of proteins inhibit the enzymatic activity of
mature caspases (M iller, 1999). In the past few years several distinct IAPs have been
identified, all of which exhibit anti-apoptotic activity. Table 1.2 summarises the known
IAPs. All IAPs contain a highly conserved functional region known as the baculovirus
IAP repeat (BIR), which contains approximately 80 amino acids folded around a zinc
atom (Shi, 2001). M ost IAPs have more than one BIR region, with the various BIR
domains exhibiting different functions. Caspase inhibition occurs through precise
interactions between the BIR domains of IAPs and the mature caspase.

XIAP

BRUCE

Survivin

ML-IAP

CIAP-1

CIAP-2

NAIP

Livin

Apollon

Table__L2: Members of the IAP Family (Gastman, 2001).
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1.3.2

Mitochondria-Associated Proteins

1.3.2.1

Bcl-2 Family

In recent years, extensive research has been conducted on the Bcl-2 family proteins, as
they have been strongly implicated as important regulators of apoptosis. A primary
mechanism by which these proteins regulate apoptosis is probably by controlling
cytochrom e c release, however, further research is needed to determ ine the exact
function of these specialised proteins. A number of Bcl-2 family members have been
identified and are summarised in Table 1.3. Each family member contains at least one of
the four conserved functional regions called Bcl-2 homology domains (BH1-BH4),
schematically shown in Figure 1.2. These domains enable the different members of the
family to form homo- or hetero-dim ers with each other, thereby enhancing or
antagonising their functions (Mignotte and Vayssiere, 1998; Kelekar et al., 1997). They
are divided into three different groups based on Bcl-2 homology and function. The antiapoptotic members, such as Bcl-2, harbour at least three, but generally four, BH
domains, while the pro-apoptotic members have between one and three BH domains.
The pro-apoptotic group is subdivided into two groups - those with only one BH
domain and those that possess up to three domains. Many of the pro-apoptotic family
members, such as Bax, Bid and Bad, are synthesised in the cytosol, however, following
an apoptotic stimulus, they undergo a conformation change and are translocated to
mitochondria (Dengy and Wu ^ al., 2000; Datta et al., 2000).
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Anti-apoptotic

Pro-apoptotic
Multi-domain

BH3 domain Only

Bcl-2

Bcl-xs

Bad

Bcl-xL

Bok/Mtd

Bid

Bcl-w

BAX

BIM/BOD

Mcl-1

BAK

Harakiri/DP5

Al/Bfl-1

Bcl-Gl

BLK

Boo/Diva

NIX/BINP3

N r-13

Noxa
Bcl-Gs
MAP-1

Table 1.3 : Functional groupings of Bcl-2 family members (B-cell leukemia/lymphoma
2). (Gastman, 2001; Cory and Adams, 2002).

BH4

Rm

BH1

JZL

BH2
Anti-apoptotic
Multi-domain
(pro-apoptotic)

□

BH3 only
(pro-apoptotic)

Figure 1.2: Schematic representation of the BH domains contained within the Bcl-2
family members (Adapted from Hengartner, 2000; Cory and Adams, 2002).
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Cytochrome c

Cytochrome c is a 12.3 kDa extrinsic membrane protein, normally associated with the
outer surface of the inner membrane of mitochondria (Gastman, 2001). It is encoded by
a nuclear gene and is translated by cytosolic ribosom es as apocytochrom e c.
Apocytochrome c is subsequently translocated into mitochondria where a haeme group
is attached covalently to form holocytochrom e c (Yang et al., 1997; reviewed by
Waterhouse et al., 2002). The release of holocytochrome c from mitochondria has been
implicated as one of the critical steps in apoptosis; much debate continues over the
mechanism and the order of events that lead to the release of the protein. The Bcl-2
proteins are thought to be involved in this process. This is supported by Gross et al.
(1999) and others, who have shown that the addition of pro-apoptotic Bcl-2 family
members to isolated mitochondria is sufficient to induce cytochrome c release, whereas
the over-expression of anti-apoptotic Bcl-2 family proteins inhibits cytochrome c
release. In addition to Bcl-2, mitochondrial lipids (e.g. cardiolipin) have also been
suggested to be involved in the release of cytochome c. Cardiolipin is thought to induce
the detachment of cytochrome c from the inner mitochondrial membrane (Ott et al.,

2002).

1.3.2.3

Smac / DIABLO

Smac (second m itochondria-derived activator of caspases), also known as DIABLO
(direct IAP binding protein with low pi) is a recently discovered mitochondrial protein.
It is comprised of 239 amino acids, including an N-terminal 55 residue-long targeting
sequence that is cleaved upon transport into mitochondria (Du et al., 2000; Verhagen et
al., 2000, Reed, 2002). During apoptosis, Smac/DIABLO is released, in conjunction
with cytochrome c, from the intermembrane space of mitochondria. However, it is yet to
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be determined if these two proteins are released by the same mechanism. Smac interacts
with multiple IAPs, thereby preventing their inhibitory effect on both initiator and
effector caspases (Chai et al., 2000). The interaction between Smac and various IAPs is
thought to involve the four N-terminal residues of Smac and the BIR domains of the
IAPs (Liu et al., 2000; Wu et al., 2000).

1.3.2.4

Omi/HtrA2

The serine protease Omi is the most recent m itochondrial protein im plicated in
apoptosis to be identified. Like Smac, Omi is localised predom inantly in the
intermembrane space of mitochondria but is released into the cytosol, in conjunction
with Smac and cytochrome c, during apoptosis (Hegde et al., 2002). As yet, it is not
known if Omi, cytochrome c and Smac are released by the same mechanism (Martins et
al., 2002). In the cytosol, the N-terminal 133 amino acids are cleaved from the rest of
the protein and mature Omi protein is generated (van Loo et al., 2002). To date the
function of Omi remains unclear, however, it is thought to interact with the BIR
domains of IAP proteins, thereby promoting caspase activity (van Loo et al., 2002;
Martins et al., 2002; Verhagen et al., 2002). Hegde et al. (2002) have also shown that
Omi can induce cell death in mammalian cells independent of caspases, Apaf-1 or IAP,
via its serine protease activity; they suggest that it may be involved in a caspaseindependent mechanism of cell death.

1.3.2.5

AIF

AIF (apoptosis inducing factor) is a 50 kDa protein which is normally confined to the
interm em brane space of m itochondria but translocates to the nucleus following
induction of apoptosis (Susin et al., 1999a; Daugas et al., 2000). Once inside the
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nucleus, it induces chromatin condensation and cleavage of DNA into 50 Kb fragments,
however the mechanism involved remains unresolved (Ye et al., 2002). AIF has now
been shown to induce caspase-independent peripheral chromatin condensation and
DNA fragmentation when added to purified nuclei. In addition to its apoptogenic action
on nuclei, A IF can also participate in the regulation of apoptotic m itochondrial
permeabilisation (reviewed by Cande et al., 2002).

1.4

Pathways Involved in Apoptosis

There are two major apoptotic pathways known to date: the intrinsic pathway, which is
initiated by mitochondria, and the extrinsic pathway, initiated by cell surface receptors.
The extrinsic pathway, or death receptor pathway, is triggered by members of the death
receptor family, such as CD95 and tumour necrosis factor receptor 1 (TNFR1). The
binding of a specific ligand to these receptors results in the formation of a deathinducing signalling complex. This complex, together with an adaptor molecule known
as FADD (Fas-associated death domain protein), associates with multiple pro-caspase-8
molecules to cause caspase-8 activation (Hengartner, 2000). The activation of caspase-8
in turn activates other downstream caspases and causes apoptotic death (Figure 1.3).

The intrinsic pathway occurs in response to a wide range of death stimuli, including the
activation of tumour suppressor proteins and oncogenes (Shi, 2001). It is thought that
these diverse pathways converge on mitochondria, possibly via the action of proapoptotic Bcl-2 proteins. This is followed by the release of many proteins from the
interm em brane space, such as cytochrom e c, A IF (L orenzo et al.,

1999),

Smac/DIABLO (Du et al., 2000; Verhagen et al., 2000) and several pro-apoptotic
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caspases, including pro-caspase-2,-3, and -9 (Loeffler and Kroemer, 2000). Exactly how
these proteins are released and the order of release is still greatly debated and will be
discussed later (Sections 1.5 and 1.6). Once in the cytosol, cytochrome c is thought to
bind tightly with Apaf-1; this binary complex then associates with dATP or ATP and
pro-caspase-9 to form a complex known as the apoptosome (Zou et al., 1999; Saleh et
al., 1999; Green and Evan, 2002), which in turn activates pro-caspase-9 to form
caspase-9. Interestingly, caspase-9 remains bound to the apoptosome as a holoenzyme,
as caspase activity is only retained while it is bound in this conformation (Rodriguez
and Lazebnik, 1999). The holoenzyme caspase-9 activates caspase-3 and subsequent
apoptotic events (Hengartner, 2000; Desagher and Martinou, 2000). The final events
include the activation of DNA fragmentation factor 45 (DFF45) which, when activated,
functions as a nuclease and degrades chromatin into nucleosomal fragments.

The intrinsic and extrinsic pathways converge at the level of caspase-3 activation. The
activation of caspase-3 is inhibited by IAP proteins, which are themselves antagonised
by Smac/DIABLO following release from mitochondria (Hengartner, 2000). These
pathways are linked by the action of Bid, a pro-apoptotic Bcl-2 family member (Yin,
2000). The activation of caspase-8, in the extrinsic pathway, increases the pro-death
activity of Bid and its translocation to mitochondria, where it promotes release of
cytochrome c and Smac (Yin 2000; Li et al., 2002). Figure 1.3 schematically represents
the extrinsic and intrinsic pathways.
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Death Receptor Ligand
Death Receptor

Intrinsic
Pathway
Chemotherapeutic

Adaptor
Molecule
Procaspase-8
o r -10

Ceramide

Agents

Oxidants

Bcl-2
Bcl-xL H

Bax
Cytochrome c
OO

Active
caspase-8
or -10

Downstream
caspases
E.g. caspase-3/-7

Bcl-2
Bcl-xL

IAP’s

□

Inactive
Apaf-1

Active Apaf-1
and Pro-caspase-9
dATP

Substrate Cleavage

Figure 1.3: Schematic representations of the two major pathways of apoptosis. In the
extrinsic pathway, death receptor ligands bind to death receptors and in turn activate
caspase 8 and further dow nstream caspases, thereby causing apoptotic death. In
contrast, the intrinsic pathway can be triggered by various cell death stimuli, which
cause m itochondria to release proteins, such as cytochrome c. This then triggers a
cascade of events, including the activation of caspases and DNA fragm entation
(Adapted from Gastman, 2001).
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Mitochondria and Apoptosis

Mitochondria are now accepted as key players in the execution phase of apoptosis. The
culm ination of results from many independent research groups has led to this
conclusion. Some of these results are summarised below:
1. Kroemer and others (reviewed by Loeffler and Kroemer, 2000) have shown that
mitochondrial membrane permeabilization often precedes the signs of advanced
apoptosis and necrosis, irrespective of the cell type or death-inducing stimulus.
They

have also

shown

th at in h ibition

of m itochondrial

m em brane

permeabilization by specific pharmacological interventions (i.e. agents acting on
mitochondrial proteins) prevents or retards cell death.
2. Balakirev and Zimmer (1998) reported major changes to mitochondrial integrity
prior to the classical sign of apoptosis, and also mitochondrial depolarisation
preceded DNA fragmentation.
3. Pastorino et al. (1998) and Zamzami et al. (1998a,b) have shown that the Bcl-2
family of proteins act on mitochondria to regulate apoptosis.
4. Green and Kroemer (1998), Kroemer and Reed (2000) and Boya et al. (2001)
have shown that several pro-apoptotic signals converge on mitochondria to
induce mitochondrial membrane permeabilisation and this phenomenon is under
the control of Bcl-2 related proteins.
5. G ilm ore et al. (2001) have shown that pinocytic loading of the pro-apoptotic
m itochondrial protein cytochrom e c in to intact cells induces activation of
caspase-3 and - 9 like enzym es, and a loss of mitochondrial depolarisation
coincident with an increase in mitochondrial permeability.
6. Num erous proteins, such as Smac, Omi and cytochrom e c, which have
downstream apoptotic functions, are primarily localised in mitochondria (Du et
16
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al., 2000; Verhagen et al., 2000; van Loo et al., 2002; M artins et al., 2002;
Verhagen et al., 2002).

Two models for the involvement of mitochondria have been proposed:
1. The first model was initially proposed by Kroemer et al. (1997) and involves the
phenomenon referred to as mitochondrial permeability transition (MPT). MPT results in
the opening of mega channels or pores (permeability transition pores-PTP), which are
formed under specific conditions at points where the inner and outer membranes of
mitochondria touch. The opening of the pores allows for the equilibration of ions and
respiratory substrates (<1500 Da) between the cytosol and the mitochondrial matrix,
leading to the reduction of mitochondrial transmembrane potential (Axpmit) (Mignotte
and Vayssiere, 1998).

results from the asymmetric distribution of protons and

other ions on either side of the inner mitochondrial membrane, which gives rise to a
chemical (pH) and electrical gradient which is essential for mitochondrial function
(Kroemer et al., 1997). Following

water moves into the mitochondrial matrix,

causing swelling and the outer mitochondrial membrane is broken (Sklachev, 1996). As
a result, mitochondrial proteins (cytochrome c, AIF, Smac and Omi) are released into
the cytosol, promoting caspase activation and triggering DNA fragm entation and
chromatin condensation (Ferri and Kroemer, 2001) (Figure 1.4). This MPT-dependent
model has been supported by studies of many cell types in response to various toxic
stimuli (Zamzami et al., 1997; Petit et al., 1996; Boise and Thompson, 1997; Hirsh et
al., 1997; Zamzami et al., 1998a,b; Cassarino et al., 1999; Fulda et al., 1999; Heiskanen
etal., 1999).
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2. The second model of mitochondrial involvement in apoptosis proposes the release of
mitochondrial proteins through an M PT-independent mechanism (Liu et a l, 1997).
Many studies have suggested that cytochrome c release occurs in the absence of or prior
to mitochondrial depolarisation (Goldstein et al., 2000; Kluck et al., 1997). For
example, in Jurkat and FL5.12 cells, the release of cytochrome c was shown to coincide
with swelling of the outer mitochondrial membrane. This change was apparent before
the loss of Wmit, which is normally associated with MPT (Kluck et al., 1997). To date,
four alternative mechanisms have been suggested for the M PT-independent release of
mitochondrial proteins, however none of these have been established. These include: (1)
formation of a lipid-pore complex in the outer mitochondrial membrane (Vander Heiden
et al., 1997), (2) Bcl-2 family members (e.g. Bax) forming channels in the outer
mitochondrial membranes, thereby allowing cytochrome c and other proteins to be
released but not damaging mitochondria (Shimizu et al., 1999; Antonsson et al., 1997),
(3) direct action of upstream caspases on mitochondria (Susin et al., 1997) and (4) Bcl-2
family members (e.g. Bax), in conjunction with mitochondrial permeability transition
pores proteins (e.g. voltage dependent anion channel (VDAC)), forming pore in the
outer mitochondrial membrane.
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MODEL 1

MODEL 2

PT /
Collapse
o f V ...

►

(3) Caspases
(2) Bax
proteins

Release o f ...
Cytochrome C
Smac
Omi
AIF

(1) Lipid-pore
complex

(4) Bax and
VDAC

I

Caspase Activation
DNA Fragmentation
DEATH

Figure 1.4: Schematic representation of two models of the involvement of mitochondria
in apoptosis. In model 1, PTP open causing MPT, collapse of Wmit swelling of
mitochondria and release of mitochondrial proteins, such as cytochrome c, into the
cytosol. This is followed by caspase activation and DNA fragmentation. In model 2,
mitochondrial proteins are released by an M PT-independent mechanism. Many MPTmdependent mechanisms have been proposed, including (1) formation of a lipid-pore
complex, (2) Bax proteins forming large pores in the outer mitochondrial membrane and
releasing proteins, (3) caspases acting directly on mitochondrial membranes, and (4)
Bax forming pores in conjunction with VDAC.
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Regulation of Apoptotic Pathways

Slight alterations in the apoptotic process can have drastic consequences. For example,
abnormal dow n-regulation of apoptosis is a contributor to cancer and autoimmune
diseases, w hereas up-regulation of cell death is im plicated in neurodegenerative
disorders such as A lzheim er’s disease (Thompson, 1995). Therefore, the apoptotic
process must be highly regulated. In a wide variety of cell types, Bcl-2 and Bcl-2related proteins are critical in preventing cells from undergoing apoptosis induced by
various stimuli. The mechanism(s) by which these proteins modulate apoptosis is not
yet known but several theories have been proposed:

1. One of the unique characteristics of the Bcl-2 family members is their ability to form
homo- and hetero-dimers. One of the first theories advanced to account for the effects of
Bcl-2 family members on apoptosis focussed on the interaction between Bax and Bcl-2
related proteins. Sedlak et al. (1995) reported that the formation of Bax homo-dimers
promotes apoptosis and the formation of hetero-dimers between Bcl-2 related proteins
and Bax prevents apoptosis in murine FL.5.12 cells. However, in some cell systems, the
binding of Bax to Bcl-2 was not sufficient to prevent apoptosis (Knudson and
Korsmeyer, 1997). It was suggested that the process of hetero-dimerization may inhibit
apoptosis by preventing the translocation of Bax to mitochondria (Gross et al., 1998;
Nomura et al., 1999).

2. Bcl-2 and Bcl-xL may inhibit apoptosis by preventing the over-production of ROS
and shifting the redox potential to a more reduced state. The mechanism for this effect is
not known but it has been suggested that Bcl-2 may act in an antioxidant pathway
(Mignotte and Vayssiere, 1998).
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3. Pro-apoptotic Bcl-2 proteins may also regulate apoptosis through interaction with
caspases. In mammalian cells a com plex between caspase-9, Bcl-xL Apaf-1 and
cytochrome c is formed in many different types of cells induced to undergo apoptosis,
including murine thymocytes (Hsu et al., 1997). Caspase-9 and Bcl-xL bind to distinct
domains in the Apaf-1 molecule (Pan et al., 1998). It has been suggested that the
formation of this complex may regulate mammalian cell death (Pan et al., 1998).
Regulation is achieved by the binding of the Bcl-xL to Apaf-1, which blocks the ability
of Apaf-1 to promote the activation of caspase-9, hence preventing activation of other
caspases and DNA fragmentation. Bcl-2 related proteins such as Bax, Bak and Bik are
able to disrupt the interaction between Bcl-xL and Apaf-1 by forming hetero-dimers
with Bcl-xL (Pan et al., 1998: M ignotte and Vayssiere, 1998), allowing apoptosis to
proceed.

4. Reed (1997) suggested that the Bcl-2 family inhibits apoptosis by inserting, following
a conformational change, into the outer mitochondrial membrane, forming channels or
even large holes. M uchmore et al. (1996) originally reported the ability of Bcl-xL to
form channels with discrete conductances in synthetic lipid membranes. Recently, Zhai
et al. (2000) and Basanez et al. (1999) showed that Bid and Bax are also able to form
pores in liposomes and release encapsulated molecules such as cytochrome c. However,
this pore forming ability does not establish a corresponding function in vivo. The
synthetic membranes used in these studies do possess a similar negative charge to the
outer m itochondrial membrane. Therefore, it is possible that Bcl-2 proteins and
mitochondrial membranes might interact in a similar manner.
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5. It is hypothesised that the Bcl-2 family members may be involved in the formation of
large pores through the recruitm ent and interaction of other outer mitochondrial
membrane proteins. Bcl-2 family members have been shown to interact with a large
m itochondrial protein called the voltage dependent anion channel (VDAC). In
electrophysiological studies, Shimizu and colleagues (1999 and 2000) have shown that
Bax and VDAC specifically interact in synthetic membranes to form novel ion
channels, which are bigger than pores formed by VDAC or Bax alone.

6. It is possible that Bcl-2 family members may regulate the release of cytochrome c by
controlling the opening and closing of the PTP and in turn MPT. The precise molecular
composition of the PTP remains elusive, however, it is thought to be a multi-protein
assem blage, incorporating proteins such as the VDAC, the adenine nucleotide
translocator (ANT), the benzodiazapine receptor and cyclophilin D. Bax has been
shown to interact specifically with two of these proteins, VDAC and ANT (Tsujimoto
and Shimizu, 2000). Therefore, this model suggests that Bcl-2 family members, in
particular Bax, may control MPT and the release of cytochrome c.

1.7

Lysosomes and Apoptosis

Lysosomes, together with late endosomes, are the main cellular compartment for intra
cellular degradation and contain a large number of enzymes, particularly non-specific
proteases. Accumulating evidence suggests that lysosomes, perhaps in conjunction with
mitochondria, may be intimately involved in apoptosis. However, the role of lysosomes
in apoptosis is still poorly understood.
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M any researchers believe that lysosom es are sturdy structures w hose integrity rem ains
intact until the final stages of cell death (review ed by A ntunes et al., 2001; Brunk and
Svensson, 1999; Li et al., 2000; H elliquist et al., 1997), thereby contributing little to the
process. D espite this com m on opinion, it is now known that in certain pathological
situations, as well as in norm al aging (Bi et al., 2000), lysosom al integrity may be
com prom ised, causing leakage o f lysosom al proteases into the cytosol. It has also been
shown that m inor lysosom al destabilisation produces degenerative alterations that are
efficiently repaired by autophagocytic processes, suggesting that m inor lysosom al
leakage m ight be a com m on and reversible occurrence (review ed by B runk and
Svensson, 1999). M any independent research groups have now reported that partial
rupture of lysosom es seem s to be an early and consistent event preceding apoptosis,
caused by a variety o f agonists, including oxidative stress, grow th factor w ithdraw al,
FAS recep to r ligation, and exposure to low density lipoprotein, p hoto-oxidative
dam age, v itam in

E (in

p a rtic u la r a -to c o p h e ry l su ccin a te) and a sy n th etic

lysosom otrophic detergent, O -m ethyl-serine dodecylam ine hydrochloride (M SD H )
(Roberg et al., 1999; Kagedakl et al., 2001; A ntunes et al., 2001; Brunk and Svensson,
1999; Hellquist et al., 1997; Neuzil et al., 1999; Li et al., 2000).

Rupture of lysosom al m em branes is thought to result in the release o f many hydrolytic
proteases, fo r exam ple cathepsins, to the cytosol. C athepsins are proteases that are
present in nearly all anim al cells (R oberg et al., 1999). They have various functions,
however, their m ost interesting role in relation to the field o f apoptosis is their ability to
activate pro-caspases (G ardner et al., 1997). This activation may be upstream to the
m itochondrial release o f cytochrom e c (R oberg, 2001). The precise m echanism of
caspase activation by cathepsins is currently not known. Kagedal and associates (2001)
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suggest that cathepsin D may activate caspases directly, through proteolytic interaction,
or indirectly, through proteolytic attack on mitochondrial membranes, thereby ensuring
the release of pro-apoptotic factors. Also, cathepsin B was previously shown to
contribute to bile-salt induced apoptosis by a caspase-8-dependent process and is
thought to be involved in the activation of specific proinflam m atory caspases
(Guicciardi et al., 2000; Schotte et al., 1998).

Oxidative stress induces apoptosis in many cell lines. In fibroblast cells, oxidative stress
induces relocation of cathepsin D from lysosomes to the cytosol. This was observed to
be an early event, preceding other apoptotic changes, such as the release of cytochrome
c to the cytosol (Roberg et al., 1999). This sequence of events is consistent with
lysosomes being involved in the initiation of apoptosis. Recently, Antunes et al. (2001)
and Olejnicka et al. (1999) have reported lysosomal membrane rupture in Jurkat and
NIT-1 cells following exposure to hydrogen peroxide. A similar sequence of events to
that found in fibroblast cells was observed in both Jurkat and NIT-1 cells. Partial
lysosom al m em brane rupture was the initial event, follow ed by m itochondrial
depolarisation, cytochrome c release and activation of downstream caspases. These
events did not occur until 1-2 hours after the removal of hydrogen peroxide. Antunes et
al. (2001) noted that following treatment of Jurkat cells with hydrogen peroxide the
number of lysosomes decreased. This decrease is thought to result from a feed-back
loop, where the early release of lysosomal enzymes feed-back to activate further
lysosomal rupture. Interestingly, over-expression of Bcl-2 was found to inhibit this
feed-back loop and further apoptotic changes in J774 cells following oxidative stress. It
is possible that Bcl-2 somehow blocks down-stream events that result in later lysosomal
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rupture (Zhao et al., 2000) and cytochrome c release. Thus, this is another putative
function for Bcl-2 (see Section 1.6).

Until recently, it was agreed in much of the published literature that death caused from
lysosomal rupture was the result o f direct pro-caspase activation by lysosomal
proteases. However, some research groups were unable to detect caspase activation.
Vandenabeele’s group argue that the primary role of released cathepsins may be related
to an inflammatory response, as opposed to an apoptotic response. Their results suggest
that lysosomal proteases, in particular cathepsin B, efficiently process pro-caspase 1 and
11 (caspases involved in inflamm ation) but only weakly process the precursors of
caspase-2, -3, -6, -7 and -14. Stoka and colleagues (2001) have recently proposed an
alternative model in which proteases released from lysosomes following lysosomal
injury are involved in the activation of Bid. As previously discussed, Bid is a proapoptotic member of the Bcl-2 family that is typically activated by proteolysis. Stoka et
al. (2001) reported the ability of proteases, such as cathepsin D, to cleave and activate
Bid. Once Bid is activated, it is translocated from the cytosol to mitochondria, thereby
causing release of cytochrome c (Stoka et al., 2001). It is currently unclear if proteases
released from lysosomes directly activate caspases or specific members of the Bcl-2
family. It may be that both the activation of caspases and Bid by proteases are required
for the onset of apoptosis. Irrespective of the precise action of lysosomal proteases, the
recent literature strongly suggests that lysosomal rupture may (at least under some
conditions) be extremely important in the initiation of apoptosis. Figure 1.5 depicts a
hypothetical scheme of how early lysosomal rupture may initiate downstream apoptotic
events.
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Figure 1.5: Proposed pathway of lysosomal involvement in apoptosis. Under some
conditions, lysosomal rupture is thought to be an early event, preceding many apoptotic
events such as cytochrome c/AIF release and caspase activation. It has been suggested
that cathepsins may activate pro-caspases, thereby forming active caspases, or interact
with Bcl-2 proteins to induce apoptosis, however, the exact mechanism is not known.
Other undiscovered enzymes may also be involved (adapted from Zhao et al., 2000).

1.8

Cancer Therapeutics

As previously m entioned, dysfunctions of apoptosis have been im plicated in the
pathogenesis of many serious diseases, including cancer. Cancer is the second most
common cause of death in highly developed countries (Szekeres and Novotny, 2002).
For many years now, clinical treatment for cancer has typically involved chemotherapy,
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radiotherapy and surgery. Despite the extensive use of these therapies, there are still
many disadvantages associated with them, such as a lack of specificity that often causes
many harmful side effects (Luo and Prestwich, 2002). In addition, cell death caused by
chemo- and radiotherapy is through an indirect mechanism, that is, cell death results
from interference with DNA replication or metabolic processes, not by the direct
induction o f apoptosis (Baell and Huang, 2002). This m echanism of killing is
sometimes insufficient to kill all cancer cells and, furthermore, makes it possible for
cancers to develop radio-or chemo-resistant sublines that survive successive rounds of
treatm ent and ultim ately result in patient mortality (Ali et a l , 1999; Igney and
Krammer, 2002). Therefore, a need exists to develop therapeutic approaches that can
overcome these disadvantages.

Over the last five years, a diverse range of experimental therapeutic strategies have been
developed. Typically, these involve targeted delivery of anticancer drugs to cell surface
proteins specifically expressed by tum our cells. These types of approaches have
significant potential to improve efficacy and minimise toxicity to normal healthy cells
(Kreitm an, 1999; Trail and Bianchi, 1999; Luo and Prestwich, 2002). The most
promising strategies involve monoclonal antibody (Mab) fragm ents, hormones or
growth factors conjugated to drugs, toxins, radionuclides, enzymes, photosensitizers or
cytokines. A small number of these are being trialled clinically. For example, the use of
radio-labelled Mab 17-1A has resulted in improved survival of patients with Dukes C
collateral cancer (Trail and Bianchi, 1999), while immunotoxins using anti-CD22 and
anti-CD 19 Mabs have been used to target B-cell lymphoma and leukaemia (Kreitman,
1999). Immunotoxins are constructs of either a plant or bacterial protein toxin bound to
an antibody. Although these newly developed treatment methods signify a marked
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im provem ent in the area of cancer therapeutics, problem s involving specificity,
immunological reactions and the treatment of solid tumours still remain. Furthermore,
the majority of these new treatm ents require parallel treatm ents in order to be
successful.

A non-immunogenic complex that delivers the killing agent or toxin specifically to
cancer cells in order to directly activate apoptosis, in the absence of bystander cell
damage would be an ideal cancer therapeutic. C urrently, there are few cancer
therapeutics available that directly manipulate apoptosis. However, in the past few
years, cancer research has started to focus on therapeutic agents that directly affect the
apoptotic pathway. Mai et al. (2001) and Arap et al. (2002a) have recently reported a
novel peptide (comprised of a protein transduction domain) which, when coupled to an
antimicrobial peptide ((KLAKLAK)2 ) and injected, induces apoptosis. This conjugate,
known as D P I, has greater efficiency than other potential therapeutics such as the
immunotoxins. Unfortunately, disadvantages are still associated with it: for example (1)
it can’t be used alone, other therapies would still be required, and (2) it must be injected
directly into the tumour. Kessel and Horwitz (2001) also recently reported another
sy n th etic

a n ti-tu m o u r

ag en t,

X K 469,

(2 -[4 -(7 -c h lo ro -2 -q u in o x a lin y lo x y )

phenoxypropionic acid), which induces apoptosis in solid tumours in vitro. These
researchers suggested that this drug may induce apoptosis by interacting with the
peripheral benzodiazepine receptor (which is thought to form part of the PTP); however,
further experiments are required to confirm this.
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Potential Applications of Synthetic Polymers
in Cancer Therapy

Despite continued efforts to find more potent and selective compounds for treating
cancers, advances have been disappointing, particularly for the treatment of commonly
occurring solid tumours (Duncan, 1997). Major limitations include the inability to (1)
specifically target cancer agents to tumour sites, and (2) induce apoptosis only within
cancer cells. Ideally, cancer drugs need to be concentrated preferentially in tumour cells,
in order to maximise tumour cell death and minimise bystander cell damage.

In recent years many synthetic polymers have been investigated as potential drug
delivery agents for cancer therapy, some of which are currently in clinical trials. These
include pH-sensitive polymers, and HPMA (N-(2-hydroxypropyl)methacrylamide) and
SMA (poly(styrene-co maleic acid/anhydride)) polymers.

1.9.1

pH-Sensitive Polymers

Linhardt and Tirrell (2000) investigated the behaviour of three polymers from a family
of polymers referred as polyacrylic acids (Figure 1.6). These have a simple chemical
structure with a carbon backbone conjugated to either a methyl (polymethylacrylic acid
- PMAA), ethyl (polyethylacrylic acid - PEAA) or propyl side chain (polypropylacrylic
acid - PPAA).
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Figure 1.6: Chem ical structures of pH -sensitive polyacrylic acid polym ers (A)
polypropylacrylic acid (B) polyethylacrylic acid (C) polymethylacrylic acid (adapted
from Kim and Tirrell, 1999).

The most striking feature of these polymers is their ability to disrupt membranes in a
pH-sensitive manner. The pH is not constant throughout a cell for example, the pH
within an endosome is lower than that of the cytosol by 1 or 2 pH units, depending on
the stage o f endosom al developm ent (M urthy et al., 1999). A nti-tum our drugs
introduced into cells are trafficked from early endosomes to late endosomes and
eventually to lysosom es w here they are degraded (M ukherjee et al., 1997).
Unfortunately, this trafficking process prevents the release of the internalised drug into
the cell cytosol, inhibiting its cytotoxic action. Endosom e-destabilising peptides
(Tolstikov et al., 1997) and pH-triggered bispecific antibodies (Raso et al., 1997 a and
b) have previously been used to release internalised drugs into the cytosol. Linhardt,
Tirrell and associates suggest that the variation of pH in endosomes and lysosomes must
be considered when investigating possible delivery of cancer drugs in vivo (Linhardt et
al., 1999). They suggest that the use of pH-sensitive polymers, such as PEAA and
PPAA, would be ideal as part of a membrane-disruptive system which could enhance
the release of drugs from endosomes into the cell cytosol. Such polymers would need to
disrupt lipid bilayers at pH 6.5 and below but should be non-lytic at physiological pH
(pH 7.4) (Murthy et al., 1999).
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Despite the similar structures of PEAA, PMAA and PPAA, they have significantly
different pKa values (Stayton et al., 2000). This results in each of the polymers
disrupting membranes at different pH values (the “critical pH”). Linhardt et al. (1999)
suggest that control of the critical pH can be attained either by altering the properties of
the lipid bilayer or by variation of the polymer chain structure. Polymer side chains
have been modified in length and chemical composition (by copolymerisation with
methacrylic acid) (cited by Linhardt et al., 1999). In order to determine the critical pH,
initial experiments were conducted using red blood cells (RBC). Synthetic polymers
such as PEAA have also been shown to disrupt liposomes and synthetic vesicles (Meyer
et al., 1998; Hughes et al., 1996). With RBC, PPAA produces maximum haemolysis at
approximately pH 6.0, whereas maximum haemolysis for PEAA is reached at pH 5.0
(Stayton et al., 2000). On a molar basis, PPAA is 15 times more effective than PEAA at
pH 6.0 (Murthy et al., 1999).

Recently, Lackey and colleagues (1999) have demonstrated the ability of PPAA to
retain haemolytic ability following conjugation with streptavidin. PPAA-streptavidin
complexes not only retain the capacity to lyse RBC lipid bilayers at low pH but the
haemolytic activity is similar to that of unmodified PPAA (Lackey et al., 1999). The
ability of these synthetic polymers to lyse membranes at specific pHs and to retain this
function after conjugation could be valuable in the development of novel polymer-based
cancer therapeutics.

Another pH-sensitive polymer that has potential for use as a membrane-disruptive agent
is pDMAEM A. pDM AEM A was originally described by Van de W etering and
colleagues and has previously been used in gene therapy (Van de Wetering et al., 1999).
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The ability of pDMAEMA to deliver genes into cells is consistent with it doing this by
disrupting endosomes. The mechanism of putative pDM AEM A-mediated endosomal
disruption is probably different from that of PAAA. At physiological pH, the polymer is
partially protonated. However, Van de Wetering et al. (1999) suggests that, at low pH,
the polym er acts as a ‘proton sponge’. They propose that, when inside endosomes,
pDMAEMA causes massive ATPase-driven proton accumulation, which is followed by
passive chloride influx into the endosomes to prevent the build up of a charge gradient.
In this model water is then absorbed into endosomes as a result of the increased
osmolarity (due to the uptake of protons and chloride ions), causing osmotic swelling
and endosomal membrane rupture (Van de Wetering et al., 1999). However, there is no
direct experimental evidence to support this model. There are very few previous studies
that have examined the effects of pDMAEMA on intact cells. pDMAEMA has not
previously been conjugated to other com pounds, including anti-tum our agents. The
ability of derivitized pDMAEMA to disrupt endosomes remains unknown.

1.9.2

HPMA and SMA Polymers

In recent years, extensive research has implicated HPMA and SMA synthetic polymers
as potential cancer therapeutic agents, in particular for treating solid tumours (Maeda et
al., 2001; Duncan et al., 2001). In vivo, many cancer drugs, in particular those of low
molecular weight, rapidly penetrate many types of cells to cause extensive bystander
cell damage. Furthermore, these drugs can be quickly removed from circulation via the
action of the kidneys, thereby reducing tumour killing potential. Duncan (1997) and
Etrych (1999) have shown that conjugating a potent anti-tumour agent to a polymeric
carrier, such as HPMA or SMA, temporarily inactivates the drug and increases its
distribution in the body, as the conjugate can only gain entry into cells via endocytosis.
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The increased circulation of the drug-polym er conjugate results in enhanced
accumulation of the drug in tum ours and thus enhanced cancer cell killing. This
phenomenon is known as the enhanced permeability and retention effect (EPR - Figure
1.7) (Maeda et al., 2001; Duncan, 1997).

Figure 1.7: Schematic representation of the enhanced permeability and retention effect
(EPR). A. Due to the higher permeability of tumour blood vessels, the drug-polymer
conjugate is easily able to escape into the tumour. B. The low permeability of blood
vessels in normal tissue prevents the drug-polym er conjugate from escaping to areas
where it is not needed. C. Tumour tissues have poor lymphatic drainage and thus tend to
retain drug-polymer conjugate (adapted from Duncan, 1997; Duncan et al., 1996).

HPMA has been conjugated to a variety of drugs but the most promising is doxorubicin
(Dox), an anthracycline antibiotic with activity against a broad range of tumours
(Seymour, 1991). Duncan (1997) reported studies of the first Dox-HPM A conjugate.
HPMA and Dox were conjugated by a Gly-Phe-Leu-Gly-peptidyl side-chain, which is
cleaved intracellularly by lysosomal thiol-dependent proteases, releasing free Dox into
the cell. Proteases, like cathepsin B, are known to be present at higher levels in some
human tumours. The Dox-HPMA conjugate, now known as PK1, is a 25 kDa complex
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w hich successfully capitalises on the EPR effect to concentrate up to 70 tim es more
than free Dox in m ouse m elanom a tum ours in vivo (D uncan, 1997; Pimm et al., 1996;
reviewed by Luo and Prestwich, 2002). Pre-clinical tests revealed that PK1 was 5-10
times less toxic than free Dox and displayed im proved antitum our activity, particularly
in solid tum our models (Duncan et al., 1992; Ulbrich et al., 1996). In recent years, PK1
has been trialled on a broad range o f tum ours, fo r exam ple M AC 15A and M AC26
(Loadm an et al., 1999). These tum ours display distinctly different m orphology and
vasculature, leading to the suggestion that PK1 may have therapeutic potential fo r a
variety o f cancers. PK1 is currently undergoing Phase II evaluation fo r treatm ent of
breast, colon and non-small cell lung cancer (Duncan et al., 2001).

M any variations o f the sim ple PK1 construct, including changes in (1) the chem ical
bond used to produce the conjugate, (2) the overall mass o f the conjugate, and (3) the
structure and length of the spacers (U lbrich et al., 1996) have been m ade, in order to
improve the EPR effect and the toxicity to tum ours. Etrych et al. (2001) constructed a
conjugate between HPM A and Dox, using a hydrolytically unstable hydrazone linkage.
This spacer is stable under physiological conditions (pH 7.4) but is hydrolytically
degraded in mildly acidic environm ents (e.g. the lum en of endosom es at pH 5.0). Initial
in vitro experim ents indicate that the com plex is relatively stable at physiological pH
and that the drug activity increases under mildly acidic conditions (pH 5) (Etrych et al.,
2001). Com pared w ith PK1, this conjugate is significantly m ore efficient at treating
EL 4T -cell lym phom a in mice (Ertych et al., 2001).

here are now at least seven HPM A polym er-drug conjugates that have entered phase
M l clinical trials as anticancer agents, including N -(2-hydroxypropyl)m ethacrylam ide
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further 4 hours. For these latter ex p erim en ts, cells w ere analysed by confocal
microscopy and flow cytometry.

3.2.2.6

Identification o f Intracellular V esicles D isrupted by PAAA Polym ers

Im m unofluorescence assays were used to exam ine the m orphology and distribution of
both early and late endosom es and lysosom es follow ing endocytosis o f polym ers. This
enabled determ ination of the specific intracellular vesicle/s that the polym er/s disrupted.
M onoclonal antibodies reactive with early endosom al antigen 1 (E E A l), lysosom alassociated m em brane p rotein-1 (Lamp-1), and Golgin-97 were used. EE A l is thought to
only be associated with early endosom es. Lamp-1 is associated with various vesicles,
how ever, it seem s to predom inately accum ulate in late endosom es and lysosom es
(Akasaki, 1995). Anti-golgin-97 recognizes a 97 kDa protein called G olgin-97, which is
a m ember of the granin fam ily of proteins localised on the cytoplasm ic face of the Golgi
apparatus.

U937 cells w ere treated as described fo r m easuring the release o f calcein from
endosomal vesicles (section 3.2.2.3), except that calcein was deleted from the initial
incubation m ixture. Follow ing uptake, the cells were incubated for 4 hours at 37°C in
10% F B S /D M E M :F 12 b efo re p ro cessin g fo r im m u n o flu o resce n ce.

In som e

experim ents, polym ers w ere om itted from the initial incubation buffer but 70 //M
MSDH (an acidotropic detergent know n to disrupt lysosom es (Li et al., 2000)) was
added to the m edium used fo r the subsequent 4 hour incubation. The cells w ere then
centrifuged fo r 5 m in u tes at 3 0 0 g , resu sp en d ed in 0 .4 ml o f 4%

(w /v)

paraformaldehyde in PBS, pH 7.4, and incubated with shaking at room tem perature for
30

m inutes. T he fix ed cells w ere then w ashed w ith PBS and p erm eab ilised
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results, cited by Maeda et al., 2001). Also, encouragingly, SMANCS treatment has been
associated with minimal side effects, the major one being a low-grade fever.

1.10

Development of a Novel Cancer Therapeutic

The recent development of pH-sensitive polymers (section 1.9.1) and consideration of
what was known about apoptotic signal transduction pathways, particularly the
involvement of Bcl-2 family members (sections 1.3.2.1 and 1.4) and lysosomes (section
1.7), led to the formulation of two strategies that offered the potential to develop new
kinds of cancer therapeutics. These strategies were;
1. To test whether endocytosed pH-sensitive polymers would disrupt lysosomes
and thereby induce apoptosis.
2. If strategy 1. was not feasible, to begin development of a trimolecular construct
that was designed to be taken up by cancer cells via receptor-m ediated
endocytosis, and to subsequently release a pro-apoptotic peptide into the cytosol
where it would induce apoptosis.

These strategies are further elaborated below.

1.10.1

Lysosomal Destabilisation

As previously discussed, partial destabilisation of lysosomal membranes is thought to
be an early event in some apoptotic pathways. It was hypothesised that the gradual
decrease in pH in endosom es/lysosom es might cause (1) endocytosed PAAAs to
undergo a change to a m em brane-disruptive conform ation or (2) endocytosed
PDMAEMA to become a ‘proton sponge’ which would destabilise lysosomes and

36

C hapter 1

Introduction

release their lumenal proteases into the cytosol to induce apoptosis. These hypothetical
effect(s) of PAAAs and pDMAEMA on cells have not been studied before.

1.10.2

Development of a Pro-Apoptotic Trimolecular Construct

If polymer-mediated destabilisation of lysosomes is not feasible then the alternative
approach adopted will be to develop a trim olecular construct, incorporating three
components:
1. A killing peptide to induce apoptosis.
2. A targeting ligand that, by binding to a specific receptor on the surface of cancer
cells, induces receptor-mediated endocytosis.
3. An endosomal disruptive polymer that will release the construct from endosomal
vesicles into the cytosol.

Currently, very few cancer therapeutics target apoptosis directly. However, this is an
ideal mode of killing because apoptotic cells are naturally engulfed and degraded by
phagocytes, preventing the release of toxic cellular contents into adjacent healthy tissue.
Thus, apoptotic killing would (1) result in a reduced number of side effects, and (2)
eliminate potentially dangerous inflammatory reactions. Figure 1.8 depicts the proposed
construct.
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Figure 1.8: The proposed trimolecular construct. The construct is designed to enter the
target cell via receptor-mediated endocytosis. Once inside the endosome/lysosome, the
polymer and the pH-sensitive linker are designed to facilitate release of a pro-apoptotic
peptide into the cytosol.

In theory, this construct offers many potential advantages compared to other cancer
therapeutics, including (1) efficient cell killing (i.e. direct induction of apoptosis in
target cells), (2) high specificity - the combination of the action of the targeting ligand
and the tendency of the polymer to accumulate at sites of solid tumours (via the EPR
effect) would significantly reduce bystander cell damage, and (3) repeated cycles of
treatment will be feasible, due to the construct being poorly immunogenic. A proposed
pathway of action for the trimolecular construct is schematically represented in Figure
1.9.
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Figure 1.9: Proposed pathway of action of the trimolecular construct on a target cell. It
is hypothesised that the construct will enter the cell via receptor-mediated endocytosis.
Once inside an acidified endosome, the linker between the killing peptide and the
polymer will be cleaved and the polymer will disrupt the endosomal membrane. The
released killing peptide will then target mitochondria and induce apoptosis.

1.10.2.1

Pro-apoptotic Peptide

Bcl-2 family members are known to play an important role in the release of cytochrome
c from mitochondria, to initiate downstream apoptotic events. In recent years, it was
discovered that the BH3 domain is critical for hetero-dimerisation of Bcl-2 family
members and appears to be essential for death promoting activity (Polster et al., 2001).
Since this discovery, many BH3 peptides have been developed as potential apoptosis
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inducing agents. The Bad(140-I65) peptide, developed by Kelekar et al. (1997) was one
of the first BH3 peptides to be synthesised. In vitro experim ents showed that this
peptide binds to Bcl-xLand induces characteristic features of apoptosis. Truncated forms
of pro-apoptotic Bak and Bax consisting of only the BH3 region are also sufficient to
induce apoptosis and antagonise the effects of anti-apoptotic members of the Bcl-2
family of proteins in prostate carcinoma cell lines (Finnegan et al., 2001). Finnegan and
co-workers believe that BH3 peptides interact with Bcl-2 at sites where pro-apoptotic
proteins normally bind, thereby inhibiting binding of Bak and Bax-like proteins. As a
result, BH3 peptides promote the formation of pro-apoptotic Bak/Bax homodimers,
thereby inducing cell death. Polster et al. (2001) recently developed a Bax peptide,
comprised of amino acids 53-86 that includes the BH3 domain.

Theoretically, if used in vivo to induce apoptosis of cancer cells, pro-apoptotic peptides
have several advantages when compared with other toxic agents. Firstly, pro-apoptotic
peptides must be introduced into the cytosol to have a cytotoxic effect. Since the peptide
is membrane impermeable, it can ’t easily enter the cytosol of non-target cells, thus
limiting damage to adjacent, healthy cells. Second, once in the cytosol of a target cell,
the peptide will remain there until it is naturally degraded (or the target cell membrane
loses integrity). Finally, systemic exposure to the peptide is unlikely to elicit an immune
response as it represents a human amino acid sequence. Therefore, a variety of recently
developed BH3 peptides could be used as suitable killing agents in the proposed
trimolecular construct.

To confirm that Bcl-2 peptides induce apoptosis in intact cells, processes associated
w,th apoptosis (e.g. MPT) must be measured. Two techniques have previously been
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employed to measure MPT in intact cells, however both have significant disadvantages.
Therefore a need exists for the development of a method to measure MPT in intact cells
that is free of the disadvantages associated with the other techniques. The development
of a novel technique to measure MPT in intact cells is discussed in chapter 6.

1.10.2.2

Targeting Ligand

Receptor-mediated endocytosis (RME) is the process by which a ligand makes contact
with a specific receptor on the cell surface and elicits internalisation of the ligand within
the cell. This type of uptake is highly efficient when cells display a high density of
ligand-specific receptors (Duncan et al., 1996). Many receptors, including those for
transferrin, low -density lipoprotein and growth factors have been proposed as
candidates for tumour targeting and used in many experiments. The transferrin receptor
has frequently been used in these studies. Transferrin is a 77 kDa human blood
glycoprotein with a broad cellular distribution. It regulates iron availability in the body
and mediates the transport and uptake of iron into cells, via RME (Ali et al., 1999; Luo
and Prestwich, 2002). The number of transferrin receptors on the cell surface is in direct
relationship to the amount of iron required by a cell. The iron requirement of most
human cells is generally minimal hence few transferrin receptors are present on the
plasma membrane. However, it has been found that rapidly dividing cells, like cancer
cells, express transferrin receptors at significantly higher levels. This has led to the
proposal that the transferrin uptake pathway could be exploited for targeted delivery of
chemotherapeutic agents in vivo (Ali et al., 1999). Thus, transferrin would be a suitable
prototype for initial studies.
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Synthetic Polymer

Following RME, the trimolecular construct must be released from the endosome into
the cytosol in order to cause mitochondrial changes and induce apoptosis. Non-viral (i.e.
immunological compatible in vivo) and inexpensive endosomal disruptive agents would
be ideal to use in the proposed trimolecular construct. Synthetic polymers, such as
PAAAs and pDMAEMA have been suggested as possible endosomal disruptive agents.

1.10.2.4

Covalent Linkage Between Polymer and Peptide

It is likely that a pro-apoptotic peptide will have to be released from the construct to
allow it to act on mitochondria and induce apoptosis. A wide variety of linkers that
facilitate peptide release have previously been employed. The most popular are (1)
spacers that are degraded by proteases such as cathepsins, and (2) a pH-sensitive linker
that releases the drug on entry into acidic endosomes or lysosomes. Various acidsensitive linkages, including the carboxylic-hydrazone, the c/s-aconityl and the trityl,
have been investigated (Kratz et al., 1999). The carboxylic-hydrazone linkage system is
the most extensively used and has produced promising results (Kratz et al., 1999). This
type of linkage will be used in the initial studies described in this thesis.

1.11

Aims

The aims of this thesis were to:
1. Determine if any of the available pH-sensitive polymers can disrupt lysosomal
membranes and thereby directly induce apoptosis.
If the polymers tested were incapable of this, then proceed to:
2. Identify the most efficient endosomal-disruptive polymer.
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3. Synthesise a hydrazide pH-sensitive linker and conjugate it with an endosomaldisruptive polymer.
4. Conjugate a linker-derivatised endosom al-disruptive polym er with a proapoptotic peptide.
5. Determine if the conjugate produced in 4. induces apoptosis in cultured cells.
6. Develop an improved technique to directly measure mitochondrial permeability
transition in intact cells.
If results from 5. are promising, then (if time permits)
7. Conjugate transferrin to the conjugate formed in 5. (to form a trim olecular
construct) and test its ability to be internalised via RME and kill cancer cells via
apoptosis.
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This chapter contains general materials and methods that were used throughout the
work described in this thesis. O ther chapter-specific materials and m ethods are
described in the corresponding chapters.

2.1

Materials

Many general chemicals were purchased from Sigma (MO, USA). Details of chemicals
purchased elsewhere are provided below.

2.1.1

Tissue Culture

D ulbecco’s M odified Eagles M edium: Hams F-12 (DM EM :F12) was from Life
Technologies (MD, USA) and Foetal Bovine Serum (FBS) and Trypsin-EDTA were
from Trace (Melbourne, Australia). N aH C 03 was from Ajax (Sydney, Australia) and
HEPES was from United States Biochemical Company (USB, OH, USA). M ost cell
lines used were obtained from the American Type Culture Collection (ATCC, MD,
USA) and included: Jurkat (human leukemia T cells), U937 (human myelomonocytic
cell), HL60 (human prom elocytic leukim a cells) and HeLa (human epitheloid
carcinoma cells). Hek 293 (human embryonic kidney) cells were a kind gift from P.
Poronick (U niversity of Sydney, Sydney, Australia). Sterile Greiner Labortechnik
plasticware was obtained from Interpath Services (Melbourne, Australia).

2.1.2

Purification of Annexin V

Acrylamide, tris(hydroxym ethyl)am inom ethane (Tris), and glycine were from ICN
Biochemicals (Sydney, Australia). Bradford reagent, ammonium persulphate, FITC
(fluorescein isothiocyanate), N ,N ,N ',N ’-tetramethylethylenedaime (TEMED) were from
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Sigma (Syndey, A ustralia). N ,N ’m ethylene-bis-acrylam ide and sodium dodecyl
sulphate (SDS) were from BDH (Dorset England). Annexin-V-FLUOS was from Roche
(IN, USA). N -(2-hydroxyethyl)piperazine-N ’-(2-ethanesulfonic acid) (HEPES) was
from United States Biochemical Corp. (OH, USA). DEA E-Sephacel was from
Amersham Biotech (Melbourne, Australia). The Econo pump system was purchased
from Bio-Rad (Sydney Australia). Ultrafree concentration devices were from Millipore
(MA, USA). Hoeffer Scientific “Tall-M ighty-Small” Minicell (CA, USA) was used for
electrophoresis of proteins. All other chemicals were of reagent grade and were from
either Sigma (Syndey Australia) or Ajax Chemical Co. (Sydney Australia).

2.2

Methods

2.2.1

Tissue Culture

Cells were cultured in com plete m edium , consisting of DM EM :F12 medium
supplemented with 10% (v/v) FBS. The cells were incubated in a Forma Scientific
humidified incubator at 37°C and 5% (v/v) COz. Passage of suspension cells involved
most of the culture being discarded and replaced with complete medium twice a week.
Passage of adherent cells was conducted similarly except that all the culture medium
was discarded. Pre-warmed, sterile trypsin-EDTA was then added to the flask, ensuring
that the base of the flask was covered. Cells were then incubated (37°C and 5% (v/v)
C 0 2) for 2-3 minutes or until most of the cells became suspended. Following this,
trypsin-EDTA was discarded and replaced with complete medium. All procedures were
carried out in a laminar flow hood with sterile techniques and reagents.
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Flow Cytometry

A Becton Dickinson (CA, USA) FACSort flow cytometer and CellQuest software
(version 3 .If) were used to analyse cells. A flow cytometer is an instrument used to
analyse large numbers of cells collecting information about the size, granularity and
fluorescence of each cell (Darzynkiewicz and Li, 1996). In the FACSort, cells are
delivered upwards in a stream of liquid and are intercepted by a laser that excites the
cells at 488 nm. As shown in Figure 2.1 the signals produced include forward scatter
(FSC, relating to the size of the cell), side scatter (SSC, measuring the granularity of the
cell), and three different fluorescent signals: FL1 (green fluorescence), FL2 (orange
fluorescence) and FL3 (red fluorescence), all of which are measured by dedicated
detectors (Darzynkiewic and Li, 1996). A series of three dichroic mirrors allows for the
detection of three fluorescent signals. D ichroic m irrors discrim inate between
wavelengths, allowing specific wavelengths to pass through but reflecting others (Carter
and Meyer, 1994; Mechtold and Radbruch, 1992).
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Figure 2.1: A schematic diagram of the operation of a flow cytometer. A stream of cells
is intercepted by a laser beam. The size, granularity and fluorescence of each cell are
measured.

2.2.3

Confocal Microscopy

A Leica TCS SP confocal m icroscope mounted on a Leica DM IRBE inverted
microscope (Leica M icrosystems, Heidelberg, Germany) was used to analyse cells.
Confocal microscopy is used to image either fixed or living tissues that have been
labelled with one or more fluorescent probes. Confocal microscopes are built around a
conventional microscope but use lasers rather than a lamp for a light source. They also
have sensitive photom ultiplier tube detectors (PMTs) that detect the points of light
produced by the specimen and a com puter to control the scanning mirrors and to
facilitate the collection and display of images (Paddock, 1999). Images are subsequently
stored and analysed via software. Leica TCS NT software was used (Version 1.6.587:
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Leica M icrosystem s, H eidelberg, G erm any). The im ages produced have greater
resolution than those achieved by conventional microscopy. In all confocal image
analyses signals collected were adjusted to remain within the linear range of the
detectors.

2.2.4

SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE)

A Hoeffer Scientific “Tall-M ighty-Small” vertical slab-casting unit connected to a BioRad model 1000/500 power supply was used for electrophoresis. Melted agar (1%) was
used to seal the bottom of the chamber. The separating gel (10% acrylamide) was
placed in the cham ber and allowed to set. The stacking gel was then added to the
chamber. Immediately following loading of the stacking gel, a comb (used to form the
sample wells) was placed in the top of the chamber. The stacking gel was then left to
solidify while the comb was in place. Once the stacking gel was set, the comb was
removed and the chamber placed in the electrophoresis unit.

For each sample, approximately 10 /^g of protein in PBS was mixed with an equal
volume of sample buffer. Samples were then boiled for 5 minutes before loading into
the wells. Running buffer (250 mM TRIS, 1.9 M Glycine, 1% SDS) was subsequently
poured into the buffer chambers before the gel was electrophoresed at a constant 180 V
until the dye front had reached the bottom of the gel (approximately 2 hours). Following
completion of electrophoresis, gels were placed into a Coomassie Blue staining solution
(0.1% Coomassie Blue, 40% methanol, 10% glacial acetic acid) and left to stain, on a
platform rocker, for 1 to 1.5 hours. Gels were then destained using ‘destain’ solution
(50% methanol, 50% glacial acetic acid) until the bands were clearly visible (data not
shown).
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Bradford Assay

To a clean 96-well microtitre plate, 100 fi\ of BSA protein standards were added to the
wells in the first three columns (setting up a triplicate series), in order of increasing
concentration (i.e. from 0.05 mg/ml to 1 mg/ml) down the plate. To the next three
columns, a series of binary dilutions of the “unknown” protein sample was performed
down the plate (giving a final volume of 100 //1/well). To each well, 100 //I of Bradford
reagent was added and mixed. The plate was incubated at room temperature until a blue
colour developed in wells containing protein (usually between 5 and 60 minutes). The
plate was subsequently read at 595 nm using a spectrophotometer. A plot of absorbance
versus concentration for the BSA standards was generated and used to interpolate the
concentration of “unknown” proteins.

2.2.6

Purification of Annexin V from Chicken Liver

Crude annexin V protein, isolated from chicken liver, was supplied by a previous
colleague. It was isolated by homogenisation and density gradient centrifugation as
described by Boustead et al. (1993). The crude annexin V protein was then purified by
ion-exchange chromatography. A DEAE-Sephacel column was connected to an Econo
pump system, including UV detector and chart recorder (running speed 2 cm/h). The
column was equilibrated with 20 mM HEPES buffer pH 7.4. Following equilibration,
the crude annexin V solution was passed over the column. The unbound protein was
eluted and a linear gradient of 0-0.6 M NaCl in 20 mM HEPES buffer pH 7.4 was
applied to the column. The column was eluted at 1 ml/min and 5 ml fractions were
collected. Elution of annexin V was expected at 0.1 M NaCl (Clarke, 1998). Fractions
were analysed by SDS PAGE (section 2.2.4) and annexin V was identified based on
molecular w eight. Fractions containing annexin V w ere pooled together and
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concentrated, using Ultrafree concentration devices (cut off 20 kDa) to a final volume of
1.5 ml. The final concentration of the purified annexin V protein was determined by a
Bradford protein assay (section 2.2.5).

2.2.7

Conjugation of Annexin V with FITC

An aliquot of a stock solution of FITC (40 mg/ml in DMSO) was added to the protein to
give a final concentration of 250 /yg FITC per mg of protein. The reaction mixture was
then incubated (protected from light) at room temperature for 2 hours on a platform
rocker. Following incubation, the reaction mixture was placed in dialysis tubing and
dialysed against several changes of PBS, pH 7.4, over 24 hours. Unconjugated FITC
was removed from the reaction mixture by dialysis performed at 4°C protected from
light. The protein concentration and the substitution ratio were determined by taking
Azgo and A295absorbance readings of the dialysed protein.

The protein concentration and substitution ratio (S.R.) were determined using the
following formulas, respectively.

Iprotein] mg/ml = A280 - (0.35 x A495)

S.R. =

A 280 —(0.35 x A495)

2.2.8

2.87 x A495
A280 —(0.35 x A495)

Staining Cells with Annexin V-FITC

Annexin V labelling solution was made by diluting 1:100 annexin V-FITC in annexin V
buffer (10 mM HEPES, pH 7.4, 140 mM NaCl, 5 mM CaCl2). lxlO 6 cells were
centrifuged at 300 g for 5 minutes. The cells were resuspended in 1 ml of lx PBS and
re-centrifuged. Cells were then drained thoroughly and resuspended in 50 jaI of the
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annexin V labelling solution, followed by a 15 minute incubation at room temperature
in the dark. Immediately before flow cytometric analysis of the cells, 500 |al of annexin
V buffer was added to the cells. FSC, SSC and FL1 signals were acquired. Increased
exposure of phosphatidylserine (PS) on the surface of the cells was measured by an
increase in FL1. M anufacturer's instructions were followed when cells were stained
using annexin-V-FLUOS.

2.2.9

Comparison of Annexin-V-FLUOS and Purified Annexin
V Conjugated to FITC

The ability of purified annexin V conjugated to FITC (annexin V-FITC) to detect
exposed PS was compared to annexin-V-FLUOS (commercial annexin V-FITC). U937,
HL60 and Jurkat cells were induced to undergo apoptosis using three different stimuli,
respectively: T N Fa/cyclohexim ide (10 ng/ml and 10 /^g/ml respectively, 4 hours),
etoposide (20 /^g/ml, 6 hours) and a-F as antibody (100 ng/ml, 4 hours). Following
incubations, cells were stained with either annexin-V-FLUOS or annexin V-FITC. Cells
were also stained with PI to ensure that only viable cells were analysed (see section
3.2.2.1). All experiments were performed in triplicate to ensure reproducibility. In all
cases, annexin V-FITC and annexin V-FLUOS gave comparable detection of exposed
PS. The results shown in Figure 2.2 are representative.
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Control

Annexin
V-FITC

Annexin
V-FLUOS

U937

C/3

Jurkat

U

HL60

FITC-Annexin V (Green Fluorescence)
M l values (%)

Control

Annexin V-

Annexin V-FITC

FLUOS
U937

4.79

83.07

81.81

Jurkat

10.56

33.22

36.76

HL60

8.22

60.39

63.18

Figure 2.2: Flow cytometry histograms showing comparisons of annexin V-FLUOS
(commercial annexin V-FITC) and annexin V-FITC. Comparable detection of PS,
detected as an increase in FL1 fluorescence, was found for both reagents in all cases
(see table).
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Poly(2-Alkylacrylic Acid) Polymers
Deliver Molecules to the Cytosol by pHDependent Disruption of Endosomal
Vesicles
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PAAAs

Introduction

In recent years, many attempts have been made to improve cancer therapy, for example,
by the developm ent of synthetic polym ers as m acrom olecular carriers. Synthetic
polymers have significant potential for the delivery of molecules and drugs to cells both
in vitro and in vivo. They offer several advantages in therapeutic situations, including
(1) increased plasm a half-life (because their size is above that required for renal
exclusion), (2) controlled release of the drug at lower drug doses, and (3) enhanced
accumulation of drugs at sites of solid tumours (due to the “enhanced permeability and
retention” effect) (Luo and Prestwich, 2002).

Poly(2-alkylacrylic acid) (PAAA) polymers have recently been suggested as a possible
delivery agent for anti-cancer drugs. Three PAAA polymers have been synthesized.
Polypropyl(2-alkylacrylic acid) (PPAA), poiyethyl(2-alkylacrylic acid) (PEAA) and
polym ethyl(2-alkylacrylic acid) (PM AA) are distinguished by the length of the
hydrocarbon side chain. To date, few studies have examined the effects of PAAAs on
intact cells. Murthy et al. (1999) have reported the ability of these polymers to disrupt
red blood cells in a pH-dependent manner. The precise molecular mechanism(s) by
which these polymers disrupt lipid bilayers is not known, although it is thought that the
polymer undergoes a conformational transition from an expanded coil shape to a more
complex shape upon acidification (Linhardt et al., 1999). This change in conformation
is most likely related to the increased hydrophobic character when the many carboxylate
ions become protonated at low pH. At low pH, partitioning of the polymer into cell
membranes increases significantly, resulting in membrane rupture (Murthy et al., 1999).
Cheung et al. (2001) have also shown that when PPAA is incorporated into lipoplexes
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(mixtures of lipids, DNA and PPAA) formed with dioleyltrimethylammonium propane
(DOTAP) it facilitates the delivery of genes into cells.

Currently, the effects of PAAAs on nucleated mammalian cells are not known. It has
been hypothesised that PAAAs may be endocytosed by cells into acidified vesicles and
are there triggered by low pH to disrupt endosomes and release their contents to the
cytosol. However, the ability of PAAAs to disrupt specific endosomal compartments,
and the pH dependence of this action, has not previously been measured.

The following chapter investigates the effects on cells of constitutively endocytosed
PAAAs. Cells continually endocytose materials and particles from their extracellular
environment. The cell membrane invaginates and forms specific vesicles called early
endosomes. The contents of early endosomes then transit to more acidic compartments,
late endosomes and lysosomes. The toxicity and pH-dependent lytic activity of each
polymer was initially determined. Further investigations were carried out to (1) test the
ability of PAAAs to disrupt endosomes and/or lysosomes in cultured human cells, and
(2) determine whether this action was dependent upon vesicle acidification. Similar
studies of pDMAEMA were also carried out; these results are presented in chapter 4.
We predicted that if the PAAAs disrupted lysosomal membranes, apoptotic death would
result (see section 1.7). Many independent research groups have shown that partial
lysosomal rupture induces apoptosis; enzymes released from lysosomes are thought to
produce this effect by interacting with proteins associated with mitochondria (Brunk
and Svensson, 1999). If the PAAAs disrupt lysosomes and induce apoptosis it is
feasible that they could themselves be used as cancer therapeutics.
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Materials and Methods

3.2.1

Materials

Poly(2-alkylacrylic acid) (PAAA) polymers were supplied by P. Stayton (University of
Washington, WA, USA). Lipofectamine was from Invitrogen (Melbourne, Australia).
Propidium iodide, acridine orange, bafilomycin and calcein were from Sigma (MO,
USA). M onoclonal antibodies reactive with early endosom al antigen 1 (EEA1),
lysosom al-associated m em brane p ro tein -1 (Lam p-1) and G olgin-97 were from
Pharmingen-Transduction Laboratories (CA, USA). Alexa 488-conjugated goat-antimouse Ig, streptavidin-A lexa 546 and LysoTracker Yellow DND-68 were from
Molecular Probes (OR, USA). O-methyl-serine dodecylamide hydrochloride (MSDH)
was a kind gift from G. Dubowchik (Bristol-Myers Squibb. CT USA). The pEGFP-Nl
plasmid, encoding enhanced green fluorescent protein, and the pCM Vp plasmid,
encoding |3-galactosidase, were obtained from Clontech (CA, USA). The pCat-EGFP
plasmid, encoding green fluorescent protein was a generous gift from G. Gores (Mayo
Medical School, M innesota, USA). All other chemicals were of reagent quality and
were obtained either from Sigma Chemical Co. (MO, USA) or Ajax Chemical Co.
(Sydney, Australia).
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3.2.2

Methods

3.2.2.1

Viability of Cells Following Constitutive Endocytosis o f Synthetic
Polymers

The cytotoxicity of endocytosed PAAAs is unknown. The viability of cells was
determined by staining cells with propidum iodide (PI), at intervals during 24 hours
following uptake of PAAAs. PI is a cell-im permeant fluorescent stain. Loss of cell
viability coincides with a decrease in membrane integrity, allowing PI to enter the cell
and stain the DNA, which is detected as an increase in red fluorescence.

Cells (2 x l0 6) were centrifuged (5 minutes, 300 g) and resuspended in 500 /A of polymer
buffer (PB, 145 mM NaCl, 5 mM KC1, 0.5 mM HEPES) containing 200 /*g/ml polymer
(added from a stock solution of 2 mg/ml in 0.1 M NaOH). Cell suspensions were
incubated for 30 minutes at 37°C and then washed 3 times with DMEM:F12 before
being resuspended in 10% FBS/DMEM:F12. Cells were then incubated for 24 hours at
37°C. Cell viability was determ ined at 2, 4, 8 and 24 hours, following the initial
incubation with polymer. Imm ediately before flow cytom etric analysis, cells were
stained with PI (1 //g/ml). 10,000 cells were analysed for each sample and FSC, SSC
and FL3 signals were collected.

3.2.2.2

Confirming Endocytic Entry of Polymers into Cells

Endocytosis is the process by which all mammalian cells internalise macromolecules
and particulates from the extracellular environment. Internalised materials are initially
held within vesicles known as early endosomes. We reasoned that PAAAs, internalised
by endocytosis, would be localised in early endosomes. To confirm this, we traced the
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initial movements of PEAA through the cell. This was achieved by biotinylating PEAA
(b-PEAA, details below) and staining permeabilised cells with anti-EEA l antibody
(EEA1 is used for the detection of early endosom es). b-PEAA was detected by
streptavidin-Alexa 546 and anti-EEAl antibody was detected by Alexa 488-conjugated
goat anti-mouse Ig antibody.

PEAA was biotinylated as follows; 5.1 mg PEAA was dissolved in 0.5 ml anhydrous
dimethylsulfoxide (DMSO). This was mixed with biotin-x-hydrazide (0.7 mg dissolved
in 0.5 ml anhydrous DMSO and 2 mg of 4 ’dim ethylam inopyridine (DMAP)). This
mixture was then mixed with 2.7 mg of N ,N ’-dicyclohexylcarbodiimide (DCC) on a
shaker for 2 hours at room temperature. The solution was diluted with 10 ml of 0.1 M
NaOH and incubated for a further 10 minutes at room temperature. The precipitate was
then collected by filtration and 1 ml of 3 M sodium acetate was added (pH
approxim ately 4.5). This m ixture was then incubated for 10 m inutes at room
temperature to allow a precipitate to form, and filtered through a glass filter. The
precipitate was washed with 3x1 ml of 60 mM sodium acetate (pH 5), filtered again and
air dried, giving biotin-x-PEAA as a product.

Biotin-x-PEAA (2.3 mg) was dissolved in 100 pi\ of DMSO. U937 cells were
centrifuged (5 minutes, 300 g) and resuspended in 500 ml polymer buffer containing
200 /*g/ml of biotin-x-PEAA and incubated for 30 minutes at 37°C. The cells were then
centrifuged fo r 5 m inutes at 300 g , resuspended in 0.4 ml o f 4% (w/v)
paraformaldehyde in phosphate buffered saline (PBS), pH 7.4, and incubated with
shaking at room temperature for 30 minutes. The fixed cells were then washed with
PBS and permeabilised by incubation with 0.4 ml of 0.5% (v/v) triton X-100 in PBS for
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15 minutes on ice. Fixed, permeabilised cells were washed with 0.1% (w/v) bovine
serum albumin (BSA) in PBS (0.1% BSA/PBS), then suspended in 50 //I of anti-EEAl
antibody (diluted 1:50 in 1%BSA/PBS) and incubated on ice for 1 hour. The cells were
then washed with BSA/PBS, suspended in 50 //I of goat-anti-m ouse Ig-Alexa 488
(diluted 1:50 in 1% BSA/PBS) and streptavidin Ig-Alexa 546 (diluted 1:50 in 1%
BSA/PBS). Cells were then incubated on ice for 1 hour. Finally the stained cells were
washed with PBS and examined by confocal microscopy. Cells were excited at 488 and
543 nm and fluorescence collected simultaneously using emission windows set at 500540 nm and 550-600 nm.

3.2.2.3

M easuring Polym er-M ediated Release of Tracer M olecules from
Intracellular Vesicles

Endocytosed m olecules are transported w ithin cells via a series of vesicular
compartments, namely endosomes and lysosomes. Vesicular traffic can be traced using
fluorescent markers. Calcein, a 622 Da membrane-impermeable fluor, was used as a
tracer molecule to follow the uptake of external medium by constitutive endocytosis,
and, in turn, trace the effects of synthetic pH-dependent polymers on internalised
vesicles.

In these experiments, 2 x l0 6 U937 cells were centrifuged for 5 minutes at 300 g. Cells
were resuspended in 0.5 ml of polymer buffer (PB) containing 2 mg/ml calcein with or
without the addition of polymers from stock solutions at 6 mg/ml in 0.1 M NaOH.
Following the addition of the polym er, and prior to adding to cells, the pH of
PB/calcein/polym er solution was re-adjusted to pH 7.4. Cell suspensions were
incubated for 30 minutes at 37°C and then washed 3 times with DMEM:F12 before
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being resuspended in 10% FBS/DMEM:F12. Subsequently, the distribution of calcein
within cells was examined by confocal microscopy. Cells were excited at 488 nm and
fluorescence collected using an em ission window set at 500-540 nm. In some
experiments, calcein distribution was determined each hour over a 4 hour time period.

The TCS NT software was also used to calculate the average pixel intensity of calcein
fluorescence within regions of interest (ROI) drawn onto collected images. In these
cases, for each treatment, images of 15-25 individual cells were analysed as follows.
For each cell, the mean fluorescence intensity was determined for three ROI drawn to
represent (1) cytoplasm (these were drawn to exclude any calcein-containing vesicles),
and (2) background (drawn outside the cell). The values for each set of three ROI were
averaged. The mean background value was then subtracted from the mean value for
cytoplasm and the results for each cell obtained in arbitrary fluorescence units.
Differences between treatments were analysed using Oneway ANOVA (JMP software,
v3.0.2, SAS Institute Inc., Cary, NC, USA).

3.2.2.4

Transient Transfection o f Hek293 Cells with a Plasmid Encoding
Cathepsin B-EGFP Fusion Protein

Cathepsin B (Cat B) is a 38 kDa lysosomal cysteine protease, primarily involved in
protein degradation within lysosomes. Roberts et al. (1997) constructed a plasmid
encoding a fusion protein comprised of rat Cat B fused at its C terminus to an enhanced
green fluorescent protein (EGFP). A rat cDNA fragment containing the coding sequence
for amino acids 1-334 of rat Cat B was excised from the pRSG-2A vector and ligated
into the pEGFP-Nl expression vector, which has a multiple cloning site adjacent to its
EGFP sequence (Cat-B-EGFP). Transfection of this plasmid DNA into mammalian
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cells was used to show that cat B is translocated to the nucleus during bile salt-induced
apoptosis (Roberts et al., 1997).

To determine if synthetic polymers release macromolecules from endosomes, Hek293
cells were transiently transfected with Cat-B-EGFP prior to polymer loading. Hek293
cells were seeded into 6 well plates (2 x l0 5 cells in 2 ml of 10% FBS/DMEM:F12 per
well) and incubated for 24 hours at 37°C. Cells were then transfected with either
pEGFP-Nl (used as a control) or Cat-B-EGFP, using lipofectAMINE, according to the
m anufacturer’s instructions (Invitrogen, M elbourne, A ustralia). Seeded cells were
washed with 2 ml of serum-free medium (SFM). 200 /d of transfection mixture (24 //I
plasmid DNA/transfection, 18 /d lipofectAM INE reagent and 158 /d SFM) was then
added to each well. Cells were then incubated for 5 hours at 37°C in a 5% C 0 2
incubator. The transfection mixture was subsequently removed and replaced with 2 ml
of com plete medium. Cells were assayed for gene expression by confocal and
epifluorescence microscopy at 48 hours post transfection.

Once expression had been confirmed, complete medium was removed and replaced with
500 /d of PB containing 50 /.<g/ml of PPAA. The cells were then returned to a 37 °C, 5%
C 0 2 incubator and 2 and 4 hours later analysed by confocal microscopy for the release
of Cat-B-EGFP to the cytosol.

3.2.2.5

Determ ining if Polym er-M ediated Endosom al Disruption is pHDependent

The ability of PAAAs to disrupt membranes in a pH-dependent manner was determined
using three assays. Each assay is described below.
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1. Whole cell experiments were conducted to determine the ability of PAAAs to disrupt
membranes in a pH-dependent manner. Cells were incubated in different buffers at
various pH levels in the presence of 200 ^g/m l of polymer. The pH-dependence of
membrane-lytic activity was determined by measuring the proportion of non-viable
cells at different pHs. lxlO 6 U937 cells were pelleted and resuspended in 400 /d of 100
mM MES buffer (100 mM NaCl, 100 mM MES, 5 mM KC1) at various pH levels. The
pHs used were 5, 5.5, 6, 6.5 and 7. PPAA, PEAA or PMAA was added from a 10 mg/ml
stock solution in 0.1 M NaOH, to give a final concentration of 200 /^g/ml (no additions
were made to the control tubes). The samples were then incubated at 37°C for 30
minutes and stained with propidum iodide (PI) immediately before flow cytometric
analysis. For each sample, FL3 (red fluorescence) was acquired for 10 000 cells.

2. Bafilomycin was then used to determine the ability of PAAAs to disrupt membranes
in a p H -d ep en d en t m anner.

B afilo m y cin

is a sp ecific

in h ib ito r o f the

endosomal/lysosomal H+-ATPase (Ohkuma, 1993). H+-ATPase is responsible for the
acidification of endosomes. In these experiments, 1 mM bafilomycin was added to cell
suspensions during calcein uptake (section 3.2.2.3) and the subsequent 4 hour
incubation.

3. Finally, the ability of PAAAs to disrupt membranes in a pH-dependent manner was
determined by increasing the concentration of Hepes buffer in the PB; this is known to
alkalinize the contents of endosomes (Sullivan, 1987). In these experiments calcein was
again constitutively endocytosed into cells as described in section 3.2.2.3. Control cells
were incubated in 0.5 mM Hepes-buffered PB (that had been adjusted to an equivalent
osmotic pressure by the addition of 75 mM sucrose) and PAAA-exposed cells were
incubated in 50 mM Hepes-buffered PB. Following uptake, cells were incubated for a
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further 4 hours. For these latter experim ents, cells were analysed by confocal
microscopy and flow cytometry.

3.2.2.6

Identification o f Intracellular Vesicles Disrupted by PAAA Polymers

Immunofluorescence assays were used to examine the morphology and distribution of
both early and late endosomes and lysosomes following endocytosis of polymers. This
enabled determination of the specific intracellular vesicle/s that the polymer/s disrupted.
Monoclonal antibodies reactive with early endosomal antigen 1 (EEA1), lysosomalassociated membrane protein-1 (Lamp-1), and Golgin-97 were used. EEA1 is thought to
only be associated with early endosomes. Lamp-1 is associated with various vesicles,
however, it seems to predominately accum ulate in late endosomes and lysosomes
(Akasaki, 1995). Anti-golgin-97 recognizes a 97 kDa protein called Golgin-97, which is
a member of the granin family of proteins localised on the cytoplasmic face of the Golgi
apparatus.

U937 cells were treated as described for m easuring the release of calcein from
endosomal vesicles (section 3.2.2.3), except that calcein was deleted from the initial
incubation mixture. Following uptake, the cells were incubated for 4 hours at 37°C in
10% FB S/D M E M :F12 before processing fo r im m unofluorescence. In some
experiments, polymers were omitted from the initial incubation buffer but 70 jaM
MSDH (an acidotropic detergent known to disrupt lysosomes (Li et al., 2000)) was
added to the medium used for the subsequent 4 hour incubation. The cells were then
centrifuged fo r 5 m inutes at 300 g , resuspended in 0.4 ml of 4% (w/v)
paraformaldehyde in PBS, pH 7.4, and incubated with shaking at room temperature for
30 minutes. The fixed cells were then washed with PBS and perm eabilised by
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incubation with 0.4 ml of 0.5% (v/v) triton X-100 in PBS for 15 minutes on ice. Fixed,
permeabilised cells were washed with 0.1% (w/v) bovine serum albumin (BSA) in PBS
(0.1% BSA/PBS), then suspended in 50

/a \

of either, anti-EEA l, anti-Lamp-1 or anti-

golgin-97 antibodies (diluted 1:50 in 1%BSA/PBS) and incubated on ice for 1 hour. The
cells were then washed with BSA/PBS, suspended in 50 //I of goat-anti-mouse Ig-Alexa
488 (diluted 1:50 in 1% BSA/PBS) and incubated on ice for 1 hour. Finally the stained
cells were washed with PBS and examined by confocal microscopy. Cells were excited
at 488 nm and fluorescence collected using an emission window set at 500-540 nm.

In experiments analysing the effects of treatments on Lamp-1 immunofluorescence,
TCS NT software was used to measure for 50 randomly chosen cells from each
treatment, in a constant arbitrary plane, the diameter of globular areas of fluorescence
within cells (see Figure 3.11). The measurement taken was used to score each cell as
being in one of four categories: (1) no globular regions of fluorescence (i.e. diameter
(grf) = 0 mm), (2) diameter (grf) = 0.1-1.5 mm, (3) diameter (grf) = 1.6-3.0 mm, or (4)
diameter (grf) > 3.0 mm. Histograms were then plotted from these scorings. In the small
number of cases in which there was more than one globular area of fluorescence within
a cell, only the largest was measured.

3.2.2.7

Lysosomal Assays

To further test the effects of polym ers on lysosom es, in addition to the
im m unofluorescence assay with Lamp-1 antibody, cells were stained with the
fluorescent acidotropic probes acridine orange and LysoTracker Yellow. Acridine
orange accumulates to high concentrations in the lysosomal lumen where it forms red
fluorescing dimers (Zelenin, 1999). An increase in dimer formation can be detected by
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flow cytom etry. The LysoTracker dyes are thought to partition into lysosomal
membranes. The morphology and distribution of lysosomes was determined, following
staining, by confocal microscopy.

Polymers were loaded by constitutive endocytosis into U937 cells as previously
described (section 3.2.2.3). Following the 4 hour incubation, cells were centrifuged for
5 minutes at 300 g and resuspended in DMEM:F12 containing 5 /*g/ml acridine orange,
incubated for 20 minutes at room temperature in the dark, and finally analysed by flow
cytometry. The cells were excited with a 488 nm Argon laser and red fluorescence
collected using a 650 nm long pass filter. For each sample, 10,000 events were
acquired.

Similarly, for LysoTracker Yellow staining, cells were loaded with polymers by
constitutive endocytosis and incubated in 1 ml of 10% FBS/DMEM:F12 for 4 hours at
37°C. After 3 hours, LysoTracker Yellow (75 nM - from 1 mM stock) was added to the
cell suspension and cells were incubated for a further hour. Cells were then centrifuged
(5 minutes, 300 g), resuspended in DMEM:F12 and analysed by confocal microscopy.
Cells were excited at 543 nm and fluorescence collected using an emission window set
at 550-600 nm.

In experiments analysing the effects of treatments on LysoTracker fluorescence, the
TCS NT software was used to draw a line in a constant arbitrary plane across the entire
diameter of images of individual cells and the “profile” function used in each case to
obtain a histogram plot of the level of fluorescence along the length of the line drawn. A
constant arbitrary “baseline” level of fluorescence was selected and the number of
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continuous regions with fluorescence above this baseline was counted for each cell. For
each treatment, this was performed on 40 randomly chosen cells.
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3.3

Results

3.3.1

Viability Assays

Following uptake of PPAA, PEAA or PMAA by constitutive endocytosis, cell viability
was determined. During the ensuing 24 hour period, like control cells, more than 95%
of cells treated with PPAA remained viable. Similar results were obtained for cells
treated with PEAA and PMAA (data not shown).
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Figure 3.1: Line graph showing the viability of PPAA-treated (dashed line) and control
U937 cells (solid line) over a 24 hour period following uptake of PPAA by constitutive
endocytosis. Over the 24 hour time period, no significant change in cell viability was
detected in either PPAA-treated or control cells. Each data point represents the mean of
3 independent experiments. Error bars are too small to be seen.
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Testing the pH-Dependent Lytic Activity of PPAA, PEAA
and PMAA

Whole cell experiments were conducted to determine the pH-dependent lytic activity of
the polymers; cell lysis was measured as a function of pH. Cytolysis was detected by
flow cytometric analysis of Pi-stained cells (Figure 3.2). At all pH levels tested, little
cell lysis (approxim ately 5%) was detected in control and PM AA-treated cells. In
contrast, at some pHs, cell viability was significantly reduced following treatment with
PPAA and PEAA. Following exposure to PPAA, the percentage of non-viable cells
increased considerably between pH 7.0 and 6.5, but gradually decreased with further
reductions in pH (Figure 3.2). At pH 7.0 neither PPAA nor PEAA induced significant
loss of cell viability. However, at pH 6.5, exposure to PPAA lysed nearly 90% of cells
(Figure 3.2). At progressively more acidic pH, the proportion of cells lysed by PPAA
decreased slightly. In contrast, the proportion of cells lysed by PEAA did not increase
significantly until the pH was reduced to 6.0 (where about 15% of the cells were lysed).
At pH 5.5 and 5.0, PEAA lysed more than 90% of cells. For unknown reasons, PMAA
does not have the ability to disrupt cell membranes, regardless of the pH level tested.

69

C hapter 3

PAAAs

pH

Figure 3.2: Line graph showing the percentage of non-viable U937 cells following
exposure to either 200 ^g/ml PPAA ( A ), PEAA ( ■ ) or PM A A (X ). Each data point
represents the mean values for three independent experiments. Errors bars represent the
standard errors of the mean in each case.

3.3.3

Polymers are Endocytosed and Release Calcein from
Intracellular Vesicles

Following a 30 minute incubation in polymer buffer containing b-PEAA, U937 cells
were stained with anti-EEA l antibody and Alexa 488-conjugated goat anti-mouse Ig;
b-PEAA was detected using streptavidin-Alexa 546. Confocal microscopy showed the
polymer (b-PEAA) in punctate structures, many at the periphery of the cell. Many of
these punctate structures co-stained with anti-E E A l antibody. This pattern of
fluorescence suggests that the polymer, which is hydrophilic at pH 7.4, enters the cell
via the process of endocytosis (Figure 3.3).
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Figure 3 .3 : Confocal m icroscopy im ages of U937 cells incubated in PB containing bPEAA (red fluorescence). Images show cells stained with (a) anti-E E A l antibody only
(green fluorescen ce), (b) strep tav id in -A lex a 546, and (c) an overlay o f the tw o
fluorescence im ages. In m any cells, vesicles show co-localisation o f green and red
fluorescence (white). This result is representative o f four independent experim ents. 4050 cells were scanned to ensure reproducibility. Bar = 10 /<m.

W hen U937 cells w ere incubated in PB containing the m em brane- im perm eable fluor
calcein, they subsequently show ed fluorescent intracellular vesicles, consistent with
constitutive endocytosis o f the external m edium . N um erous fluorescent intracellular
vesicles w ere detected (Figure 3.4). W hen PPAA was included in the buffer together
with calcein, there was a tim e-dependent release of calcein from vesicles to the cytosol.
The pattern of intracellular fluorescence significantly changed during a 4 hour period
following the initial uptake. Im m ediately follow ing constitutive endocytosis o f calcein
and polym er, intracellular fluorescence was punctate. Tw o hours after uptake, larger
fluorescent vesicles were clearly seen in many polym er-treated cells (Figure 3.4, panel
b, indicated by arrow) but were absent in control cells, suggesting that PPAA induced
vesicle fusion. At the same point in tim e, some cells showed partial release of calcein to
the cytosol (Figure 3.4, panel b). A t 4 hours follow ing loading, fluorescence was
considerably m ore diffuse, suggesting m ovem ent of calcein from vesicles to the cytosol
(Figure 3.4, panel c). A sim ilar pattern o f fluorescence was detected when PEA A was
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used. PEAA-treated cells also showed vesicle fusion and cytosolic calcein release,
although this occurred later then in PPAA-treated cells. After 4 hours, calcein release
was also detected in cells treated with PMAA, however the extent of this was less than
in PPAA or PEAA-treated cells.

Figure 3.4: Confocal microscopy images of U937 cells incubated in PB containing 200
Hg/ml of polymer and 2 mg/ml calcein. (a) Image of U937 cells immediately following
PPAA treatment. Fluorescence is largely in punctate regions, (b) U937 cells 2 hours
following PPAA-treatment. (c-e) Images of U937 cells 4 hours after loading of PPAA
(c), PEAA (d), and PMAA (e) by constitutive endocytosis. In some cells vesicles have
fused (arrows) and in others fluorescence is diffuse. This result is representative of six
independent experiments. 40-50 cells were scanned to ensure reproducibility. Bar = 10
pim.

These interpretations are supported by quantitative analysis. For all polymers tested
there was an increase in cytosolic fluorescence over time. At 4 hours following PPAA
exposure the average cytosolic fluorescence (in arbitrary units) was 107. The
corresponding level of fluorescence was 96 for PEAA-treated cells and 58 for PMAA72
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treated cells. All these readings are significantly higher than those of control cells
(Figure 3.5).
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Figure 3.5: Plot showing the cytosolic calcein fluorescence of U937 cells, following
constitutive endocytosis of media containing 2 mg/ml calcein and either 200 jAg/ml
PPAA, 200 fdglml PEAA or 200 fdg/m\ PM AA. O ver tim e, cytosolic calcein
fluorescence increased by 60-70 arbitrary units in all treatments. 50 randomly chosen
cells were analysed for each treatment. Error bars represent the standard error of the
mean cytosolic calcein fluorescence in each case.

The ability of polymers to mediate calcein release showed a biphasic dependence on
polymer concentration (Figure 3.6). For any one polymer, the level of calcein release
was comparable for polymer concentrations of 5-25 p g/ml but increased to a higher
similar level at either 50 or 200 /<g/ml of polymer. The level of calcein release obtained
following exposure of cells to either 50 or 200 //g/ml PPAA was significantly greater
than that obtained with 25 //g/ml PPAA (P<0.001, F450=13.87, pairwise Tukey-Kramer
comparisons). Significant differences between either of the higher concentrations of
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PEAA or PMAA (i.e. 50 /^g/ml or 200 //g/m l) were not observed. In further
experiments, 50 or 200 /*g/ml of polymer was used.
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Figure 3.6: Dependence of endosomal calcein release on the concentration of poly(2alkylacrylic acid)s. Plots show the level of cytosolic calcein fluorescence in U937 cells
(determined as described in section 3.2.2.3), 4 hours after a 30 minute incubation in PB
containing 2 mg/ml calcein and the indicated concentrations of PEAA, PPAA or
PMAA. Each data point represents the mean values determined for 15 cells. The error
bars shown are standard errors of the mean.

3.3.4

Polymers Release a Cathepsin B-GFP Fusion Protein from
Intracellular Vesicles

Results in section 3.3.3 demonstrate that PAAAs can mediate release of a 622 Da fluor,
calcein, from intracellular vesicles. To investigate whether the polymers could also
Mediate the release of macromolecules from vesicles, Hek293 cells were transiently
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transfected with pCatB-EGFP plasmid encoding a fusion protein consisting of cathepsin
B fused at its C-term inus to enhanced green fluorescent protein. Cathepsin B is an
enzyme that is concentrated in lysosomes but is also found in early and late endsomes
(Seaman, 2001). Control cells were transfected with control DNA (pE G FP-N l).
Cells expressing EGFP showed a homogeneous distribution of green fluorescence
within the entire cell (Figure 3.7A, panel a). In contrast, cells expressing Cat B-EGFP
showed a restricted distribution of intracellular fluorescence consistent with the fusion
protein being localized within endosomes/lysosom es (Figure 3.7A, panel b). When
these latter cells were incubated in PB containing 50 /^g/ml PPAA for 30 minutes, and
subsequently examined by confocal microscopy, the intracellular fluorescence was more
diffuse (Figure 3.7A, panel c), indicating partial release of cathepsin B-EGFP to the
cytosol. Quantitative image analysis (as described in section 3.2.2.3) indicated that
under the conditions tested, uptake of PPAA caused a statistically significant 2.4-fold
increase in the cytosolic level of green fluorescence in pCatB-EGFP transfectants
(p<0.001, Students t-test; Figure 3.7B). Sim ilar changes in the distribution of
fluorescence were also found when pCatB-EGFP-transfected cells were treated as above
with PEAA or PMAA, but not when they were treated the same in the absence of any
polymers (data not shown).
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Figure 3.7: A. Confocal m icroscopy im ages of transiently transfected Hek293 cells
show ing (a) diffuse cytoplasm ic fluorescence in cells transfected with a plasm id
encoding (cytosolic) EGFP, (b) fluorescence restricted to intracellular vesicles in cells
transfected with a plasm id encoding a cathepsin B-EGFP fusion protein, and (c) the
same type o f transfectants shown in (b) 4 hours after incubation in PB containing 50
/<g/ml PPAA, show ing release of cathepsin B -EG FP from vesicles to the cytosol.

B

follow ing polym er uptake (data not shown). PEAA and PM AA were also able to
m ediate release of cathepsin B-EGFP to the cytosol; this release did not occur in cells
treated similarly but in the absence of PAAAs (images not shown). Bar = 10 ;/m. B.
H istogram plots sum m arising the results of quantitative image analysis o f cytosolic
calcein fluorescence in Hek293 cells following transient transfection with (i) p-EGFP or
(ii) pCatB-EG FP (with or without a subsequent 4 hour exposure to 50 //g/m l PPAA).
Results are representative of 2 independent experiments and for each treatment 30 cells
were analysed. Error bars represent the standard error o f the mean cytosolic calcein
fluorescence in each case.

Cytosolic Calcein Fluorescence
(arbitrary units)

Release of cathepsin B-EGFP to the cytosol was also visible at earlier time points

pEGFP
tran sfe cta n t

pCat BFRFP

pCat B-EGFP
tran sfe cta n t
s/P P A A
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3.3.5

Polymer-Mediated Disruption of Intracellular Vesicles is
pH-Dependent

Stayton (2000) previously reported that PAAAs disrupt membranes in a pH-dependent
manner and their membrane disruptive ability is significantly enhanced at acidic pH.
The intra-vesicular pH of the m ajor vesicles involved in the endocytic pathway
gradually decreases from approxim ately 6.5 (early endosomes) to 4.5 (lysosomes).
The progressive acidification of these vesicles is achieved primarily by the operation of
an H+-ATPase pump found in the vesicle membrane. Acidification can be inhibited by
membrane-permeable vacuolar ATPase inhibitors such as bafilomycin (Vandeurs et al.,
1996; Schoonderwoert et al., 2000).

Results discussed in sections 3.3.3 and 3.3.4 suggest that PAAAs are able to mediate the
release of small and macro-molecules from endosomes to the cytosol. Bafilomycin
significantly inhibits the release of calcein from intracellular vesicles mediated by
PPAA, PEAA or PMAA (Figure 3.8). In each case, the effect of bafilomycin was
statistically significant (p<0.02, Student’s t-test). These result suggest that acidification
of endosomal contents effected by the H+-ATPase is required for PAAA-mediated
disruption of endosomes.
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Figure 3.8: Plot showing that bafilom ycin-m ediated alkalinization of endosom es
inhibits PAAA-m ediated release of calcein to the cytosol. Q uantitative results of
confocal microscopy analyses of U937 cells measuring calcein release into the cytosol
(see section 3.2.2.3 for details), 1.5 hours after a 30 minutes incubation in PB containing
2 mg/ml calcein and (where indicated) other additions. The histogram plots show results
for cells incubated only with calcein (control) or with calcein and other additions (e.g.
PEAA, cells incubated with calcein and 200 /*g/ml PEAA). W here indicated (e.g.
PEAA/BAF), cells were also treated with 1

bafilomycin to inhibit H+-ATPase-

mediated acidification of endosomal vesicles. Data points represent the mean of 25 cells
and error bars represent the SE of the mean in each case.

This result was confirmed by showing that strong buffering of the solution from which
cells endocytosed calcein and polymers inhibited the subsequent release of calcein into
the cytosol. A 50% decrease in calcein release was detected in cells incubated in the
strongly buffered solution, containing 200 /^g/ml PPAA, compared to those incubated in
the control buffer (Figure 3.9, p<0.001, Students t-test).
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Figure 3.9: Buffer-m ediated alkalinization of endosomes inhibits PAAA-mediated
release of calcein to the cytosol. Plots show quantitative results of confocal microscopy
analyses of U937 cells measuring calcein release into the cytosol (see section 3.2.2.3 for
details). Cells were analysed 1.5 hours after a 30 minute incubation in PB containing 2
mg/ml calcein and where indicated (Hepes), the buffering of PB was increased from 0.5
mM to 50 mM Hepes. The histograms show results for cells incubated with calcein only
(control) and cells incubated with calcein and 200 J4g/m\ PPAA (PPAA). W here
indicated (Control/Hepes and PPAA/Hepes), cells were incubated in PB containing 50
mM Hepes. Pairwise comparisons indicated that 50 mM Hepes significantly inhibited
the release of calcein (p<0.001, S tudent’s t-test): the small difference between
Control/Hepes and Control is not statistically significant. This data are representative of
three independent experiments and error bars represent the standard error of the mean in
each case.
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3.3.6

Effects of Polymer Uptake on EEA1 and Lamp-1
Immunofluorescence

Results thus far indicate that PAA A s, particularly PEAA and PPAA, disrupt
intracellular vesicles in a pH-dependent manner. Im m unofluorescence was used to
examine the effects of individual polymers on the morphology and distribution of
different vesicle populations. Early endosomes were identified by staining cells with
anti-EEA l antibody. In both control and polymer-treated cells, fluorescence was in
distinct punctate regions, generally towards the periphery of the cell (Figure 3.10),
suggesting that the uptake of polymers did not affect the morphology or distribution of
early endosomes. The lysosomal disruptive agent MSDH also had no effect on early
endosomes (data not shown).
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Figure 3.10: Confocal microscopy images showing U937 cells stained with anti-EEAl
antibody following constitutive endocytosis of PAAAs. A similar punctate pattern of
fluorescence was detected in both control cells (a) and polymer-treated cells; PEAA (b),
PPAA (c) and PMAA (d), suggesting that internalised polymers have no effect on early
endosomes. These images are representative of cells analysed from 4 independent
experiments. B ar= 10 //m.

Late endosom es and lysosomes were detected by staining cells with anti-Lamp-1
antibody. In control cells, one or two regions of bright concentrated fluorescence were
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detected. These concentrated regions were approximately 2-4 ^m in diameter and were
surrounded by smaller fluorescent vesicles distributed throughout the cell (Figure 3.11A
Panel a). In polym er-treated cells, these bright fluorescent globular regions were
significantly reduced in size and in many cells these regions were not identifiable at all.
Interestingly, the smaller fluorescent vesicles distributed throughout the cell were
unaffected by polymers. This notable change in fluorescence was most obvious in cells
treated with MSDH. In the majority of M SDH-treated cells, no globular regions of
Lamp-1 specific fluorescence were detected (Figure 3 .1 1A). These interpretations were
confirmed by quantitative image analysis (Figure 3.1 IB).
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Figure 3.11: A: Confocal microscopy images of U937 cells following uptake of PAAAs
by constitutive endocytosis and staining with anti-Lamp-1 antibody. Images show:
Lamp-1 positive globular regions of fluorescence (grf; arrow) in cells incubated with (a)
no added polymer, (b) 70 //M MSDH (to disrupt lysosomes), or 200 piglm\ of (c) PEAA,
(d) PPAA or (e) PMAA. B: Histogram plots summarising the results of quantitative
image analysis of the diameter of grf of 50 randomly chosen cells from each treatment
(see section 3.2.2.6 for more details regarding this analysis). Bar = 10 /<m.
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Compartment(s) Disrupted by PAAAs
Lamp-1 is a major lysosomal protein but is also found in the membranes of late
endosomes and the trans Golgi network (Akasaki, 1995). Thus, the changes in the
pattern of Lamp-1 immunofluorescence induced by uptake of PAAAs might result from
changes to one or more of these compartments. To eliminate the possibility that PAAAs
might be transported from endosomes to the trans-Golgi and there disrupt the Golgi,
following uptake of polymer, U937 cells were stained with anti-golgin 97 antibody.
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Anti-golgin-97 antibody recognizes a 97 kDa protein called golgin-97 that is located on
the trans-Golgi network. Golgin-97 is not located in any other compartment. Cells were
analysed by confocal microscopy following polymer uptake and antibody staining.
In both the control cells and polym er-treated cells, fluorescence was in distinct
elongated clumps around the periphery of the cell (Figure 3.12), suggesting that the
uptake of PAAAs did not affect the morphology or distribution of the trans-Golgi
apparatus.

Figure 3.12: Confocal microscopy images of U937 cells showing Golgin-97 positive
vesicles (trans-Golgi apparatus). Four hours after a 30 minutes incubation in PB alone
(a) or PB containing 200 //g/ml PPAA (b), U937 cells were fixed, permeabilized and
then stained with anti-golgin-97 antibody. Images are representative of two independent
experiments. Bar = 5 //m.

To investigate the effects of polymer uptake on lysosomes, LysoTracker Yellow and
acridine orange were used. Control cells stained with LysoTracker Yellow showed one
or a small number of patches of peri-nuclear fluorescence (Figure 3.13, panel a). In cells
treated with MSDH, the areas of fluorescence were smaller in size and more punctate
(Figure 3.13, panel b), indicating changes in lysosomal morphology. However, the
effects of the polymers were less pronounced. Polymer-exposed cells showed a more
irregular pattern of staining with LysoTracker Yellow than control cells (Figure 3.13,
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panels c-d). Uptake of PEAA produced a pattern of fluorescence that was similar to that
of MSDH-treated cells. Cells that had taken up PPAA or, particularly, PMAA showed
lesser effects but the pattern of fluorescence was still more dispersed than that of the
controls. Image analysis (see section 3.2.2.7) confirmed that MSDH and the polymers
had induced changes in the pattern of LysoTracker fluorescence (Figure 3.13B). Flow
cytometric analysis of cells treated with either MSDH or polymers and stained with
acridine orange indicated that MSDH induced loss of lysosomal integrity but that
uptake of any of the polymers did not (Figure 3.14). Collectively, these results suggest
that polymers were causing changes in lysosomal morphology but were not causing
physical disruption of the lysosomal membrane.
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(ab o v e arbitrary level o f flu o rescen ce)

Figure 3.13 A: Confocal microscopy images of U937 cells loaded with PAAAs by
constitutive endocytosis and stained with LysoTracker Yellow. U937 cells were
incubated in PB containing various additions for 30 minutes. Cells were then washed
and resuspended in com plete m edium and incubated for a further 4 hours.
LysoTracker Yellow was added directly to the cells 1 hour before confocal analyses
(see section 3.2.2.7 for more details). Images show: (a) control cells (no added
polymer); (b) M SDH-exposed cells (MSDH disrupts lysosomes); (c) PEAA-treated
cells (200

(d) PPAA-treated cells (200 /*g/ml) and (e) PMAA-treated cells (200

I*g/ml). For each treatment, the images shown are representative of 40 cells analysed in
three independent experiments. Bar = 10 //m. B: Each histogram plot summarises the
results of quantitative image analysis (performed as described in section 3.2.2.7) of 25
cells treated as in the image above. Cells from three independent experiments were
analysed.
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Figure 3.14: Overlay flow cytometry histograms showing U937 cells stained with
acridine orange 4 hours after a 30 minute incubation in PB containing no additions (thin
solid line) or 200 j<g/ml PEAA (dashed line), or after 4 hours incubation in culture
medium containing 70 p M M SDH (thick solid line). The results shown are
representative of four independent experiments. In similar experiments, the uptake of
PPAA and PMAA also had no effect on the level of red fluorescence associated with
acridine orange-stained cells (data not shown).
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Discussion

This chapter describes work in which PAAAs were introduced into cells via constitutive
endocytosis and the effects on cells were characterised. No significant decrease in cell
viability was detected over a 24 hour time period following polymer uptake. Whole cell
experiments indicated that both PEAA and PPAA destabilize membranes at mildly
acidic pH. The membrane-disruptive activity was greatest at pH 5.5 for PEAA and pH
6.5 for PPAA. Interestingly, the membrane-disruptive activity of PPAA appeared to
decrease at pH<6.5. At these pHs, PPAA has a tendency to precipitate from aqueous
solution. It has been suggested that at pH 5 and 5.5, PPAA may form micro-aggregates
with a reduced ability to disrupt membranes (Jones et al., 2003). Thus, the greater
hydrophobicity of PPAA may explain why it had reduced lytic efficiency at lower pH.
Previous work has suggested that PAAAs are likely to deliver molecules into cells by
endocytic uptake followed by low pH-induced disruption of endosomes/lysosomes to
release their contents to the cytosol (Murthy et al., 1999). The membrane-disruptive
activity results suggest that PPAA might achieve maximum mem brane-disruptive
activity during the earlier stages of endosomal acidification, whereas PEAA might only
achieve this in the final most acidic endosomal compartments. In these whole cell
experiments PMAA did not display any membrane-disruptive activity. The reason(s) for
this are unknown.

Results displayed in Figure 3.3 show U937 cells with biotinylated PEAA (b-PEAA) in
punctate structures located primarily at the periphery of the cell; some of the punctate
structures are co-stained with anti-EEAl antibody. This suggests that PEAA (which is
hydrophilic at pH 7.4) is taken up by endocytosis and transits through early endosomes
before moving onto other vesicular compartments. Similarly, when U937 cells were
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incubated in buffer containing the m em brane-im perm eable fluor calcein, they
subsequently showed fluorescent intracellular vesicles, consistent with constitutive
endocytosis of the external medium (Figure 3.4). Uptake of PAAAs induced fusion of
calcein-containing endosomes followed by release of calcein to the cytosol (Figure 3.4).
This effect appears similar to the PEAA-induced fusion of phosphatidylcholine vesicles
observed in vitro at mildly acidic pH (Linhardt and Tirrell, 1999).

Time course studies conducted over a 4 hour period showed a time dependent release of
calcein from intracellular vesicles into the cytosol. PPAA produced more rapid
disruption of vesicles than PEAA. PMAA produced the least disruption of vesicles and
its effect was the slowest of the three polymers tested. The faster kinetics and greater
extent of vesicle disruption mediated by PPAA and PEAA compared to PMAA may
result from the greater hydrophobicity of PPAA and PEAA.

In contrast to the results reported here, Plank et al. (1994) previously showed that pHsensitive endosomal disruptive peptides were able to induce significant release of
fluorescent dextran from intracellular vesicles 15 minutes after endocytic uptake.
However, in these experiments no measurements of the time dependence of release
were reported. Both PPAA and PEAA mediated measurable release of calcein from
vesicles im m ediately after uptake, how ever, the extent of release increased
progressively with time, reaching a maximum at approximately 4 hours after uptake.
It appears that, once endocytosed, PAAAs may disrupt endosomes more slowly than
pH-sensitive peptides. It has been suggested that endosomal-disruptive peptides only
require protonation of a small number of side-chain groups (e.g. 3) to bring about
transition to a mem brane-disruptive conform ation (Plank et a l, 1994). In contrast,
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PAAA are polyanions at physiological pH: when internalised within endosomes they
will act as polyvalent buffers and will require the transport of hundreds of H+ ions per
polymer molecule before becoming membrane-disruptive. Another possible reason for
the apparently slower kinetics of vesicle disruption mediated by PAAAs versus peptides
may be that PAAAs appear unable to disrupt lysosomes (Figure 3.14). Mellman (1996)
suggests that undegraded endocytosed material is continually recycled between late
endosomes and lysosomes. Therefore, the PAAAs may only mediate the release of
molecules when they are intermittently and transiently resident in late endosomes.

The default pathway for endocytosed materials is to be carried through vesicle
compartments towards lysosomes for eventual degradation. During this trafficking the
contents of the vesicles become progressively acidified, reaching a pH of less than 5.0
in lysosomes. We reasoned that endocytosed PAAAs would probably follow this
pathway and when the vesicle contents became sufficiently acidic, the polymers would
adopt a conformation competent to disrupt membranes. Acidification of the lumen of
endososomes/lysosomes is effected by an H+-ATPase found in the vesicle membrane,
which can be specifically inhibited by bafilomycin (Vandeurs et al., 1996). Results
shown in Figures 3.8 and 3.9 show that disruption of intracellular vesicles was
significantly

decreased

fo llo w in g

b afilo m y cin -m ed iated

in h ib itio n

o f the

endosomal/lysosomal H+-ATPase or strong buffering of the medium from which
polymers were endocytosed. These results indicate that endocytosed PAAAs are
triggered by the progressive acidification of endosomal/lysosomal contents to become
membrane-di srupti ve.
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The ability of PAAAs to mediate calcein release showed a biphasic dependence on
concentration (Figure 3.6). Cytosolic calcein fluorescence was comparable when cells
endocytosed PAAAs from concentrations of 5-25 /<g/ml increased significantly to a
similar higher level when either 50 ^g/m l or 200 ^g/ml PAAA were used. The reason
why this occurs is not known, however, it is possible that at higher concentrations in an
acidic environment, individual polymer molecules may co-operate in some way to more
efficiently disrupt membranes.

PAAAs disrupt intracellular vesicles to release both small molecules (e.g. 622 Da
calcein) and m acrom olecules (e.g. a 64 kDa fusion protein) (Figure 3.4 and 3.7,
respectively). In addition, Lackey et al. (2002) have shown that PPAA similarly
mediated release of a large (approximately 264 kDa) polymer-antibody-streptavidin
complex to the cytosol. These results suggest that PAAAs are capable of sufficiently
disrupting intracellular vesicles to effect the indiscriminant release of their contents to
the cytosol.

There are three major types of acidified intracellular vesicles through which most
endocytosed materials pass through. These are early and late endosomes and lysosomes.
These vesicles are thought to be the location of expressed Cat B-EGFP (Guicciardi et
al., 2000). Results shown here indicate that Cat B-EGFP is released from intracellular
vesicles following polymer treatment (Figure 3.7). Therefore, it was reasoned that one
of these three com partm ents would be the site(s) disrupted by endocytosed PAAA
polymers. There was no measurable effect of polymer uptake on the pattern of EEA1
immunofluorescence, suggesting that early endosomes were unaffected (Figure 3.10).
The early endosome is the first compartment that endocytosed materials are delivered to
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and its lum en is mildly acidic at pH 6.0-6.2 (Cain, 1989). D espite the fact that PPAA
has potent haem olytic activity at this pH, it does not appear to disrupt early endosomes.

In contrast, Lamp-1 im m unofluorescence was significantly affected following uptake of
PAAAs (Figure 3.11). Lamp-1 proteins belong to a series of proteins that are located on
the surface of late endosom es, lysosom es and the trans Golgi network. This suggests
that the polym ers were disrupting one or m ore of these com partm ents. To identify the
precise com partm ent that the polym ers disrupt, various other assays were perform ed.
Changes in L ysoTracker Y ellow staining suggested that, 4 hours after uptake (when
extensive release o f calcein from vesicles could be m easured), the polym ers w ere
effecting changes in the m orphology of lysosom es. H owever, at this sam e tim e point,
flow cytom etric analysis o f cells stained with acridine orange (which accum ulates inside
lysosom es (Z elenin, 1999)) indicated that lysosom es rem ained structurally intact
(Figure 3.14). Extensive lysosomal bursting is known to induce cell death (Brunk et al.,
2001); we found that after continuous exposure of cells to 200 /ig/m l polym er fo r 24
hours, >95% of cells rem ained viable (Figure 3.1). C ollectively, these results suggest
that the release o f calcein and cathepsin B -EG FP fusion protein m easured at 4 hours
after polym er uptake w as occurring from a com partm ent o th er than lysosom es.
Im m unofluorescence analyses indicated that the morphology of the trans-Golgi network
was not affected follow ing polym er treatm ent (Figure 3.12). Therefore, we conclude
that late endosom es are likely to be the in tracellu lar com partm ent that becom es
disrupted follow ing constitutive endocytosis o f PAAAs.

It is unclear why endocytosed PAAAs alter the m orphology of lysosom es but do not
Physically disrupt them. Tw o possible explanations are as follow s: (1) The lysosom al
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membranes may be resistant to the disruptive effects of the polymers. It is known that
the lumenal face of the lysosomal membrane is heavily coated with a fam ily of
glycoproteins that are thought to provide the membrane with protection from the many
lytic enzymes in the lumen (Granger, 1990). This coating may also sterically shield the
membrane from the actions of the protonated, hydrophobic polymers; (2) At a pH of
less than 5 (which is found in lysosomes), if present at a sufficient concentration, the
heavily protonated, hydrophobic polymers may precipitate and become ineffective as
membrane disruptants. Supporting the latter possibility, as stated before, PPAA
precipitates from aqueous solution at pH<5. The two above explanations may not be
mutually exclusive.

Collectively, these results suggest that cells endocytose PAAAs and transport them to
late endosomes, where acidification of the lumen by the membrane H+-ATPase triggers
polymer-mediated vesicle disruption and release of endosomal contents to the cytosol.
PPAA and PEAA show great potential for use as drug delivery agents for cancer
therapies.
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Investigation of Poly[l(dimethylamino)ethyl methacrylate] as a
Potential Delivery Agent for ProApoptotic Cancer Therapeutics
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Introduction

In recent years, many polymers have been tested for their ability to enhance delivery of
anti-cancer agents to tumours. A few polymers show great potential and are now in
stage I and II clinical trials. Unfortunately, progress is slow due to various limitations in
vivo, for example, retaining polymer conjugates at tumour sites. Therefore, research
continues to search for a suitable delivery agent. Initial investigations of PAAAs were
discussed in the previous chapter. Results are promising and indicate that PAAAs
disrupt late endosomes in a pH-dependent manner and deliver m olecules into the
cytosol.

The current chapter describes an investigation of another polym er, p o ly [ 1(dimethylamino)ethyl methacrylate) (pDMAEMA). pDMAEMA was analysed for its
ability to (1) induce apoptotic cell death by disruption of lysosomal membranes and (2)
deliver m olecules into the cytosol of cancer cells. The chem ical structure of
pDMAEMA is schematically represented in Figure 4.1.
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Figure 4 .1 : Schem atic representation of the

O

chemical structure of poly(2-(dimethylamino)ch7

ethyl methacrylate (pDMAEMA). Adapted from
van de Wetering et al. (1999).
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Van de W etering and colleagues (1999) suggested that pDM AEM A may have
properties, sim ilar to PAAAs, which enable it to disrupt endosomal membranes.
Currently there is no direct evidence that pDMAEMA disrupts endosomes. Van de
Wetering et al. (1999) have suggested that at physiological pH, pDMAEMA is partially
protonated but at lower pH it becomes completely protonated (i.e. acts as a ‘proton
sponge’). They have hypothesised that at low pH, the proton sponge action of
pDMAEMA causes massive ATPase-driven proton accumulation within endosomes
that is followed by passive chloride ion influx to prevent the build up of a charge
gradient. The influx of the protons and chloride ions would increase the osmolarity of
the endosomal contents and cause water influx resulting in osmotic swelling and
subsequent disruption of endosomes (Boussif et al., 1995; van de Wetering et al., 1999,
Funhoff et al., 2003).
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pDMAEMA, and derivatives thereof, have previously been used as delivery agents in
gene therapy to kill cancer cells (Fonseca et al., 1999). In these experim ents,
pDMAEMA was complexed with plasmids encoding a therapeutic toxin and then used
to transfect cancer cells. The pDMAEMA-plasmid complex has shown some favourable
results in vitro, however, like many other potential cancer therapies, unfavourable
complications such as lack of cell specificity have arisen (van Steenis et al., 2003).

Previously, relatively few studies of pDMAEMA have been performed. It has only been
characterised in term s of m olecular m odelling, pKa values, cytotoxicity, and
transfection efficiency (Van de W etering et al., 1999; Arigitia et al., 1999). Therefore,
experiments described in the current chapter further characterise pDMAEMA by
determining (1) its mechanism of entry into cells, (2) the mode of cell death it induces
(i.e. apoptosis or necrosis) and (3) its ability to disrupt endosomes and release molecules
into the cytosol of cells. These investigations were intended to identify whether
pDMAEMA might by used in the development of novel cancer therapeutics such as a
trimolecular construct (section 1.10).

97

pDM A EM A

C hapter 4

4.2

Materials and Methods

4.2.1

Materials

pDMAEMA (Mw = 22 kDa) and pDMAEMA/AEMA (Mw = 31 kDa; a copolymer of
pDMAEMA and am inoethylmethacrylate, polymerised in the ratio 19:1) were gifts
from Dr. Wim E. H ennink, D epartm ent of Pharm aceutics, U trecht Institute for
Pharmaceutical Sciences (UIPS), Utrecht University, The Netherlands. Propidium
iodide and calcein were from Sigma (MO, USA). Annexin V-FITC was purified and
conjugated to FITC within the laboratory (see section 2.2.5). CaspACE FITC-VADFMK was from Prom ega (WI, USA). M onoclonal antibodies reactive with early
endosomal antigen 1 (EEA1), lysosomal-associated membrane protein-1 (Lamp-1) and
cytochrome c were from Pharmingen-Transduction Laboratories (CA, USA). Alexa
488-conjugated goat-anti-mouse Ig and 3,3’-dihexyloxacarbocyanine iodide (DiOC6(3))
were from Molecular Probes (OR, USA).

4.2.2

4.2.2.1

Methods

Determining Cell Viability Following Introduction o f pDMAEMA

U937 cells were incubated in polymer buffer (PB; 145 mM NaCl, 5 mM KC1, 0.5 mM
HEPES) containing pDMAEMA and constitutive endocytosis allowed to proceed before
determining cell viability. U937 cells (2x l0 6) were centrifuged for 5 minutes at 300 g.
Cells were resuspended in 0.6 ml of PB, with or without the addition of pDMAEMA to
give a final concentration of 1 //g/ml or 2 //g/ml (added from a stock solution at 4
mg/ml). Cell suspensions were incubated for 1 hour at 37°C; at 15, 30 and 60 minutes,
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200 ]A of the cell suspension was removed. Cell viability was then determined by
staining cells with PI as described in section 3.2.2.1.

4.2.2.2

Confirming the Mode of Entry of pDMAEMA into Cells

Previous experiments involving pDMAEMA have presumed that the mode of entry of
the polymer into cells was via endocytosis, however, this was not conclusively shown.
Endocytosis is a process by which cells internalise material from their external
environment (Mellman, 1996). Internalised material is then transported through the cell
in a series of compartments called endosomes. Like PAAAs (Chapter 3), we predicted
that pDMAEMA, internalised by endocytosis, would pass through the early endosomal
compartment. To confirm this, we traced the initial movements of pDMAEMA through
the cell. This was achieved by biotinylating pDMAEMA/AEMA (which contains free
amine groups), and staining fixed permeabilised cells with anti-EEAl antibody (EEA1
is used for the detection of early endosomes). Biotinylated pDMAEMA/AEMA (bpDM AEM A/AEM A) was detected using streptavidin-A lexa 546 and anti-E E A l
antibody was detected using Alexa 488-conjugated goat anti-m ouse Ig antibody.
Biotinylation, cell fixation and permeabilisation, and confocal analyses were performed
as described in section 3.2.2.2.

To further test the hypothesis that pDM AEM A enters cells via endocytosis, the
dependence of its cytotoxicity on temperature was determined. Endocytosis works most
efficiently at 37 C and is inhibited at lower tem peratures, for example, 4 C. Two
parallel experim ents were performed; one at 37 C and the other at 4 C. For each
experiment, cytotoxicity assays were performed as described above (section 4.2.2.1). A
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decrease in cytotoxicity at 4 C was expected if the mode of entry of pDMAEMA into
cells was by endocytosis.

4.2.2.3

Staining Cells with Annexin V-FITC to Measure Phosphatidylserine
Exposure

Phosphatidylserine (PS) is a phospholipid, normally confined to the inner leaflet of the
plasma membrane. However, during apoptosis, and in some necrotic cell systems, it is
exposed on the outer leaflet of the plasma membrane (Kerr, 1995; Martin et al., 1996).
The exposure of PS on the surface acts as a trigger for the recognition of apoptotic cells
by phagocytes. Phagocytes contain specific receptors for exposed PS, thereby allowing
rapid removal of the cells (Martin et al., 1996). PS externalisation is most commonly
measured using a protein known as annexin V. Annexin V has high affinity for
aminophospholipids such as PS (M eers and Mealy; 1993, Meers and M ealy, 1994;
Martin et al., 1996). Fluorescent conjugates of annexin V (e.g. FITC conjugates) can be
used to detect PS exposure on the surface of cells by flow cytometry (Kroemer et al.,
1995).

Annexin V labelling solution was made by diluting annexin V-FITC (1 mg/ml) 1:100 in
annexin V buffer (10 mM HEPES, pH 7.4, 140 mM NaCl, 5 mM CaCl2). 2 x l0 6 cells
were centrifuged at 300 g and resuspended in 500 ji\ of PB containing either 1 pig/ml or
2 ng/m \ polymer. Cells were incubated for 30 minutes at 37°C to allow constitutive
endocytosis to occur. The cells were resuspended in 1 ml of lx PBS and re-centrifuged
as above. The supernatant was removed and cells were resuspended in 50 /,i\ of the
annexin V labelling solution, followed by a 15 minute incubation at room temperature
ln the dark. Immediately before flow cytometric analysis, 500 n\ of annexin V buffer
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was added and cells stained with PI (see section 3.2.2.1). FSC, SSC, FL1 and FL3
signals were acquired. Increased PS exposure on the cell surface was measured as an
increase in FL1 fluorescence. Non-viable (i.e. PI positive) cells were excluded from all
analyses. Figure 4.2 shows an example of how flow cytometry data was analysed.
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Figure 4.2 : FL1 histograms of U937 cells exposed to 2 //g/ml pDMAEM A for 30
minutes and stained with annexin V-FITC. The margins used for the control cells were
the same as those used for cells treated with pDMAEMA. M l is the population of cells
that had not bound annexin V-FITC to their surface. The percentages of cells that bound
annexin V-FITC to their surface (M2) are shown under each histogram. Histogram A
represents the control cells. Histogram B represents cells exposed to pDMAEMA. Nonviable cells were excluded from all analyses.

4.2.2.4

Staining Cells with 3,3’-D ihexylo\acarbocyanine Iodide (DiOC6(3))
to Measure Mitochondrial Depolarisation

DiOC6(3) is a cationic lipophilic fluor that accumulates in the matrix of mitochondria.
The negative charge of the matrix attracts the positive charge of the fluor, while the
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lipophilic properties allow the fluor to diffuse across membranes and enter the matrix.
W hen there

is reduced

m itochondrial

m em brane

potential

(m itochondrial

depolarisation), accumulation of the fluor is reduced and is measured by flow cytometry
as a decrease in cell-associated fluorescence (Kroemer et al., 1997).

Following loading of polymers by constitutive endocytosis (section 4.2.2.1) cells were
centrifuged at 300 g for 5 minutes. The supernatant was discarded and the pellet was
resuspended in 1 ml of com plete medium containing 40 nM DiOC6(3). This was
prepared from a 1 M stock, which was diluted to 1 mM in 500 //I of lx PBS and then
diluted to 40 nM in complete medium. The cells were incubated at 37°C for 15 minutes
in the dark. Immediately before flow cytometric analysis, cells were stained with PI (see
section 3.2.2.1). FSC, SSC, FL1 and FL3 signals were collected. Non-viable cells were
excluded from all analyses. Figure 4.3 is an example of how flow cytometry data was
analysed.
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Figure 4.3 : FL1 histograms of U937 cells exposed to 2 /^g/ml pDMAEMA for 30
minutes and stained with DiOC6(3). The margins used for the control cells were the
same as those used for cells treated with polymer. M l is the population of cells with
depolarised mitochondria. The percentages of cells with depolarised mitochondria are
shown under each histogram. H istogram A represents control cells. Histogram B
represents cells exposed to pDMAEMA.

Non-viable cells were excluded from all

analyses.

4.2.2.5

Measuring Caspase Activation Following Exposure to pDMAEMA

Several caspases, in particular caspase 3, are known to be involved in apoptosis.
Caspase 3 has been implicated in virtually all apoptotic systems tested. Caspases
interact with proteins normally stored within mitochondria and other intracellular
proteins to regulate apoptosis. Following exposure to pDMAEMA, caspase activation
was determ ined using CaspACE™ FIT C -V A D -F M K (carbobenzoxy-valyl-alanylaspartyl-|0-m ethyl]-fluorm ethylketone). CaspACE™

FITC -V A D -FM K

is a cell

Permeable probe that irreversibly binds to a number of activated caspases (Flores and
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M acklin, 2000; Perkins et al., 2003).

pDM AEM A was loaded by constitutive

endocytosis into 2 x l0 6 U937 cells (as previously described in section 4.2.2.1).
Follow ing loading, cells w ere w ashed with D M EM :F12 and resuspended in
DM EM :F12 containing 10

CaspACE™ FITC-VAD-FM K. Cells were then

incubated for 20 minutes at 37°C in the dark. Immediately before flow cytometric
analysis, cells were stained with PI (see section 3.2.2.1). FSC, SSC, FL1 and FL3
signals were collected. Caspase activation was measured by an increase in FL1
fluorescence. Non-viable cells were excluded from all analyses.

4.2.2.6

M easu rin g

C ytoch rom e

c R elease

F ollow in g

E xp osu re

to

pDMAEMA
Cytochrome c is an extrinsic membrane protein, normally associated with the outer
surface of the inner membrane of mitochondria (Gastman, 2001). Cytochrome c release
from m itochondria to the cytosol has been reported in many different systems of
apoptosis (Kluck et al., 1997; Zhaung and Cohen, 1998). Immunofluorescence staining
of cells allows the release of cytochrome c from m itochondria to be visualised by
fluorescence microscopy as a change from punctate regions of intensely concentrated
fluorescence (corresponding to mitochondrial localisation), to diffuse fluorescence
located throughout the cell cytosol.

U937 cells (2xl06) were centrifuged (300 g, 5 minutes) in a 15 ml tube. Cells were fixed
and permabilised as described in section 3.2.2.2. Cells were then diluted with ice-cold
0.1% (w/v) BSA/PBS to pre-block non-specific binding sites and to minimise cell loss
during centrifugation. Cells were centrifuged again (900 g, 10 minutes), drained and
resuspended in 50 /vl o f 1% (w/v) BSA/PBS containing 2.5 |/g/m l mouse anti
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cytochrome c primary antibody. Cell suspensions were transferred to pre-chilled 1.5 ml
tubes and incubated on ice for 1 hour. Cells were then diluted to 1.5 ml with 0.1%
BSA/PBS, centrifuged (900 g, 10 minutes) and thoroughly drained. Cells were then
resuspended in 50 jil of goat-anti-m ouse Ig-Alexa 488 (diluted to 2 ^g/m l in 1%
BSA/PBS) and incubated in the dark, on ice, for 1 hour. Cells were subsequently
washed twice with PBS, resuspended in 1% PF/PBS and exam ined by confocal
microscopy. Cells were excited at 488 nm and fluorescence collected using an emission
window set at 500-540 nm. All signals collected were adjusted to remain within the
linear range of the detectors.

4.2.2.7

D eterm ining if pDM AEM A Causes R upture o f Endosom es or
Lysosomes

Similar to studies conducted with PAAAs (Chapter 3), a variety of assays were
conducted to determine if pDMAEMA disrupted endosomes and/or lysosomes and
released their contents to the cytosol. Initially, calcein was simultaneously loaded with
pDMAEMA into cells to determ ine if pDM AEM A induced calcein release from
endosomes. O ther polymers, such as PAAAs (section 3.2.2.2), have the ability to
release molecules from endosomes into the cytosol. pDMAEMA (at 1-2 fig/ml) was co
loaded into cells w ith calcein as described for PAAAs in section 3.2.2.2.
Immunofluorescence assays were then used to examine the morphology and distribution
of both early and late endosomes and lysosomes following uptake of pDMAEMA by
constitutive endocytosis. A nti-EEAl and anti-Lamp-1 antibodies were used to visualize
early endosomes and late endosom es/lysosom es, respectively. Immunofluorescence
assays were conducted as previously described in section 3.2.2.6. Globular regions of
fluorescence were measured and scored as before (see section 3.2.2.6). For each
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treatment, 50 randomly chosen cells were analysed. To further test the effects of
pDMAEMA on lysosomes, cells were stained with the fluorescent acidotropic probes
acridine orange and LysoTracker Yellow. This was done as described in section 3.2.2.7,
except in these experiments cells were only incubated for 1 hour (as opposed to 4
hours). For each treatm ent, 50 randomly chosen cells that had been stained with
LysoTracker Yellow were analysed.
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4.3

Results

4.3.1

Effects of pDMAEMA on U937 Cells

Cell viability was initially tested follow ing exposure of cells to 1 or 2 /^g/ml
pDMAEMA for 15, 30 and 60 minutes. Non-viable cells were detected by staining with
PI. Poniris (2001) previously showed that 80-90% of cells exposed to 10-100 nglm\
pDMAEMA for 15 m inutes died. Likewise, substantial cell death was apparent
following exposure of cells to 5 //g/ml polymer for 15 minutes (data not shown). At
lower concentrations of pDMAEMA (e.g. 1 or 2 /<g/ml), the extent of cell death was
significantly less. However, 1-2 ^g/m l pDMAEMA induced a time-dependent increase
in cell death (Figures 4.4 and 4.5). Under these conditions, pDMAEMA caused the
appearance of a population of cells that stained with PI to an intermediate level (Figure
4.5, indicated by the rectangle). This population most likely represents cells with ‘leaky
membranes’- a characteristic that is often associated with cells undergoing apoptosis.
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Figure 4.4: Bar graph showing the percentage of non-viable U937 cells, as a function of
time, during exposure to 1 /*g/ml or 2 //g/ml of pDMAEMA. Each data point represents
the mean value from three independent experiments. Error bars represent the standard
error of the mean in each case.
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Figure 4.5: Flow cytometry density plots of (a) untreated U937 cells and U937 cells
exposed to 2 //g/ml pDMAEMA for (b) 15, (c) 30 and (d) 60 minutes. The elipses
indicate dead cells and the rectangles indicate cells with 'leak y ’ membranes. The results
shown are representative of 4 independent experiments.

Cells were exposed to b-pDMAEM A/AEM A and stained with anti-EEA l to confirm
that pDMAEMA is internalised by endocytosis. Cells were exposed to 1 or 2 j/g/ml bpDMAEMA/AEMA for 30 minutes and then stained with anti-EEA l antibody and
Alexa 488-conjugated goat anti-mouse Ig; b-pDMAEMA/AEMA was detected using
streptavidin-Alexa 546. Confocal microscopy showed that the polymer was largely at
the periphery of the cell. In approximately 40% of cells there was co-localization of the
fluorescences associated with b-pDMAEMA/AEMA and early endosomes (Figure 4.6).
Approximately 200 cells were analysed in these experiments.
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Figure 4 .6 : C onfocal m icroscopy im ages o f U 937 cells exposed to 2 //g/m l bpD M A EM A /A EM A fo r 30 m inutes. Im ages show cells stained w ith (a) anti-E E A l
antibody only (green fluorescence), (b) streptavidin-A lexa 546, and (c) an overlay of the
two fluorescence im ages. In m ost cells, vesicles show partial co-localisation o f green
and red flu o rescen ce (w hite). T his resu lt is rep resen tativ e ot tw o in d ep en d en t
experiments. 200 cells were scanned to ensure reproducibility. Bar = 10 fim.

The percentage of non-viable cells was reduced considerably w hen cytotoxic assays
were performed at 4°C com pared to 37°C. A pproxim ately 50% of cells were non-viable
follow ing exposure to 1 //g/m l pD M A EM A for 1 hour at 37°C. In com parison, only
20% of cells were non-viable follow ing exposure to 1 fig/m \ pD M A EM A fo r 1 hour at
4°C (Figure 4.7). Sim ilar results were observed follow ing exposure of cells to 2 fig/m \
pDMAEM A (results not shown).
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Figure 4.1: Bar graph showing the percentage of non-viable U937 cells, as a function of
time, during exposure to 1 //g/ml of pDMAEMA. Parallel experiments were conducted
at 37 C (grey bars) and 4 C (white bars). Each data point represents the mean value
from three independent experiments. Error bars represent the standard error of the mean
in each case.

To determine if death was via apoptosis, measurements of mitochondrial depolarisation,
phosphatidylserine exposure, caspase activation and m itochondrial release of
cytochrome c were made.

M itochondrial depolarisation was detected by staining

control and polym er-exposed cells with DiOC6(3). Time course experiments were
conducted over 60 minutes. Approximately 10% of cells had depolarised mitochondria
following exposure of cells to either 1 //g/ml or 2 /^g/ml pDMAEMA for 15 minutes. At
60 minutes, this increased to approxim ately 20% for cells treated with 1 /^g/ml
pDMAEMA and to 30% in cells treated with 2 //g/ml pDMAEMA (Figure 4.8). Nonviable cells were excluded from all analyses.
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Figure 4.8: The percentage of U937 cells with depolarised mitochondria, as a function
of time, during a 60 minute exposure to pDMAEMA. Cells were either left untreated
(black bars), or exposed to 1 /*g/ml (grey bars) or 2 pig/ml pDMAEMA (white bars) for
15 to 60 minutes. M itochondrial depolarisation was measured as described in section
4.2.2.4. Each data point represents the mean value from three independent experiments.
Error bars represent the standard error of the mean in each case.

Exposure of cells to pDMAEMA also resulted in PS exposure. Following 15 minutes
exposure to 1 /<g/ml of pDMAEMA, approximately 25% of cells had surface-exposed
PS. A pproxim ately 60% of cells had surface-exposed PS following a 60 minute
exposure to 2 /<g/ml pDMAEMA. The proportion of cells with surface-exposed PS was
significantly different between treatments at all time points (p<0.001 F 14 = 447.55,
pairwise Tukey-Kramer comparisons), however, the differences over time for any one
treatment were not significant (Figure 4.9). Non-viable cells were excluded from all
analyses.
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Figure 4.9: Bar graph showing the percentage of cells with surface-exposed PS, as a
function of time, following a 15 to 60 minute exposure to either 1 /Yg/ml or 2 /<g/ml
pDMAEMA. Each data point represents the mean value from three independent
experiments. Error bars represent the standard error of the mean in each case.

Caspase activation was also assayed follow ing the exposure of U937 cells to
pDMAEMA but none was detected (Figure 4.10). Caspase activation was detected in
U937 cells induced to undergo apoptosis by exposure to T N F a and cyclohexim ide
(Figure 4.10, inset panel A).
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Figure 4.10: Bar graph showing the percentage of cells with bound CaspACE FITCVAD-FMK, as a function of time, following a 15 to 60 minute exposure to 1 /<g/ml or 2
fig/ml pDMAEMA. Panel A: Positive Control; U937 cells exposed to 10 ng/ml T N F a
and 10 /^g/ml cycloheximide for 4 hours. Each data point represents the mean value
from three independent experiments. Error bars represent the standard errors of the
mean in each case.

Cytochrome c was not released from mitochondria following exposure of cells to 1-2
/<g/ml pDMAEMA for 30 minutes. Immunofluorescence staining of cytochrome c in
untreated control cells showed a punctate distribution typical of m itochondrial
localisation (Figure 4.11, panel a). A similar pattern of immunofluorescence to that of
control cells was observed in cells treated with either 1 /^g/ml or 2 /<g/ml pDMAEMA
(Figure 4.11, panels b and c). Diffuse cytosolic fluorescence was not observed in cells
exposed to pDMAEMA. However, a diffuse cytosolic fluorescence was observed when
cells were induced to undergo apoptosis by exposure to 10 ng/ml T N F a and 10 /^g/ml
cycloheximide (Figure 4.11, panel d).
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Figure 4.11: Immunofluorescence images obtained by confocal microscopy of U937
cells stained with anti-cytochrom e c antibody. A sim ilar punctate pattern of
fluorescence was detected in both untreated control cells (a) and cells exposed for 30
minutes to either 1 /yg/ml (b) or 2 /<g/ml (c) pDMAEMA. However, in some cells
exposed to 10 ng/ml T N F a and 10 ^g/m l cycloheximide for 4 hours (positive control;
d), fluorescence was more diffuse (arrows). These images are representative of cells
analysed from two independent experiments. Bar = 5 //m.

Finally, light microscopy was used to examine cells for pDMAEMA-induced changes
in the morphology of the cell membrane. Significant membrane blebbing occurs in
apoptotic U937 cells (e.g. following exposure to T N F a and cycloheximide). Membrane
blebbing was not observed following exposure to pDMAEMA (results not shown).

4.3.2

Characterisation of the Morphology and Distribution of
Intracellular Vesicles Following Exposure of Cells to
pDMAEMA

A final series of assays, similar to those described in chapter 3, were completed to
determine if endocytosed pDMAEMA disrupts endosomes or lysosomes. Following
exposure to pDMAEM A, U937 cells were assayed by confocal microscopy for the
release of calcein (a small tracer molecule) from endosomes to the cytosol. U937 cells
were incubated for 30 minutes in medium containing 2 mg/ml calcein with or without
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the addition of 1-2 //g/ml pDMAEMA and subsequently assayed. In both control and
polymer-treated cells, fluorescence was in punctate regions around the periphery of the
cell (Figure 4.12A). This suggests that pDMAEMA did not induce release of calcein
from intracellular vesicles. Results were also quantified by measuring the cytosolic
calcein fluorescence of many cells from each treatment (see section 4.2.2.7). There was
no significant difference in cytosolic calcein fluorescence of the control and polymertreated cells (p>0.7154 F257=0.3369, pairwise Tukey-K ram er com parisons). In all
treatments, the cytosolic calcein fluorescence was less than 10 arbitrary units (Figure
4 .12B). Similar results were obtained when Jurkat cells were used (results not shown).
Cytosolic calcein fluorescence of cells treated similarly with PAAAs (discussed in
chapter 3) was 4-10 times greater than control cells (section 3.3.3). The level of
cytosolic calcein fluorescence for the control cells was similar for these experiments and
those described in section 3.3.3.
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Figure 4.12: A Confocal images of U937 cells incubated for 30 minutes in medium
containing 2 mg/ml calcein and 1 ^g/m l or 2 //g/ml pDMAEMA. Panel a represents
control cells (i.e. incubated in the absence of pDMAEMA) and panels b and c represent
cells exposed to 1 j/g/m l or 2 /*g/ml pDM AEM A, respectively. Im ages are
representative of three independent experiments. Bar = 10 //m. B Bar graph comparing
cytosolic calcein fluorescence of U937 cells exposed for 30 minutes to 1-2 /^g/ml
pDMAEMA or 200 //g/ml PPAA. Quantitative image analyses were performed as
described in section 3.3.3. Data points represent means of values determined for 15-20
cells and error bars shown are standard errors of the mean in each case.

Im m unofluorescence assays were conducted to determ ine the m orphology of
endosomes and lysosomes following a 30 minute exposure of cells to pDMAEMA.
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A nti-EEAl and anti-Lamp-1 antibodies were used to stain early endosomes and late
endosom es/lysosom es, respectively. Following staining with anti-EEA l antibody,
fluorescence within both control and polymer-treated cells was in punctate regions.
Early endosomes appeared as roughly circular, bright fluorescent patches distributed
mainly at the cell periphery (Figure 4.13). The pattern of fluorescence suggests that the
morphology and distribution of early endosomes was not affected by exposure of cells
to pDMAEMA.

•

a

b

_

«.

c

Figure 4.13: Confocal microscopy images showing U937 cells stained with anti-EEAl
antibody following exposure to pDMAEMA. Cells were incubated for 30 minutes with
(a) no additions, or 1 //g/ml (b) or 2 /<g/ml (c) pDMAEMA. Images are representative of
two independent experiments. Bar = 5 /^m.

The pattern of Lamp-1 immunofluorescence in untreated control cells was different
from that of cells exposed to pDMAEMA. Untreated control cells stained with antiLamp-1 antibody showed large globular regions of fluorescence (grf), with
approximately 40% of these regions being greater than 3 ]Am in diameter. A similar
pattern of fluorescence was evident in some cells following a 30 minute exposure to 1-2
/<g/ml pDMAEMA, however the size of the grf was, on average, considerably smaller
(Figure 4.14A). In approximately 25-30% of cells exposed to 1-2 /^g/ml of pDMAEMA,
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grf were not detected. Q uantitative analysis (Figure 4.14B) showed a negative
correlation between the concentration of pDMAEMA in which cells were incubated and
the size of grf. This indicates that the morphology of late endosomes/lysosom es is
affected by exposure of cells to pDMAEMA.
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0

Figure 4.14: A Confocal images of U937 cells stained with anti-Lamp-1 antibody
following exposure to pDMAEMA. Images shown represent untreated control cells (a),
and cells exposed for 30 minutes to 1 /^g/ml (b) or 2 /^g/ml (c) pDMAEMA. A large
globular region of fluorescence (grf) is indicated by the white arrow. These images are
representative of three independent experiments. Bar = 5 n m. B Histogram plots
summarising the results of quantitative image analysis of the diameter of grf of 50
randomly chosen U937 cells treated as in the panel above (see section 3.2.2.7 for more
details regarding this analysis).

LysoTracker Yellow and acridine orange were used to further investigate the effects of
pDMAEMA on lysosomes. Fluorescence in control cells stained with LysoTracker
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Yellow was largely concentrated around the periphery of the cell (Figure 4 .15A, panel
a). In contrast, following pDMAEMA uptake, cells showed a more diffuse pattern of
LysoTracker fluorescence (Figure 4.15A: compare panels b and c), suggesting changes
in lysosom al m orphology. Image analysis (see section 3.2.2.7) confirm ed that
pDMAEMA (both at 1 //g/ml and 2 /<g/ml) had induced changes in the pattern of
LysoTracker Yellow fluorescence (Figure 4.15B). Under the conditions tested, flow
cytometric analysis showed that control cells and cells exposed to 1 /^g/ml pDMAEMA
had similar level of red AO fluorescence (Figure 4.16). Similar results were obtained
when cells were exposed to 2 ^g/m l pDMAEMA (data not shown). However, in cells
exposed to MSDH (a known lysosomal disruptive agent) a population of cells with
substantially decreased red AO fluorescence was detected (indicated by the arrow on
Figure 4.16). The remaining M SDH-treated cells not in this population had red AO
fluorescence slightly low er that that of control or pD M A EM A -treated cells. A
substantial decrease in red AO fluorescence indicates lysosomal rupture. Collectively,
these results indicate that (1) MSDH caused lysosomal bursting and (2) exposure of
cells to pDMAEMA caused changes in lysosomal morphology but did not physically
disrupt lysosomes.
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Figure 4.15: A: Confocal m icroscopy images of U937 cells exposed to 1 /*g/ml
pDMAEMA for 30 minutes and stained with LysoTracker Yellow. See section 4.2.2.7
for details of methods. Images show: (a) control cells (no added polymer) and cells
treated with 1 /*g/ml or 2 //g/ml pDMAEMA (panels b and c, respectively). The images
shown are representative of three independent experiments. Bar = 10 ^ m . B: Each
histogram plot summarises the results of quantitative image analysis, performed as
described in section 3.2.2.7, for 50 cells treated as in the image above. For the purpose
of these analyses, fields of view were selected at random from three independent
experiments.
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Figure 4.16: Overlay flow cytometry histograms of U937 cells stained with acridine
orange following a 30 minute incubation in PB containing no additions (thin solid line)
or 1 nglm \ pDMAEMA (dashed line), or after a 4 hour incubation in culture medium
containing 70 //M MSDH (thick solid line). In some MSDH-treated cells a substantial
decrease in red AO fluorescence was detected (arrow ). The results shown are
representative of three independent experiments.
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Discussion

In the past few years, pDM AEM A has successfully been used in gene therapy
(Foneseca et al., 1999). In these experiments, pDMAEMA was complexed with plasmid
DNA to yield polym er/plasm id complexes (polyplexes). OVCAR-3 human ovarian
carcinom a and CO S-7 cells were then transfected with the polyplexes and the
transfection efficiency and cell viability measured (van de Wetering et al., 1999). The
most promising results were obtained when low concentrations of polymer, similar to
those used in this study, were used. Based on these previous experiments and functional
predictions about pDM AEM A, experim ents were perform ed to determ ine the
mechanism of entry of pDMAEMA into cells, the mode of cell death following
pDM AEM A internalisation, and finally, the ability o f pDM AEM A to disrupt
endosomes and release molecules into the cytosol of cells.

Following a 30 minute incubation of cells in 2 ^g/m l b-pDM AEM A/AEM A, the
biotinylated polymer was detected inside U937 cells primarily at the cell periphery
(Figure 4.6). In approximately 40% of the cells, a fraction of the b-pDMAEMA/AEMA
co-localised with anti-EEA l stained vesicles (early endosomes). These results are
similar to those from experiments using b-PEAA described in Chapter 3 and suggest
that, like PAAAs, pDMAEMA is taken up by endocytosis and transits through early
endosom es

before

m oving

onto

oth er

v esicu lar co m p artm en ts

(e.g.

late

endosomes/lysosomes). Endocytic entry of pDMAEMA into cells is also consistent with
the effects of temperature on its cytotoxicity. Endocytosis works most efficiently at
37 C and is inhibited at 4 C (Mellman, 1996). Thus, the reduced number of non-viable
cells following exposure of cells to pDMAEMA at 4 C compared to 37 C supports the
conclusion that entry of pDMAEMA into cells occurs via endocytosis (Figure 4.7).
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These results are also supported by Zuidam et al. (2000); they showed that
internalisation of pDM AEM A-polyplexes was inhibited at 4 C and that internalised
pDM AEM A-polyplexes remained contained within what appeared to be endocytic
vesicles.

The second aim of this study was to determ ine the mode of cell death following
exposure of cells to pDMAEMA. There was a time-dependent increase in non-viable
cells following exposure of cells to either 1 or 2 n g/ml pDMAEMA (Figure 4.4). Cell
death did not occur im m ediately; the cell m embranes first became ‘leaky’ - a
characteristic that is often associated with apoptosis (Figure 4.5). The detection of
‘leaky cell m em branes’ following the exposure of cells to pDMAEMA raises the
possibility that it may affect cells by directly interacting with cell membranes. The cell
surface contains many ion channels that fluctuate between open and closed
conformations and that maintain the equilibrium of ions within the cell. The dissipation
of ion gradients leads to impairment of essential processes in the cell and finally cell
death (Ultee et al., 1999). For example, inappropriate accumulation of Ca2+ and Na+ ions
within rat striatum cells causes abnormalities in energy metabolism by increasing (1)
the activity of proteases, lipases and endonucleases, (2) the production of free radicals,
and (3) DNA damage that ultimately leads to cell death (M cLaughlin et al, 1998;
Bordelon et al., 1998). Therefore, it is possible that in addition to (or in parallel with) its
effects from within the cell following endocytosis, exogenous pDMAEMA may induce
cell death by directly interacting with the cell membranes to result in the collapse of ion
gradients. Arguing against this possibility is the observation that confocal images of
cells incubated with b-pDMAEMA/AEMA do not show a concentration of the polymer
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at the cell membrane (Figure 4.6), which would be expected if it were directly exerting
its cytotoxic effects at this site.

A series of assays were performed to determine the type of cell death induced by
pDMAEMA. Following exposure of cells to pDMAEMA mitochondrial depolarisation
(Figure 4.8) and PS exposure (Figure 4.9) were both detected. However, under these
same conditions, caspase activation (Figure 4.10), cytochrome c release (Figure 4.11)
and changes in cell morphology (data not shown) were not detected. Until recently,
mitochondrial depolarisation and PS exposure were both thought to be hallmarks of
apoptosis; however, both are now known to sometimes occur during necrosis. For
example, mitochondrial depolarisation has been detected in cells induced to undergo
necrosis with cyclosporin and trifluoperazine (Lemasters et a i, 1999) and PS exposure
has been detected in thym ocytes (W aring et al., 1999) and mouse leukaemia cells
(Bonneau and Poulin, 2000) undergoing death exclusively by necrosis. Therefore,
collectively, the results suggest that cell death caused by exposure to pDMAEMA is via
necrosis not apoptosis. The fact that cell death was very rapid also supports this
conclusion. Following a 60 minute exposure to 2 /<g/ml of pDMAEMA, approximately
50% of cells were non-viable (Figure 4.4). Apoptosis generally takes hours and in some
cell systems it may take days; necrosis is generally much faster.

Lastly, experiments were performed to determine the ability of internalised pDMAEMA
to disrupt endosomes, in particular lysosomes. If pDMAEMA disrupts endosomes it is
possible that it could be used as a delivery agent in a novel cancer therapeutic (see
section 1.0). The ability of pDMAEMA to disrupt endosomes and release a small
membrane-impermeable fluor (calcein) into the cytosol of cells was investigated. When
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U937 cells were incubated in buffer containing calcein and pDMAEMA, they showed
fluorescent intracellular vesicles (Figure 4.12). This pattern of fluorescence did not
change over 60 minutes, suggesting that calcein was not released into the cytosol. Other
characteristics associated with calcein release, such as vesicle fusion (Jones et al., 2003;
Linhardt and Tirrell 1999), were also not observed. Similar results were obtained with
Jurkat cells (data not shown). The results shown in this chapter suggest that
pDMAEMA does not have the ability to disrupt endosomes and release small tracer
molecules into the cytosol.

The morphology of early/late endosomes and lysosomes following exposure of cells to
pDMAEMA was also investigated. It is possible that pDMAEMA may change the
morphology of vesicles without physically disrupting their membranes. Similar to
PAAAs (Chapter 3), there was no measurable effect of exposing cells to pDMAEMA
on the pattern of EEA1 immunofluorescence, suggesting that early endosomes were
unaffected (Figure 4.13). In contrast, Lamp-1 immunofluorescence was significantly
affected following the exposure of cells to pDMAEMA. Lamp-1 proteins are primarily
located on the surface of late endosomes and lysosomes. Results shown in Figure 4.14
suggest that pDMAEM A caused m orphological changes to one or both of these
compartments. To further characterize the compartment affected following exposure to
pDMAEMA, cells were stained with LysoTracker Yellow and AO. Changes in the
pattern of LysoTracker Yellow staining were observed following the exposure of cells
to pDMAEMA, suggesting that pDMAEMA caused changes in lysosomal morphology
(Figure 4.15). However, flow cytometric analysis of cells stained with acridine orange
indicated that lysosomes remained structurally intact (Figure 4.16). Therefore, the
results suggest that exposure of cells to pDMAEMA changes the morphology of late
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endosomes or lysosomes but does not physically disrupt them. This latter result is
supported by Zuidam et al. (2000); they showed that a large percentage of polyplexes
(pDMAEMA bound to DNA) were retained within endosomes following a 24 hour
post-transfection incubation.

Results presented in chapter 3 showed that the uptake of PAAAs by constitutive
endocytosis disrupted late endosomes in a pH-dependent fashion and released both
small and large molecules into the cytosol. Results presented in this chapter demonstrate
that exposure of cells to pDM AEM A induced changes in the m orphology of
endosomes/lysosomes but did not disrupt them. The exposure of cells to pDMAEMA
resulted in rapid necrotic death. In contrast, cell viability was maintained following the
uptake of PAAAs. The most appropriate polymer to use as a delivery agent for a
proposed cancer therapeutic (see section 1.10) must have the ability to disrupt
endosomes and release their contents into the cytosol. Results presented in this chapter
indicate that pDMAEM A lacks this ability. In addition, the very high toxicity of
pDMAEMA could pose a significant risk of bystander cell damage in cancer therapies.
Collectively, these results indicate that, of the polymers tested, PAAAs appear to be the
best suited to deliver molecules into the cell cytosol.
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Synthesis and Functional Assays of
PAAA-X-Bad(140-165) Conjugates
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PA A A -X -B ad(140-165) Conjugates

Introduction

Chapters 3 and 4 describe the effects of two different polym ers (PAAA and
pDMAEM A) on cells. A variety of assays were performed to determ ine if these
polymers disrupted endosomes/lysosomes and induced apoptosis, and if they might be
used as part of a novel cancer therapeutic (see section 1.10). Many morphological and
biochemical changes were evident following uptake of PAAAs and pDMAEMA.
However, the results obtained suggest that, of the polymers tested, PAAAs are the most
suitable to be used as endosomal disruptive agents.

As previously described in chapter 1, the proposed novel cancer therapeutic is
comprised of a synthetic polymer conjugated to both a targeting ligand and, via a pHsensitive linker, to a pro-apoptotic peptide. For several years now, synthetic polymers
have been conjugated to anti-tum our agents using a variety of linking mechanisms
(Kratz et al., 1999). The linkers that show the greatest potential for in vivo cancer
therapy are those that are stable in plasma and only cleave within tumours to release the
anti-tumour agent. The most promising linkers recently used are pH-sensitive. These
linkers are stable at physiological pH (i.e. pH 7.4) but trigger the release of the anti
cancer drug at acidic pH, such as that found in late endosomes and lysosomes (Duncan
et al., 1996). Synthesis of such linkers has been slow because the chemistry involved is
complicated. More recently, carboxcyclic-hydrazide pH-sensitive linkers have been
developed. These linkers are stable at pH 7.4 but not at lower pH values. The chemistry
involved in the synthesis of these linkers is considerably simpler than that required for
other linkers. Synthesis of a carboxcyclic-hydrazide linker and experiments involving
its conjugation to PEAA and PPAA are described in this chapter. Conjugation of the
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carboxcyclic-hydrazide linker involves a chemical reaction between the amine group on
the linker and a carboxyl group on the polymer.

This chapter also describes a series of assays that were performed to:
1. Determine the percentage of derivatized carboxyls on the polym er (i.e. the
number of linkers attached to the polymer). Collaborators from the University of
W ashington (USA) have previously conjugated specific anti-tumour agents to
PAAAs. They found that derivatization of more than 3-5% of carboxyls on the
polym ers resulted in loss o f polym er function (C. Cheung, 2002, p e rs.
commun.).
2. Confirm that derivatized PAAAs retained their ability to disrupt endosomes in a
pH -dependent manner. One of the greatest risks involved in conjugating
m olecules to pH-sensitive polymers is the potential loss of function of the
polymers. Loss of polymer function would result in the construct being retained
within acidic endosomes, risking degradation of the pro-apoptotic peptide by
endosomal/ lysosomal proteases.
3. Determine the stability of the carboxcyclic-hydrazide bond joining the linker to
the polymer. This bond must be stable at physiological pH to ensure that
Bad( 140-165) is only released once inside the targeted cancer cells, thereby
reducing bystander cell damage.

The final section of this chapter describes (1) the conjugation of Bad(140-165) to
PEA A/PPA A via the carboxcyclic-hydrazide linker, and (2) the effects that
PEAA/PPAA-linker-Bad(140-165) constructs (PAAA-X-Bad( 140-165)) have on cells
following uptake by constitutive endocytosis. Assays similar to those described in
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chapters 3 and 4 were conducted to determine the morphological and biochemical
effects on cells of the uptake of PAAA-X-Bad(140-165) constructs. Based on the results
in chapter 3, we predicted that internalisation of PAAA-X-Bad(140-165) would disrupt
the morphology of endosomes and release Bad(140-165), which would in turn induce
apoptosis. Pro-apoptotic peptides, including Bad(104-182), Bak(82-94) and Bad(140165)) have previously been shown to bind to Bcl-XL (an anti-apoptotic protein) and in
turn elicit characteristic features of apoptosis, both in isolated mitochondria (Narita et
al., 1998) and in intact cells (Kelekar et al., 1997).
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5.2

Materials and Methods

5.2.1

Materials

4-aminobenzoic acid, dichloromethane, isobutyl chloroformate, tert-butyl carbazate,
triethylamine, maleic anhydride, trifluoroacetic acid (TFA), acetronitrile, fluorescamine,
sodium phosphate, boric acid and ethylenediamine tetraacetic acid (EDTA) were from
Sigma/Aldrich (MO, USA). Hexane and acetone were from Crown Scientific (Sydney,
Australia). Anhydrous acetone was from Merck (NJ, USA). Silica gel 60 F254 pre-coated
aluminium plates (0.2 mm thickness; used for analytical thin layer chromatography) and
Silica gel 60 (230-400 mesh; used for flash chromatography) were also from Merck.
Methanol, anhydrous sodium acetate, acetic anhydride, HC1 and magnesium sulfoxide
w ere

fro m

A jax

c h e m ic a ls

(S y d n e y ,

A u s tra lia ).

5 -(( 2 - ( a n d - 3 ) - S -

(acetylm ercapto)succinoyl)am ino)fluorescein (SAM SA fluorescein) was from
M olecular Probes (OR, USA). Biotin-X-NHS was from Calbiochem (CA, USA).
Bad(140-165) was synthesised at the U niversity of Notre Dame (USA) and was
provided as a gift from Professor Martin Tenniswood. Bad(140-165) was synthesised
with three additions at the C-terminus; firstly, a cathepsin cleavage sequence (Leu lie
Val Arg Tyr Thr Arg), then a triple glycine spacer (Gly Gly Gly) and finally, at the
extreme C-terminus, a cysteine residue. This modified peptide is subsequently referred
to sim ply as B ad(140-165). Tw o strategies were adopted to favour intraendosomal/lysosomal release of Bad(140-165); the cathepsin cleavage site was one, the
acid-labile hydrazide linkers was the second.
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5.2.2

Methods

5.2.2.1

Synthesis of Hydrazide Cross Linker

The hydrazide cross linker was synthesised according to Lau et al. (1995a, b). 4aminobenzoic acid (20 g) was suspended in 120 ml of anhydrous acetone. Distilled
methanol (20 ml) was then added drop-w ise and the suspension was stirred until
completely dissolved (Solution A). Solution B was made by adding 40 ml of anhydrous
acetone drop-wise to 16.49 g maleic anhydride. Solution B was then added drop-wise to
solution A, under nitrogen and stirred at room temperature for 1 hour. The yellow
precipitate was then filtered and washed with acetone and vacuum dried. Anhydrous
sodium acetate (3.4 g) and 20 g of the yellow precipitate were added together and then
treated with 40 ml of acetic anhydride at 50°C for 2 hours. The solution was then
evaporated to dryness. Water (500 ml) was added to the solid and stirred at 70°C for 2
hours. Again the solution was filtered off and the precipitate was vacuum dried to yield
4-maleimidobenzoic acid (MBA).

MBA (2.68 g) was suspended in 60 ml of dichloromethane and cooled to 0°C before the
addition of 1.89 ml of triethylamine and 1.76 ml of isobutyl chloroformate. The mixture
was stirred for 1 hour at 0°C and then 1.26 g of te rt-butyl carbazate in 10 ml of
dichloromethane was added drop-wise. Stirring was continued for 3 hours at room
temperature. The reaction mixture was diluted with 150 ml of acetic acid and washed
with saturated N aH C 03 (2x50 ml), 0.1 M HCL (2x50 ml), saturated NaCl (2x50 ml),
H20 (50 ml) then dried using M g S 0 4 and evaporated to give crude protected hydrazide
product. The product was purified by flash chromotography, using silica gel 60 (230400 mesh) and a mixture of solvents: initially 1:2 and then 2:3 Me2CO:hexane. Thin
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layer chrom otography (TLC) was then performed on Kieselgel 60 F254 pre-coated
aluminium plates (0.2 mm) for all samples, using standard techniques. Comparable
samples were then pooled, evaporated to produce a solid and analysed by one
dimensional H NMR. A Mercury 300 MHz Fourier Transform spectrometer was used
for all NMR analyses. Chemical shifts are reported in parts per million (ppm).

Protected hydrazide (Fraction 3; 500 mg) was dissolved in 5 ml of ice-cold TFA and
stirred for 30 minutes in an ice bath. The TFA was then removed under vacuum at room
temperature to give the final product. This was again analysed by NMR. Figure 5.1
schematically depicts the chemical reactions and the synthesis of the intermediates and
final product.
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H2N

\\ /

-COOH
4-aminobenzioc
acid
(CH3CO )20
A c20
AcO Na+

4-maleimidobenzoic
acid
Intermediate 1

Intermediate 2

hydrazide linker
- fin a l product

Figure 5.1: Schematic representation of the hydrazide synthesis. The intermediate
products are indicated in red.
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Coupling Polymer and Cross Linker

Previous results suggest that PEAA or PPAA are appropriate polymers to use as
endosom al-disruptive agents. Therefore, PEAA and PPAA were conjugated to the
hydrazide linker described in 5.2.2.1. Many small-scale experiments were conducted to
determine ideal conjugation ratios. This was done to ensure that the ability of the
polymer to disrupt membranes in a pH-dependent manner was maintained. The amounts
used are summarised in Table 5.1. Once the optimum ratios were determined, the
reactions were scaled up.

A basic summary of the conjugation procedure follows. The polymer and the hydrazide
linker were dissolved in anhydrous methanol with the addition of TFA and stirred at
room temperature, protected from light, for 24 hours. The solution was evaporated
under a stream o f N2 gas until a precipitate was form ed. The precipitate was
resuspended in acetronitrile and allowed to stand at 4°C, protected from light, for a
further 24 hours. The precipitate was then centrifuged (800 g, 10 minutes), dried under
vacuum and analysed by NMR.
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Polymer

Polymer

Linker

Methanol

TFA

Acetronitrile

(Molecular weight)

(mg)

(mg)

(ml)

0*0

(ml)

PEAA (23 kDa)

4.8

10.3

2

0.75

1

PEAA (23 kDa)

5.1

3.8

2

0.75

1

PEAA (23 kDa)

5.0

1.28

2

0.75

1

PPAA (43 kDa)

31.4

2.9

3

1.5

2.5

PEAA (32 kDa)

49.2

3.2

4

2.5

2.5

PEAA (43 kDa)

12.8

2.0

3

1.5

2.5

PPAA (105 kDa)

8.6

2.6

3

1.5

2.5

Table 5.1: Quantities of starting materials used in the small-scale conjugation reactions
between PAAAs (PPAA and PEAA, various molecular weights) and hydrazide linker
(synthesised as described in section 5.2.2.1).

5.2.2.3

Determining the Number of Hydrazide Linkers Attached to PAAAs
Using SAMSA Fluorescein

The number of hydrazide linkers attached to PEAA or PPAA was calculated using
SAMSA fluorescein. Activated SAMSA fluorescein reacts with the free malemide
group on the linker. The degree of labelling was determined from the absorbance at 495
nm. SAMSA fluorescein was activated by removal of the acetyl-protecting group. This
was achieved by dissolving 10 mg of SAMSA in 1 ml of 0.1 M NaOH and incubating
the mixture at room temperature for 15 minutes. Following activation, the solution was
neutralised with 14 ^1 of 6 M HC1 and buffered with the addition of 0.2 ml of 0.5 M
sodium phosphate, pH 7.

To determine the number of derivatized carboxyl groups on the PAAAs, a 200X molar
excess of activated SAMSA fluorescein was added to the polymer-linker mixture (200
Hg/ml polymer-linker in sodium phosphate buffer containing 0.05 M EDTA). This was
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then incubated at room temperature on an orbital shaker for approximately 2 hours to
allow conjugation to take place. Samples were then dialysed overnight in the dark
against 0.5 M phosphate buffer to remove unbound SAMSA fluorescein. Following
dialysis, the degree of labelling was determined from the absorbance of the labelled
polymer at 495 nm. The extinction co-efficient of SAMSA fluorescein is approximately
80,000 cm 'M 1at 495 nm (Molecular Probes, OR, USA).

5.2.2.4

D eterm ining if the pH -D ependent Lytic A bility o f PAAAs is
Retained Following Conjugation with Hydrazide Linker

Following conjugation of the hydrazide linker to PEAA and PPAA, the ability of
PEAA-X and PPAA-X to disrupt membranes in a pH-dependent manner was tested by
conducting whole cell experiments (as described in section 3.2.2.5). Maintaining this
function was crucial (see introduction for more details). Derivatized polym er and
control samples (underivatized polymer) were compared in the same assays.

5.2.1.5

D eterm ining the Stability o f the C arboxcyclic-H ydrazide Bond
Joining the Linker to the Polymer

It was expected that the polym er-linker construct (PAAA-X) would be stable at
physiological pH but that the hydrazide bond within the linker would cleave at mildly
acidic pH. The stability of PAAA-X was determ ined using fluorescam ine.
Fluorescamine is a non-fluorescent molecule that reacts with primary amines to form
fluorescent products. The spontaneous cleavage of the hydrazide bond that occurs at
mildly acidic pH results in the form ation of two prim ary am ine groups. Thus,
fluorescamine can be used to measure the extent of hydrazide linker cleavage.
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A stock solution of fluorescamine was made (15 mg / 50 ml acetone). PAAA-X was
added to 1 ml of 0.2 M phosphate buffer to give a final concentration of 200 ^ig/ml
(from a 6.5 mg/ml stock in 0.1 M NaOH). The pH was then adjusted to either 5 or 7.4
and the samples incubated on a rocker at room temperature for 48 hours. At 0, 24 and
48 hours, 300 pil was removed from each sample and added to 1200 pil of 0.2 M borate
buffer (pH 8.5). This was then vortexed and while vortexing, 500 (j,l of the stock
fluorescamine solution was added. Samples were mixed for 5 minutes and allowed to sit
for 1 minute. Several 100 pil aliquots were then placed in a black 96-well plate and read
on a Biolumin 960 fluorescence plate reader (M olecular Dynamics, Sydney, Australia)
with an excitation wavelength of 390 nm and an emission wavelength of 475-490 nm.
Negative (polymer only) and positive controls (glycine) were also assayed. All samples
were assayed in triplicate.

5.2.2.6

Conjugating Bad(140-165) Peptide to Polymer-Linker Constructs

Bad(140-165) was conjugated to three derivatized polymers (PEAA 23 kDa, PEAA 32
kDa and PPAA 43 kDa). Conjugation was achieved through the spontaneous reaction of
the maleimide group on the linker with the C-terminal thiol group on Bad( 140-165).
PAAA-X (2 mg) and approximately 1.5 mg of Bad(140-165) were dissolved in 460 //I
of

DMF

(d im eth y l

fo rm am id e)

and

40

}i\

of

100

mM

TA PS

(N -

tris[H ydroxym ethyl]m ethyl-3-am inopropane-sulfonic acid) buffer (pH 8.5). This
mixture was then incubated for 3 hours at room temperature under nitrogen. Following
this, the sample was dialysed for 48 hours at room temperature against 100 mM TAPS
buffer (pH 9.5). Dialysis caused some of the conjugate to precipitate; following dialysis
the sample was centrifuged (300 g , 5 minutes) to pellet the precipitate. The supernatant
(containing PA A A -X -B ad(140-165)) was then stored at -2 0 C. C onjugation of
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Bad(140-165) to PAAA-X was confirmed using fluorescamine (see section 5.2.2.5).
Bad(140-165) contains 7 free amine groups; successful conjugation of Bad(140-165) to
PAAA-X was confirm ed by m easuring a significant increase in fluorescam ine
fluorescence compared to that of PAAA-X alone.

A standard curve plotting fluorescamine fluorescence verses the concentration of free
amine groups was produced using methylamine. This was the used to calculate the
number of Bad(140-165) molecules attached to each of the PAAA-X-Bad( 140-165)
conjugates.

5 2 .2 .1

Functional Assays of PAAA-X-Bad(140-165) Constructs

PAAA-X-Bad(140-165) constructs were introduced into U937 cells via constitutive
endocytosis. Subsequently, a series of assays were conducted to determine the effects
on cells of the uptake of the constructs.

U937 cells (lx lO 6) were centrifuged at 300 g for 5 minutes. Cells were drained
thoroughly and resuspended in 1 ml of DMEM:F12 containing 200 /<g/ml of PAAA-XBad(140-165). Following a 30 minute incubation at 37°C, cells were washed with
DMEM:F12 and resuspended in 2 ml of complete medium. Cells were then transferred
to a 6-well plate and incubated for a further 4 hours at 37°C. Following this incubation,
4 ml of com plete medium was added to each of the cell cultures, which were then
incubated for up to 72 hours at 37°C. Cytotoxicity assays were performed (as described
in section 3.2.2.1) at 24, 48 and 72 hours.
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To determine if PEAA/PPAA-X-Bad(140-165) were internalised and co-localised with
early endosomes, immunofluorescence assays were performed. PAAA-X-Bad(140-165)
was firstly labelled with biotin. A stock solution of biotinylation reagent (biotin-XNHS) (40 mg/ml in DMSO) was initially made. 0.25 mg of the stock biotin reagent was
added to 1 ml of sodium carbonate buffer (pH 8.5) containing 3 mg of PAAA-XBad(140-165). This was then incubated on a rocker for 2 hours at room temperature.
Biotinylated PAAA-X-Bad(140-165) (PAA A -X-Bad(140-165)-biotin) was dialysed
against PBS for 24 hours and then introduced into U937 cells as described in section
3.2.2.3. Cells were fixed, permeabilised and stained with anti-EEAl antibody and goatanti-m ouse Ig-A lexa 488 (as described in 3.2.2.6). Cells were also stained with
steptavidin-Alexa 546 (as described in 3.2.2.2). Finally, cells were analysed by confocal
microscopy (see section 3.2.2.2).

Lastly, experiments similar to those described in section 3.2.2.3 were performed to
determine if PAAA-X-Bad( 140-165) constructs disrupted endosomes and released their
contents into the cytosol. U937 cells were incubated for 30 minutes in PB containing 2
mg/ml of calcein and 200 /^g/ml of PAAA-X-Bad(140-165). Cells were analysed 2 and
4 hours after incubation with PAAA-X-Bad(140-165).
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5.3

Results

5.3.1

Synthesis of the Hydrazide Linker

Synthesis of the hydrazide linker involved the synthesis of 2 intermediates (see Figure
5.1). Table 5.2 shows the colour and yields of each product. Intermediate 2 was purified
by flash chromatography and resulted in several different fractions. These fractions
were analysed by TLC. The Rf values were determined for each fraction (Table 5.3).
Fractions 1, 2, and 4 contained unwanted by-products. Fraction 3 contained the desired
product.

Following TLC, fractions were pooled and then analysed by one-dimensional H NMR.
The pattern of resonance peaks for each fraction was analysed; the purified hydrazide
was confirmed to be in fraction 3. The spectrum of fraction 3 showed two doublets in
the arom atic region

(7.998 and 7.969 ppm and 7.614 and 7.586 ppm). These

represented the benzene group. A singlet was evident at 7.011 ppm and represented the
maleimide group. Other peaks were visible, however these were attributed to either the
blocking group (r-but) or the solvent. The one-dim ensional H NMR spectrum for
fraction 3 is shown in Figure 5.2.

The final step in the synthesis involved the removal of the blocking group, which was
achieved by the addition of ice cold TFA. The yield of purified hydrazide was 0.79 g
(Table 5.2).

142

C hapter 5

PA A A -X -Bad(140-165) Conjugates

Compound

Amount Synthesised (g)

Colour

Starting Material

20

White

Intermediate 1 (MBA)

15.31

Beige

Intermediate 2

2.88

White

Final Product

0.79

Yellow/Brown

(4-aminobenzoic acid)

(Hydrazide linker)

Table 5.2: Summary of the hydrazide synthesis. Synthesis involved the production of
two intermediates and the removal of a protecting group.

Fraction 1

0.222, 0.349, 0.539, 0.603

Fraction 2

0.285, 0.428

Fraction 3

0.253

Fraction 4

0.126

Table 5.3: Rf values of the crude hydrazide linker mixture following flash and thin layer
chromatography (see section 5.2.2.1). Fractions 1, 2 and 4 contain various by-products
of the synthesis. Fraction 3 contained the purified hydrazide linker.
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Aromatic region

Figure 5.2: One-dimensional H NMR of fraction 3. The two doublets in the aromatic
region (7.998 /7.969 ppm and 7.614 /7.586 ppm) represent the benzene group. The
singlet at 7.011 ppm represents the maleimide group. Other peaks were visible, however
these were attributed to either the blocking group (4.95 ppm) or the solvent (3.36 ppm).

5.3.2

Conjugation of the Hydrazide Linker to PAAAs

Purified hydrazide linker (X) was conjugated to five different PAAAs using the method
described in section 5.2.2.2. Three conjugation reactions were successful. These were
PEAA(23 kDa), PEAA(32 kDa) and PPAA(43 kDa). The H NMR spectrum obtained
for PEAA(23 kDa)-X was similar to that observed for the linker alone, however a
downward chemical shift was evident (Figure 5.3). The spectrum of PEAA(23 kDa)-X
showed a doublet in the aromatic region (at 7.942 and 7.913 ppm and 7.569 and 7.541
ppm), representing the derivatized benzene ring, and a singlet at 7.000 ppm representing
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the maleim ide group. A broad range peak was evident at approxim ately 2 ppm,
representing the polymer. This peak was considerably broader than other peaks, due to
the heterogeneous mass of PAAA molecules (i.e. PAAAs are a collection of polymers
with close but not identical molecular weights). Similar spectra were also obtained for
samples of both PEAA(32 kDa)-X and PPAA(43 kDa)-X (results not shown).

Aromatic Region

~8

7

6

5

4

3

2

1

0

ppm

Figure 5.3: One-dimensional H NMR spectrum obtained for PEAA(23 kDa)-X. Two
doublets are evident in the arom atic region. These represent the benzene group. A
singlet is seen at ~7.000 ppm representing the malemide group. A broad range peak is
seen at approximately 2 ppm, representing the polymer. A distinct chemical downward
shift is evident for both the doublet and the singlet compared to the linker alone (Figure
5.2). This is caused by conjugation of the polymer to the hydrazide linker. Other peaks
were visible, however, these were attributed to either the blocking group, the solvent or
the polymer.
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5.3.3

D eterm ining

the

Number

of

H ydrazide-L inkers

Conjugated to PA A As
At acidic pH, PAAAs are thought to cause membrane rupture by inserting themselves
directly into membranes. This is thought to occur following a conformational change of
the PAAA from an expanded coil shape to a more complex shape. This conformational
change is most likely related to the increased hydrophobic character when the many
carboxylate ions become protonated at low pH (Murthy et al., 1999). Therefore, when
conjugating the hydrazide linker to a PAAA, a sufficient fraction of carboxylate ions
must rem ain unm odified to ensure that the PAAA retains its ability to disrupt
membranes. It was suggested that the ability of these polymers to lyse membranes may
be lost if more than 3-5% of carboxyl groups are altered (C. Cheung, 2002, pers.
commun.). The number of hydrazide linkers attached to the polymers was determined
using SAMSA fluorescein (see section 5.2.2.3 for details). Table 5.4 summarises the
number of hydrazides attached to PAAAs and the percentage of carboxyl groups
derivatized.

PAAA

No. of linkers

(Molecular weight)

attached per PAAA

% of COOH derivatized

molecule
PEAA (23 kDa)

4

2

PEAA (32 kDa)

6

2

PPAA (43 kDa)

13

3

Table 5.4: Number of carboxcyclic-hydrazide linkers conjugated to three PAAAs. These
num bers were calculated on the basis of results from an assay using SAMSA
fluorescein (see section 5.2.2.3 for methods).
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Determining the pH-Sensitive Membrane-Lytic Ability of
PAAAs Derivatized with Hydrazide Linker

Whole cell experiments, similar to those described in section 3.2.2.5, were performed to
determ ine if the derivatized polym ers (PAAA-X) retained their ability to disrupt
membranes in a pH-sensitive manner. Three derivatized polymers, with molecular
weights ranging from 23 kDa to 43 kDa were tested. Cytolysis was detected by flow
cytometric analysis of Pi-stained cells.

At pH 7, 6.5 and 6, approximately 5% of cells were non-viable following exposure to
either PEAA(23 kDa) or PEAA(23 kDa)-X. At pH 5.5, both PEAA(23 kDa) and
PEAA(23 kDa)-X lysed approximately 97% of cells; in both cases the extent of cell
lysis increased slightly at pH 5 to about 99%. At all pH values tested, there were no
significant differences in the extent of cell lysis induced by PEAA(23 kDa) or PEAA(23
kDa)-X (Figure 5.4 A). Sim ilar results were obtained when PEAA(32 kDa) and
PEAA(32 kDa)-X were tested, except that at pH 6, both PEAA(32 kDa) and PEAA(32
kDa)-X lysed more cells (15% and 28%, respectively) (Figure 5.4 B). The difference
between the percentage of cells lysed by PEAA(32 kDa)-X and PEAA(32 kDa) at pH 6
was not significant (p> 0.05 F u = 5.2943, Students t-test). The results shown in this
chapter indicate that derivatization of PEAA with a hydrazide linker had no significant
effect on its ability to lyse cells at pH 5-5.5.

Previously, PPAA was shown to disrupt RBC at pH 6.5 and below (Stayton et al.,
2000). Similarly, in whole cell experiments described in this chapter, cell lysis induced
by PPAA (43 kDa) occurred at pH 6.5 and below. At pH 6.5, PPAA(43 kDa) lysed
approximately 90% of cells; this increased to approximately 95% at pH 6. However, at
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pH 5.5 and below the percentage of cells lysed by PPAA(43 kDa) decreased. This
extent of cell lysis was similar when PPAA(43 kDa)-X was used. Like PEAA polymers,
there was no significant difference in the extent of cell lysis induced by either PPAA(43
kDa) or PPAA(43 kDa)-X (Figure 5.4 C).
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Testing the Effects of pH on the Stability of the
Carboxcyclic-Hydrazide Bond in the Linker Used to
Derivatize PAAAs

Theoretically, at physiological pH, the carboxcyclic-hydrazide bond within the linker is
stable. However at acidic pH, the linker is expected to be cleaved from the polymer,
generating free primary am ine groups. Stability of the PAAA-X constructs was
determ ined using fluorescam ine, a non-fluorescent molecule that reacts with free
primary amines to produce a fluorescent product. Stability tests were conducted on three
types of PAAA-X, form ed from PEAA(23 and 32 kDa) and PPAA(43 kDa).
Derivatized polymers were incubated in phosphate buffers at either pH 7 or 5. At 0, 24
and 48 hours, aliquots of these samples were assayed for free amine groups using
fluorescamine (see section 5.2.2.5).

In all cases, the resulting fluorescence for aliquots taken from the pH 7 buffer was
significantly lower than those obtained for corresponding aliquots taken from the pH 5
buffer (Figure 5.5 A, B and C). For the PAAA-X samples incubated at pH 7, the
fluorescence ranged between 2000 and 2500 arbitrary units. Fluorescence did not
change significantly during the 48 hour time period for these samples. The fluorescence
obtained from aliquots taken from the pH 7 buffer was similar to that of the controls
(i.e. buffer containing PAAA plus fluorescam ine (data not shown) or fluorescamine
alone). These results suggest that the carboxcyclic-hydrazide bond in the linker is stable
at pH 7.

For PEAA(23 kDa)-X incubated at pH 5, the level of fluorescence measured for the 0
hour sample was approximately 6000 arbitrary units. Surprisingly, a significantly lower
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7000

■ Fluorescamine only

Fluorescence (arbitrary units)

□ PEAA(23 kDa)-X pH 7
□ PEAA(23 kDa)-X pH 5
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Figure 5.5: Bar graphs showing the level of fluorescam ine fluorescence m easured for
7000

PAAA-X samples incubated in either pH 5 or pH 7 buffers for up to 48 hours. PAAAs

in pH 5 or pH 7 buffer. The level of fluorescence measured for samples containing only
fluorescam ine are also shown. Each data point represents the mean of the values from
three independent experiments. Error bars represent the standard errors of the mean in
each case.
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Conjugation of Bad(140-165) to PAAA-X

Bad(140-165) was conjugated to both PPAA-X and PEAA-X. Bad(140-165) has 7 free
amines; conjugation of Bad(140-165) to PAAA-X was confirmed by measuring an
increase in primary amine groups associated with the conjugate (by fluorescamine
assay; section 5.2.2.5). The fluorescence obtained for PPAA(43 kDa)-X alone was
approximately 14000 arbitrary units. The fluorescence obtained for PPAA-X-Bad(140165) was significantly higher (~17000 arbitrary units) than that obtained for PPAA(43
kDa)-X alone (p<0.0001, F, 14 = 93.54, Student’s t-test; Figure 5.6). These results
suggest that conjugation between PPAA-X and Bad(140-165) was successful.
Conjugation of Bad(140-165) to PEAA-X was also successful (results not shown).
(Note: In these experiments the sensitivity settings on the Biolumin fluorescence plate
reader were different from those used in previous experiments, hence the fluorescence
values shown in Figure 5.6 are considerably higher than those previously displayed in
Figure 5.5). The number of Bad(140-165) molecules attached per PAAA molecule were
calculated using the results of fluorescamine assays and are shown in Table 5.5.
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Figure 5.6: Bar graph showing the results of fluorescamine assays testing PPAA-XBad(140-165) (white bar), PPAA-X (grey bar) and fluorescamine only (black bar). Each
data point represents the mean of values from three independent experiments. Error bars
represent the standard errors of the mean in each case and in some cases are too small to
be seen.

PAAA

No. o f linkers attached

No. of Bad(140-165)

(Molecular weight)

per PAAA molecule

molecules attached per
PAAA molecule

PEAA (23 kDa)

4

2

PEAA (32 kDa)

6

2

PPAA (43 kDa)

13

5

Table 5.5: Number of Bad( 140-165) molecules conjugated to PAAA-X.
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Introduction of PPAA/PEAA-X-Bad(140-165) into U937
Cells by Constitutive Endocytosis

PEAA(23 kDa)-X-Bad(140-165), PEAA(32 kDa)-X-Bad(140-165) and PPAA(43 kDa)X-Bad( 140-165) were introduced into U937 cells by constitutive endocytosis, using
methods described in section 3.2.2.1 (except that, following the initial incubation, cells
were incubated in 4 ml of complete medium containing the constructs for 3 days). Cell
viability was determined after 24, 48 and 72 hours. Over this time, there was a small,
but insignificant, increase in the proportion of dead cells in both control and PAAA-XBad(140-165)-treated cells. An increase in cell density over the 72 hours (due to normal
cell multiplication) may have resulted in the increase in non-viable cells. Results
obtained for PEAA(32 kDa)-X-Bad(140-165) are shown in Figure 5.7.
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Figure 5.7: Bar graph showing the viability of U937 cells following uptake of PEAA(32
kDa)-X-Bad(140-165) by constitutive endocytosis. Graph shows the percentage of nonviable cells in: control (white bars) and cells incubated with PEAA(32 kDa)-XBad(140-165) (grey bars). Each data point represents the mean value from three
independent experiments. Error bars represent the standard errors of the mean in each
case and in some cases are too small to be seen.

PAAAs are internalised into cells by constitutive endocytosis and transit through early
endosomes. To determine if this is also true for PAAA-X-Bad(140-165) constructs,
cells were incubated for 30 minutes in PB containing PPAA-X-Bad( 140-165)-biotin.
U937 cells were then stained with anti-EEAl antibody and Alexa 488-conjugated goat
anti-mouse Ig; PPAA-X-Bad( 140-165)-biotin was detected using streptavidin-Alexa
546. Confocal microscopy showed PPAA-X-Bad(140-165)-biotin located primarily at
the periphery of the cell. In approximately 50% of cells there was partial overlap of the
fluorescences attributable to PPAA-X-Bad(140-165)-biotin and EEA1. This pattern of
fluorescence suggests that, like PPAA alone, PPAA-X-Bad( 140-165)-biotin enters cells
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via endocytosis and transits through early endosomes (Figure 5.8). A similar pattern of
fluorescence was observed when PEAA-X-Bad(140-165)-biotin was introduced into
U937 cells (data not shown).
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Figure 5.8: Confocal microscopy images of U937 cells incubated for 30 minutes in PB
containing PPAA-X-Bad(140-165)-biotin. Images show cells stained with (a) antiEEA1 antibody only (green fluorescence), (b) streptavidin-A lexa 546, and (c) an
overlay of the two fluorescence images. In approximately 50% of cells, vesicles show
partial co-localisation of green and red fluorescence (arrow s). This result is
representative of two independent experiments. Approximately 240 cells were scanned
to ensure reproducibility. Bar = 10 n m.

To determ ine if the membrane disruptive ability of PAAAs is retained following
conjugation of Bad(140-165), U937 cells were incubated in PB containing the
membrane-impermeable fluor calcein and PEAA(32 kDa)-X-Bad(140-165) (see section
5.2.2.7). There was a time dependent release of calcein from vesicles to the cytosol
when cells were incubated in the presence of PEAA(32 kDa)-X-Bad(140-165). Two
hours after uptake, fluorescent vesicles were still clearly seen in some PEAA(32 kDa)X-Bad(140-165)-treated cells while in others the fluorescence was considerably more
diffuse (Figure 5.9, panel b). At 4 hours following loading, fluorescence was diffuse in
most cells, indicating release of calcein from vesicles to the cytosol (Figure 5.9, panel
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c). A similar pattern of fluorescence was detected when cells were incubated in the
presence of PPAA-X-Bad(140-165) (data not shown).
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Figure 5.9: Confocal microscopy images of U937 cells incubated in PB containing 200
^ig/ml of PEAA(32 kDa)-X-Bad(140-165) and 2 mg/ml calcein. Images show U937
cells immediately after uptake of PEAA(32 kDa)-X-Bad( 140-165) and 2 and 4 hours
after uptake (b and c, respectively). This result is representative of three independent
experiments. 50 cells were scanned to ensure reproducibility. Bar = 10 /im .
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Discussion

This chapter described the synthesis of a pH-sensitive hydrazide linker, the structure of
which was confirm ed by one-dim ensional H NMR. The hydrazide linker was
conjugated to various PAAAs. Results presented in this chapter show that
approximately 2-3% of the carboxyl groups were conjugated to the linker (Table 5.4).
Cheung and colleagues have previously conjugated anti-tumour agents to PAAAs. They
found that derivatization of more than 3-5% of the carboxyl groups on the polymers
inhibited their ability to disrupt membranes in a pH-sensitive manner (C. Cheung, pers.
co m m u n .). Therefore, in experim ents conducted, the percentage of derivatized
carboxylate ions was kept to a minimum.

The ability of the polymer to disrupt membranes in a pH-dependant manner was not
affected by the conjugation of hydrazide linker (X) to the polymer (Figure 5.4). In all
cases, the cytolytic efficiencies of underivatized PAAAs and the corresponding PAAAX derivatives were not significantly different (Figure 5.4). The maximum cytolysis for
both PPAA and PPAA-X occurred at pH 6.0, while that for PEAA and PEAA-X
(irrespective of molecular weight) occurred at pH 5.0-5.5. The efficiency of cytolysis of
PPAA and PPAA-X decreased at pH 5.5 and below. The reason for this is not known,
however, Stayton and colleagues have recently shown a similar trend in experiments
involving PPAA and RBCs. They showed that the haemolytic activity of PPAA was
lower at pH 5.5 than at pH 6.5 or 6. At pH 5.5 and below, PPAA has a tendency to
precipitate from solution. Stayton et al. (2000) have suggested that the greater
hydrophobicity of PPAA may explain why it had reduced haemolytic efficiency at pH
<6. It is possible that at pH <6, PPAA (and PPAA-X) form micro-aggregates which
reduces their cytolytic activity.
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To determine the stability of the carboxcyclic-hydrazide bond, PAAA-X samples were
incubated in buffer at either pH 5 or pH 7 for up to 48 hours and then assayed using
fluorescam ine. Fluorescam ine reacts with prim ary am ine groups to produce a
fluorescent product. Cleavage of the carboxcyclic-hydrazide bond generates two
primary amines that are otherwise absent from the structure of PAAA-X. For PAAA-X
samples incubated at pH 7, the level of fluorescence measured in the fluorescamine
assay was not expected to change over 48 hours; this was found to be the case for all
PAAA-X samples tested (Figure 5.5). In contrast, for PAAA-X samples incubated at pH
5, it was expected that the level of fluorescence measured in the fluorescamine assay
would increase at each consecutive tim e point. This was found to be the case for
PEAA(32 kDa)-X but not for the other two PAAA-X constructs tested. For PEAA(23
kDa)-X, the fluorescence obtained for the 24 hour sample was about 15% lower than the
values obtained for 0 or 48 hours, which were similar (Figure 5.5 A). The anomalously
low value for the 24 hour sample may have resulted from the use of an aged stock
solution of fluorescamine; several stock solutions were used in these experiments and in
some cases they may have been of different ages (up to several days old, stored at 4 C;
fluorescamine is known to oxidise slowly in solution). In the case of PPAA(43 kDa)-X,
the values obtained for the 24 and 48 hour samples were not significantly different from
each other but these values were slightly higher than the value obtained for the 0 hour
sample. Overall, the levels of fluorescence measured for all PAAA-X samples incubated
at pH 5, irrespective of the time of incubation, were significantly higher than those
measured for corresponding samples incubated at pH 7. These results suggest that the
carboxcyclic-hydrazide bond is stable at pH 7 (physiological pH) but at pH 5 (which is
found inside late endosomes/lysosomes) is very unstable and under these conditions, in
many cases, cleaves almost immediately.
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The final experiments described in this chapter involved conjugating Bad(140-165) to
PAAA-X, and determining the effects on cells of the uptake of PAAA-X-Bad(140-165)
conjugates by constitutive endocytosis. Conjugation of PAAA-X and Bad(140-165) was
confirmed using fluorescam ine (Figure 5.6). Quantitative analyses showed that the
number of Bad(140-165) molecules attached per PAAA ranged from 2 to 5, depending
on the polymer used (Table 5.5). These results indicate that approximately one third of
the linkers attached to the polymer conjugated with Bad(140-165). The reason why
Bad(140-165) did not conjugate to all of the attached linker molecules is currently
unknown but may be a result of the instability of the reactive maleimide group in
aqueous solution.

Surprisingly, uptake of PAAA-X-Bad(140-165) did not induce cell death (Figure 5.7).
We expected that endocytosis of PAAA-X-Bad( 140-165) would result in apoptosis.
This expectation was based on the following:
1. Results shown in chapter 3 demonstrate that PAAAs are taken up by endocytosis
and disrupt endosomes to release both small and macro-molecules to the cytosol.
2. Results shown in Figure 5.8 suggest that PPAA-X-Bad(140-165) is taken up by
endocytosis and transits through early endosomes before moving onto other
vesicular compartments.
3. Results shown in this chapter dem onstrate that the pH-sensitive membrane
disruptive ability of PAAAs is not affected following conjugation of the linker
and Bad(140-165). Results shown in Figure 5.9 dem onstrate that uptake of
PEAA-X-Bad(140-165) induced physical disruption of endosomes sufficient to
release calcein into the cytosol. These results are consistent with those reported
by Lackey and colleagues (1999) who demonstrated that PPAA retains its ability
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to lyse RBCs following conjugation with streptavidin. They also showed that
PPA A -streptavidin com plexes have sim ilar haem olytic activity to that of
unmodified PPAA (Lackey et al., 1999).
4. Results presented in this chapter show that the linker is stable at physiological
pH but not at the pH found in endosomes (Figure 5.5).
5. Work previously performed in this laboratory showed that pinocytic loading
(described in section 6.2.2.1) of Bad(140-165) alone into U937 cells induced
characteristics of apoptosis (Woods, 2000). Immediately after pinocytic loading
of Bad(140-165), approximately: 25% of cells had depolarised mitochondria
(compared to 2% of control cells), 40% of cells had PS exposure (compared to
6% of control cells), and 76% of cells showed a diffuse pattern of fluorescence
following staining with anti-cytochrome c antibody, suggesting cytochrome c
release (only 11% of control cells showed a diffuse pattern of fluorescence). In
addition, it was shown that caspase inhibition significantly reduced the extent of
cell death induced by pinocytic loading of Bad(140-165). These results
dem onstrated that cytosolic Bad(140-165) induces apoptosis. Several other
research groups have also shown that apoptosis is induced following cytosolic
delivery of a variety of pro-apoptotic peptides similar to the one used in this
study (Kelekar et al., 1997; Narita et al., 1998).

Collectively, the above results suggest that PA A A-X-Bad( 140-165) constructs are
internalised by cells into endosomes where the low pH of the lumen would (1)
rapidly cleave the carboxcyclic-hydrazide bond in the linker, releasing Bad(MO165), and (2) trigger the polymer to disrupt the endosomal membrane and release its
contents (including Bad(140-165)) to the cytosol. So, the question is why did uptake
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of PAAA-X-Bad(140-165) not induce apoptosis? The reason(s) for this are not yet
known but could include the following:
1. In vivo, the linker may not have been completely cleaved from the construct,
thereby limiting the amount of Bad(140-165) released into the cytosol.
2. Regardless of the extent of linker cleavage, the am ount of Bad(140-165)
released may not have been enough to induce apoptosis. To estimate the amount
of Bad(140-165) theoretically delivered into cells in the experiments described
here, the ratio of the intracellular concentration of a constitutively endocytosed
fluorescently-labelled protein to its concentration in the external medium was
determined. A standard curve plotting fluorescence versus concentration was
produced for FITC-insulin. U937 cells were then allowed to constitutively
endocytose FITC -insulin fo r a period of 20 m inutes from an external
concentration of 200 //g/ml (as described in section 3.2.2.1). Subsequently,
lOxlO6 U937 cells were disrupted using a series of five freeze/thaw cycles and
the lysate centrifuged (16,000 g, 6 minutes) to pellet cell debris. The level of
fluorescence in the supernatant was then determined and used to calculate the
amount of FITC-insulin internalised by the cells. Assuming that U937 cells are
spheres of 24 nm in diam eter (estimated from confocal microscopy), it was
calculated that the final intracellular concentration of FITC-insulin was only
0.08% of that in the external medium (results not shown). Using this value, it is
possible to estimate that after 20 minutes of endocytosis, the concentration of
PAAA-X-Bad(140-165) within U937 cells would be about 3.06 x 10 10 M.
Assuming complete cleavage of Bad(140-165) from the polymer, and knowing
that each PAAA molecule had 2-5 Bad(140-165) peptides attached (Table 5.5),
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this predicts that under these conditions the final intracellular concentration of
Bad( 140-165) would be in the range 0.61 - 1 .5 3 x 109 M.

The in vitro binding affinity (KD) of Bad(140-165) for Bcl-XL is 6.0 x 1 0 9 M
(Kelekar et al., 1997); this binding interaction is thought to be involved in
exerting the pro-apoptotic effect of Bad. Thus, the calculations outlined above
(with all their assumptions), indicate that after 20 minutes of endocytosis from
an external concentration of PA A A -X -B ad(140-165) o f 200 /^g/ml, the
intracellular concentration of Bad(140-165) would be, at most, approximately 4
fold lower than that required for significant interaction with Bcl-XL. Therefore, it
is quite feasible that the concentration of PAAA-X-Bad(140-165) released into
the cytosol may not have been enough to induce apoptosis.
3. Cleavage of the linker occurs at a double bond (Figure 5.10). This results in the
bulk of the structure of the linker remaining attached to the released peptide.
Pro-apoptotic peptides interact with anti-apoptotic proteins in a specific manner
(see sections 1.3.2.1 and 1.6). Thus, it is possible that the linker structure that
remains attached to Bad(140-165) prevents its interaction with Bcl-xL (an antiapoptotic protein, see section 1.3.2.1) and inhibits its ability to induce apoptosis.
Alternatively, or in addition, it is also possible that the cathepsin cleavage site
incorporated into Bad(140-165) may also prevent its interaction with antiapoptotic proteins.
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Figure 5.10: Schematic representation of the cleavage of PAAA-X-Bad(140-165) at
acidic pH. Cleavage occurs at the double bond (indicated by the arrow) and results in
the bulk of the linker structure remaining associated with the released Bad(140-165).

In conclusion, results presented in this chapter describe initial work directed towards the
developm ent of a novel cancer therapeutic. Additional experim ents (described in
chapter 7) will be needed to determine why PAAA-X-Bad(140-165) did not induce
apoptosis following uptake by constitutive endocytosis. However, results thus far are
positive and show great potential for further development.
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Chapter 6

Detection of Mitochondrial Permeability
Transition in Intact Cells
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6.1

M PT in Intact Cells

Introduction

Traditional cancer therapeutics don’t directly manipulate apoptosis but instead kill
cancer cells by indirect methods (e.g. by interfering with DNA replication). However,
new cancer therapeutics in development, are now focusing on targeting apoptosis
directly. Apoptosis is an ideal mode of killing because apoptotic cells are naturally
engulfed and degraded by phagocytes, preventing the release of toxic cellular contents
into adjacent healthy tissue. To confirm that the new therapeutics induce apoptosis in
intact cells it will be necessary to accurately measure apoptotic process, such as MPT.

MPT has been studied in isolated mitochondria for decades (Zoratti and Szabo, 1995)
and more recently in intact cells. In in vitro studies, MPT is associated with loss of
electrical potential difference across the inner mitochondrial membrane (i.e. the loss of
Axj)mjt) and mitochondrial swelling resulting from an increase in the permeability of
m itochondria to solutes up to 1500 Da in mass (Zoratti and Szabo, 1995). MPT is
thought to result from the sustained opening of permeability transition pores (PTP) that
form at points of contact between the inner and outer mitochondrial membranes. Other
studies of mitochondria, both in intact cells and as isolated organelles in vitro, have
provided evidence that PTP can also undergo rapid transient openings that do not result
in MPT (Petronilli et al., 1999; Ichas et al., 1997; H u serera/., 1998).

The precise biological role(s) of MPT have yet to be established. However, it has been
implicated as being important in several aspects of cell physiology and pathology,
including:
1. Control of mitochondrial calcium homeostasis (Zoratti and Szabo, 1995).
2. Initiation of autophagy (Lemasters et al., 1998).
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3. Triggering necrosis in cells undergoing ischem ia- and reperfusion-induced
injury (Lemasters et al., 1998; Di Lisa et al., 2001).
4. Triggering apoptosis (Loeffler and Kroemer, 2000).

Given the likelihood that MPT performs critical biological functions, it is important to
develop a valid technique for measuring this phenomenon in intact cells. Two previous
approaches for doing this have been described, however, both have significant
limitations. Both of these techniques utilize the membrane-permeable acetoxymethyl
ester of calcein (calcein-A M ) to stain the cytosol (Nieminen et al., 1995) or the
mitochondrial matrix (Petronilli et al., 1999).

The first reported technique measured MPT in hepatocytes by tracing the movement of
cytosolic calcein into mitochondria. The movement of calcein into mitochondria was
imaged using confocal microscopy. This technique involved introducing calcein-AM
into cells via diffusion and subsequently staining them with TMRM (TMRM labels
polarised m itochondria with bright red fluorescence). Theoretically, once inside the
cytosol, the ester bond is cleaved by non-specific esterases to release free calcein, which
is membrane-impermeable. Using this technique, polarised mitochondria fluoresced red
due to the accumulation of TMRM and, when viewing calcein fluorescence, appeared as
dark voids within a brightly green fluorescent cytosol (Nieminen et al., 1995). In this
technique, MPT is detected by a loss of mitochondrial staining with TMRM and an
increase in calcein fluorescence inside mitochondria.

M inamikawa et al. (1999a) described a second technique for measuring MPT in intact
cells. In this technique, calcein-AM is loaded into cells (by diffusion) and stained with
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TMRM. Cells are also simultaneously incubated with Co2+ ions, which enter the cytosol
but not mitochondria to complex with calcein and thereby quench its fluorescence. This
technique detects MPT by a loss of mitochondrial staining with TMRM and a decrease
in calcein fluorescence inside mitochondria (Minamikawa et al., 1999 a and b).

The following chapter describes the development of an alternative confocal microscopy
technique for the detection of MPT in intact cells that is free of the disadvantages
associated with the other techniques described above (see discussion for more details).
In this new approach, unconjugated calcein is simultaneously introduced into the
cytosol of millions of cells by the process of pinocytic loading and, to identify the
position of individual mitochondria and to measure Atjjmit, the cells are counter-stained
with TMRM. A variety of cells types were used and results show that cytosolic calcein,
which is initially excluded from polarized mitochondria, gradually enters them in
response to transient openings of the MPT pore and that induction of sustained MPT
produces a rapid net movement of calcein into mitochondria. Figure 6.1 schematically
represents the three techniques for measuring MPT in intact cells.
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Figure 6.1: Schematic representations of three confocal microscopic techniques for
measuring MPT in intact cells. In all cases, cells are stained with TMRM, which label
polarised mitochondria with bright red fluorescence, (a) Calcein-AM is loaded into cells
via diffusion (straight dotted arrow). Once inside, the ester bond is cleaved by non
specific esterases (thin solid arrow ) to release free calcein that is membrane
impermeable (thick solid arrow), (b) Calcein is loaded into cells as in (a) but cells are
simultaneously incubated with 1 mM Co2+ ions, which enter the cytosol but not
mitochondria to complex with calcein and thereby quench its fluorescence, (c) Calcein
is directly introduced into cells by pinocytic loading (PL) and is largely excluded from
the mitochondrial matrix. In these methods, MPT is detected by a loss of mitochondrial
staining with TMRM and either an increase (a and c) or a decrease (b) in calcein
fluorescence inside mitochondria.

172

C hapter 6

M PT in Intact Cells

6.2

Materials and Methods

6.2.1

Materials

Polyethylene glycol (molecular mass 1000 Da: PEG1000), sucrose, and 13-ds-retinoic
acid (RA) were from Sigma (Sydney, Australia). N-(2-hydroxyethyl)piperazine-N’-(2ethanesulfonic acid ) (HEPES) was from United States Biochemical Corp. (OH, USA).
Calcein-AM and tetramethylrhodam ine methyl ester (TMRM) were from M olecular
Probes Inc. (OR, USA). Bongkrekic acid (BA) was a gift from Prof J Duine (University
of Delft, the Netherlands). All other chemicals were of analytical reagent grade and
were from Ajax Chemicals (Sydney, Australia).

6.2.2

Methods

6.2.2.1

Pinocytic Loading of Intact Cells

Pinocytic loading is a technique that was developed for the introduction of
macromolecules into mammalian cells and is a convenient, rapid and simple procedure.
Unlike other cell loading methods, such as microinjection and electroporation, pinocytic
loading provides a more gentle cell-loading method and does not significantly alter cell
function. The pinocytic loading technique is based on the osmotic lysis of pinocytic
vesicles (Okada and Rechsteiner, 1982). Macromolecules are firstly taken up by cells
via pinocytosis. The cells are then placed in a hypotonic medium, which results in the
bursting of pinosomes within the cells and release of their contents to the cytosol
(Figure 6.2). Pinocytic loading has previously been used to load macromolecules such
as monoclonal antibodies (Chakrabarti et al., 1989), fluoresceinated dextran and
horseradish peroxidase (Okada and Rechsteiner, 1982) into intact cells. Cell viability is
maintained throughout the procedure.
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Figure 6.2: Schematic representation of the process of pinocytic loading, (a) Cells are
incubated in a hyper-osmotic buffer containing the molecule to be loaded. This causes a
loss of water from the cells and the simultaneous uptake of pinocytic vesicles containing
the target molecule, (b) During the subsequent incubation in a mildly hypo-osmotic
buffer, water re-enters the cells and the hyper-osmolar pinocytic vesicles causing them
to burst, (c) Release of macromolecules into the cytosol of the cell.

Cells (2 x l0 6) were centrifuged for 5 m inutes at 300 g and washed in 1 ml of
DMEM:F12. Cells were re-centrifuged as above and the supernatant was thoroughly
drained. The cells were then gently resuspended in 100 (.il of hyper-osmotic buffer (10
mM HEPES, 10% (w/v) polyethylene glycol (PEG), 0.5 M sucrose, pH 7.4) containing
the compound to be loaded at a concentration of 2 mg/ml. The cell suspension was
incubated for 10 m inutes at 37°C and diluted with hypo-osm otic buffer (60%
DMEM:F12 and 40% water (v/v)) to make up a final volume of 10 ml. Cells were then
incubated for 2 minutes at 37°C and centrifuged as above. Cells were washed twice with
DMEM:F12. For immediate analysis by confocal microscopy, cells were resuspended in
200 n\ of complete medium.

In some experiments, pharmacological inhibitors of MPT (100 /^M bongkrekic acid or
10 /yM cyclosporin A) were added to the calcein/hyper-osomotic buffer solution during
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cell loading and to the medium in which cells were incubated for up to 1 hour prior to
confocal microscopic analysis. In other experiments, cells were treated with 0.5 mM 13c/s-retinoic acid (to induce MPT) immediately before confocal analysis.

6.2.2.2

Staining C ells with a C ationic F luorescent Dye to M easure
Mitochondrial Membrane Potential

Tetramethylrhodamine methyl ester perchlorate (TMRM) is a cationic flurophore that
accumulates inside mitochondria in response to the Aipmit (Heiskanen et al., 1999), thus
enabling changes in Aipmit to be monitored. Depolarisation results in mitochondrial
release of TMRM and reduced mitochondrial red fluorescence.

Cells (lx lO 6) were centrifuged for 5 minutes at 300 g. The supernatant was discarded
and cells were resuspended in 500 ^1 of 50 nM TMRM in complete medium. TMRM
was added by diluting 1 mM stock (in DMSO) to 1 //M in complete medium and then
diluting the 1 //M stock 1:50 in complete medium. Samples were incubated at 37°C for
15 minutes in the dark and then immediately analysed by confocal microscopy and/or
flow cytometry.

6.2.2.3

Confocal Microscopy, Flow Cytometry and Image Analysis

Following cell labelling, cells were immediately loaded onto glass slides and examined
by a Leica DMIRBE inverted microscope coupled to a Leica TCS SP confocal system
(Leica M icrosystems, Sydney, Australia). Cells were sequentially excited at 488 nm
(calcein) and 543 nm (TMRM) and fluorescence collected using emission windows set
at 500-540 nm (calcein) and 560-610 nm (TMRM). All signals collected were adjusted
to remain within the linear range of the detectors. Images were collected using TCS NT
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software (Leica Microsystems, Sydney, Australia). In some experiments, this software
was also used to calculate the average pixel intensity of calcein fluorescence within
regions of interest (ROI) drawn onto collected images. In these cases, for each
treatment, images of 10-14 individual cells were analysed as follows. For each cell, the
mean fluorescence was determined for three ROI drawn to represent (1) mitochondria
(these were drawn to be contained within regions stained with TM RM ), (2) cytosol
(drawn inside the cells but outside those regions stained with TM RM ), and (3)
background (drawn outside the cell). The values for each set of three ROI were
averaged, then the mean background value was subtracted from each of the mean values
for mitochondria and cytosol. Finally the background corrected value for mitochondria
was divided by the corresponding value for the cytosol and expressed as a percentage.
Differences between treatments were analysed using Oneway ANOVA (JMP software,
SAS Institute INC, Cary, NC, USA). Images to be incorporated into figures were
exported as TIFF files and figures were assembled using Adobe Photoshop v5.0
software (Adobe Systems, Sydney, Australia).

In some experiments, cells stained with 50 nM TMRM (as previously described) were
subsequently analysed using a FACSort flow cytometer (Becton Dickinson, Sydney).
The cells were excited with a 488 nm Argon laser and fluorescence collected using a
585 +/- 21 nm band pass filter. Acquired data was analysed using CellQuest (v.3.1f)
software (Becton Dickinson, Sydney).
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6.3

Results

6.3.1

Imaging Mitochondria by Staining Cells with Calcein-AM
and TMRM

Results shown in section 6.3.1 were obtained by Alison Smail. They are included in this
thesis because they complement other related work (sections 6.3.2 and 6.3.3).

Jurkat cells were loaded with calcein-AM and stained with TMRM. Calcein-AM was
loaded into the cytosol and also, to a lesser extent, mitochondria. In the absence of costaining (Figure 6.3, panel a) mitochondria were detectable as areas of slightly lower
fluorescence intensity within a field of bright cytosolic calcein fluorescence. This was
also true for cells stained with 50 nM TM RM (Figure 6.3, panel b). The areas of
reduced fluorescence levels in cytosolic calcein fluorescence corresponded to red
fluorescent mitochondria stained with TMRM (Figure 6.3, panel b-d). However, under
these conditions, because of the relatively small difference between the intensity of
calcein fluorescence in m itochondria versus the cytosol, it was difficult to visually
discriminate mitochondria solely on this basis. Higher concentrations of TMRM were
also tested. In cells stained with 100 nM, 500 nM and particularly 2000 nM TMRM, the
intensity of green calcein fluorescence detected within mitochondria visibly decreased
and they became more easily discernable as darkened voids within the brightly
fluorescent cytosol (Figure 6.3 panels e and h). Thus, it is possible that when calceinAM-loaded cells were stained with TMRM (at 100 nM or 500 nM, but not at 50 nM),
mitochondrially-accumulated TMRM caused quenching of intra-mitochondrial calcein
fluorescence.
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This interpretation was confirmed by quantitative analysis of images collected for cells
pinocytically loaded with calcein and stained with a range of concentrations of TMRM.
When low concentrations of TM RM were used, the average intensity of calcein
fluorescence in ROI drawn within mitochondria was approximately 90% of that in the
cytosol, confirming that calcein-AM is poorly excluded by Jurkat cell mitochondria
(Figure 6.4). Similar results were obtained for U937 cells (data not shown). As the
concentration of TM RM used to stain cells was increased above 100 nM, calcein
fluorescence w ithin m itochondria decreased (Figure 6.4). The level o f calcein
fluorescence within mitochondria in cells stained with 1-2 //M TMRM was significantly
reduced from that in cells stained with 10-100 nM TMRM (p<0.001, F363=37.0, Tukey
Kramer HSD (Honestly Significant Difference)).
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Figure 6.3: Images acquired by confocal microscopy showing Jurkat cells incubated in 1
fiM calcein-AM and stained with 0-2000 nM TMRM. Images are representative of
several independent experiments.

179

Chapter 6

M PT in Intact Cells

[TMRM] (|iM)

Figure 6.4 : Plot showing the level of calcein fluorescence, in ROI drawn within
TM RM -stained m itochondria, expressed as a percentage of the cytosolic calcein
fluorescence for Jurkat cells loaded with 1

calcein-AM and stained with 0.01 - 2

HM TMRM. For each data point, the error bars shown represent the standard errors of
the mean of values determined for 10 cells.

6.3.2

Imaging Mitochondria by Pinocytic Loading of Calcein
into Cells and Staining with TMRM

M itochondria were imaged in both suspension-cultured (Jurkat cells) and adherent
(HeLa cells) human cells following pinocytic loading of calcein and staining with
TMRM. In HeLa cells, m itochondria excluded sufficient calcein to give them the
appearance of darkened voids in a bright green background of cytosolic fluorescence
(Figure 6.5, panel a). Polarised m itochondria stained with TM RM were clearly
discerned by their bright red fluorescence (Figure 6.5, panel b) and corresponded in
position to darkened areas in the calcein fluorescence (Figure 6.5, panel c). In some
cells, the edges of the darkened areas excluding calcein appeared ‘blurred’. Petronilli et
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al. (1999) reported a similar staining pattern in cells loaded with calcein and suggest
that this is probably the result of fluorescence spreading which magnifies the size of
emitting objects, while reducing that of dark spots. Similar results were obtained when
Jurkat cells were used (Figure 6.6 and Figure 6.7).

Figure 6.5: Confocal microscopy images showing HeLa cells pinocytically loaded with
calcein and stained with 50 nM TMRM. Images show: calcein fluorescence (a), TMRM
fluorescence (b), and fluorescence overlay (c). Images shown are representative of
many acquired in two independent experiments.

Jurkat cells were pinocytically loaded with calcein and stained with TMRM before
subsequently being analysed over a period of 1 hour; cells were analysed immediately
after pinocytic loading and again 30 and 60 minutes later. Immediately after staining,
calcein was evenly distributed throughout the cytosol and was partly excluded from
mitochondria; mitochondria appeared as darkened areas in a background of bright green
fluorescence (Figure 6.6). Polarised mitochondria stained with TMRM were clearly
discerned by their bright red fluorescence and corresponded in position to darkened
areas in the calcein fluorescence (data not shown). Quantitative image analysis indicated
that immediately after pinocytic loading with calcein, the level of calcein fluorescence
in ROI draw n w ithin m itochondria (defined by staining with TM RM ) was
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approximately 60% of that of the cytosol (Figure 6.7). A gradual time-dependent in
filling of mitochondria with calcein was observed over the hour time period (Figure 6.6,
panels b and c). This was confirmed by quantitative image analysis, which indicated
that over a 60 minute period immediately following pinocytic loading, for ROI drawn
within m itochondria of control cells, the average intensity of calcein fluorescence
increased steadily from 60% to approximately 80% of that in the cytosol (Figure 6.7).
These changes in fluorescence were statistically significant (p<0.001, F239=24.99,
Tukey-K ram er HSD) and occurred in the absence of any loss of TM RM staining
(Figure 6.8).

The slow calcein influx was inhibited by treating cells for 1 hour with bongrekic acid
(BA) or cyclosporin A prior to calcein loading and TMRM staining. Bongrekic acid and
cyclosporin A are both pharmacological inhibitors of MPT (Marchetti et al., 1996). In
contrast to control cells, over a 1 hour period following pinocytic loading of calcein,
there was no significant change in the average intensity of calcein fluorescence within
ROI drawn within mitochondria of BA-treated cells (Figure 6.7: p=0.156, F239=1.95,
Tukey-Kramer HSD). Similar results were obtained using cells treated with cyclosporin
A (data not shown).
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Figure 6.6: Confocal microscopy images showing calcein fluorescence in control (a-c)
or BA-treated (d-f) Jurkat cells pinocytically loaded with calcein (and stained with 50
nM TMRM), imaged either immediately after loading (a, d), or 30 minutes (b, e) or 60
minutes (c, f) later.
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Tim e (m in u te s)
Figure 6.7: Line graph showing the levels of intra-mitochondrial calcein fluorescence in
control cells ( ♦ ) and BA-treated cells ( □ ) , expressed as a percentage of the level of
cytosolic calcein fluorescence, as a function of time after pinocytic loading. The error
bars shown represent standard errors of the mean of measurements made for 10-14 cells
for each data point (see section 6.2.2.3 for more details).
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Figure 6.8: Overlay histograms showing the results of flow cytometric analysis of Jurkat
cells pinocytically loaded with calcein. The dashed line (the single peak to the left)
represents cells that were not stained with TMRM. The dotted and solid lines (which are
nearly identical in position) represent cells that were stained with TMRM and analysed
either im m ediately or 60 m inutes later, respectively. The results shown are
representative of three independent experiments.

6.3.3

Detecting Mitochondrial Permeability Transition Induced
by Retinoic Acid

Pinocytic loading of cells with calcein and staining with TMRM was also used to detect
MPT induced by brief incubation of cells with retinoic acid (RA). Previous research
indicates that RA acts as a mitochondrial uncoupler and induces MPT and cyctochrome
c release (R igobello et al., 1999). Im m ediately after exposure to RA, calcein
fluorescence was uniform throughout the entire cell. Mitochondria were not discernable
as dark regions or regions of significantly lower green fluorescence and mitochondria
did not stain with TM RM , indicating collapse of

(Figure 6.9). In control cells,
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most areas of reduced calcein fluorescence corresponded in position to TMRM-stained
m itochondria (e.g. the region indicated by arrow n o .l, Figure 6.9, panels a and c).
However, occasionally, areas of lower calcein fluorescence did not correspond in
position with TM RM -stained, polarised mitochondria (e.g. the region indicated by
arrow no.2, Figure 6.9, panel c). This latter type of calcein void was previously reported
in hepatocytes microinjected with calcein (Petronilli et al., 1999) but has not been
identified. It is possible that such regions may correspond to transiently depolarised
mitochondria that have not undergone MPT and that therefore still exclude calcein.

Calcein

TMRM

Overlay

Control

+RA

Figure 6.9: Confocal images showing Jurkat cells pinocytically loaded with calcein and
stained with 50 nM TMRM. Control cells (a-c) received no further treatment. Other
cells (+ RA: d-f) were stained with TMRM in the presence of 0.5 nM RA to induce
mitochondrial permeability transition. The arrow numbered 1 (panel a) indicates a ‘dark
region’ that corresponds in position to TMRM-stained mitochondria (see panel c). The
arrow numbered 2 (panel c) indicates a ‘dark region’ that does not correspond in
position to TMRM-stained mitochondria.
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Discussion

Results presented here demonstrate that pinocytic loading of calcein into cells and
staining with 50 nM TMRM can provide a useful technique for detecting MPT in intact
cells. MPT was detected by a loss of mitochondrial staining with TM RM and an
increase in calcein fluorescence inside mitochondria. Results show that, in a variety of
cell types, cytosolic calcein is excluded from normal polarized mitochondria but enters
them during MPT.

Minamikawa et al. (1999) and Nieminen et al. (1995) describe alternative techniques to
measure MPT in intact cells (see section 6.1). The technique described in this chapter is
a favourable alternative and avoids the disadvantages associated with the earlier
approaches. The advantages of this new technique are:
1. It has successfully been applied to various cell lines including HeLa (human
epitheloid carcinom a), Jurkat (human T cell leukemia) and U937 (human
myelomonocytic), suggesting that it would be applicable to use in most cell
types. The technique described by Nieminen et al. (1995) is only applicable to
some cell types. Nieminen et al. (1995) and Lemasters et al. (1998) reported that
when calcein-AM only is loaded (by diffusion) into rat hepatocytes and then the
cells are stained with TMRM, there appeared to be little calcein fluorescence
detected within mitochondria. However, results described in this chapter and
those of others (Petronilli et al., 1999) show that this is not the case when other
cell types, such as rat hepatoma MH1C1 and Jurkat cells, are loaded with
calcein-AM. In these cases, the ability of the technique (described by Nieminen
et al. (1995)) to image mitochondria as calcein-negative voids, and thereby
measure MPT in intact cells, is significantly limited.
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2. It does not involve toxic substances. The technique of Minamikawa et al. (1999)
to measure MPT (Figure 6.1, panel b) involves loading cells with calcein-AM
but quenching cytosolic calcein fluorescence with Co2+ ions (Minamikawa et al.,
1999a; Minamikawa et al., 1999b). Co2+ is a heavy metal that is known to cause
toxic and other effects on cells. For example Co2+ (1) completely stopped growth
in murine osteoblast-like MC3T3-E1 cells (Okazaki et al., 1998), (2) had
adverse effects on developmental stages of post-blastocyst mouse pre-embryos
in vitro (N iem inen et al., 1995), and (3) significantly increased lactate
production by cultured rat Sertoli cells (Monsees et al., 1998). It is difficult to
exclude the possibility that even short exposures of cells to Co2+ might induce
subtle changes that impact upon mitochondrial physiology.
3. It avoids potential artefacts arising from quenching of intra-m itochondrial
calcein fluorescence. The technique described by Nieminen et al. (1995),
(Figure 6.1, panel a) which stains cells with TMRM at a concentration of 500
nM or above, causes m itochondrially-accumulated TMRM to suppress intram itochondrial calcein fluorescence, probably by fluorescence quenching
(TMRM has been shown to quench calcein fluorescence both in a mixture of the
two fluors in solution and in dual-stained isolated mitochondria (Petronilli et al.,
1999)). Even in cell types which do not accumulate intra-mitochondrial calcein
following loading from 1 ^M calcein-A M , this quenching effect may have
important implications. For example, if calcein-AM-loaded cells are stained with
TMRM at a concentration of 500 nM or greater, TMRM-mediated quenching is
likely to make detection of calcein entry into mitochondria more difficult. This
would probably be most problematic when mitochondria remain polarised and
therefore retain a high internal concentration of TMRM, as has been reported to
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occur when m itochondria undergo transient, reversible openings of the
mitochondrial permeability transition pores (Petronilli et al., 1999). Thus, under
these conditions, MPT might go undetected.
4. It unambiguously identifies the physical movement of calcein across the inner
mitochondrial membrane barrier coincident with MPT. The technique described
by M inam ikawa and associates (Figure 6.1, panel b), relies on calcein-AM
entering m itochondria within cells and being cleaved by esterases to entrap
calcein within the matrix. This does not occur when rat hepatocytes are
incubated in a solution containing 1 j/M calcein-AM (Lemasters et al., 1998).
Thus, at least in this cell type, the technique is not successful or it may require
cell-specific adjustments to the conditions used. Also M inamikawa’s technique
can not discriminate between calcein release from mitochondria or Co2+ entry
into mitochondria.

Importantly, cell viability was maintained when calcein was loaded into cells using the
technique described in this chapter. To load calcein into the cytosol, cells were exposed
for 10 minutes to a hyperosm otic buffer follow ed by a 7 m inute exposure to a
hypoosm otic solution (the effects o f which would tend to counter the initial
hyperosm otic stress). When measured up to 3 days after treatm ent, no effects of
pinocytic loading on the viability of L929 cells were detected (Okada and Rechsteiner,
1982). Furthermore, in studies of Jurkat and HeLa cells, results confirmed that at 5
hours after pinocytic loading there was no decrease in cell viability (data not shown).
Thus, pinocytic loading has no gross effects on cell viability. Furtherm ore, the
demonstration that cytosolic hyperosmolarity induced by uptake of Na+-co-transported,
non-metabolised am ino acids did not affect either matrix volume, respiratory rate,
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in m itochondria within intact hepatocytes (Devin et al.,

1998) suggests that the mild osmotic stress associated with pinocytic loading is unlikely
to affect mitochondria. It has been shown that osmotic stress sustained for a minimum
of 30-100 minutes can induce changes in general cellular metabolism (Brunmair et al.,
2000; Ouwens et al., 2001); however, there is no evidence that short (< 10 minutes)
exposure to mild osmotic stress produces such changes. Using the technique described
in this chapter, measurem ents of M PT are best performed within 30 m inutes of
pinocytic loading. Thus, the available information suggests that the brief, mild osmotic
stress associated with the procedure is unlikely to result in any major, rapid changes in
mitochondria or cell metabolism that would compromise the measurements taken.

Results presented in this chapter show that, when cells were imaged immediately after
pinocytic loading of calcein, the level of calcein fluorescence in ROI drawn within
TM RM -stained mitochondria of control cells was approximately 60% of that in the
cytosol, and increased gradually thereafter. The high level of m easured intramitochondrial calcein fluorescence is probably a consequence of the following two
factors, which relate to features of mitochondrial ultrastructure and the physics of
confocal imaging: (1) Electron microscopy indicates that mitochondria are 0.1-0.5 fxm
thick and, when present as discrete structure, 1-2 |xm long (Frey and Mannella, 2000).
Confocal imaging collects ‘optical sections’ through the specimen of about 1 //m in
thickness. M itochondrial ROI were drawn inside areas containing red (TM RM )
fluorescence. In some planes, the 1 //m thickness of the confocal optical section would
be greater than the dim ensions of mitochondria. In these cases, three-dimensional
spaces seen (in two-dimensions) on-screen as containing TMRM fluorescence might
also contain calcein fluorescence coming from adjacent regions of intermembrane space
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or cytosol that have been captured in the same optical section. (2) Recent ultra-structural
analysis indicates that the cristae, which may occupy a large fraction of the volume of
the mitochondrial interior, are generally connected to the intermembrane space via short
tubular junctions 28 nm in diameter (Frey and Mannella, 2000). Calcein would have
free access (across the permeable outer mitochondrial membrane) to the intermembrane
space and, via the cristae junctions, to the cristae. Confocal microscopy is unable to
spatially resolve cristae within mitochondria. Therefore, using the technique described,
optical sections through the TM RM -stained mitochondrial matrix will incorporate
calcein-containing cristae, even though these are not discerned as discrete visible
structures. Therefore, acting together, both these factors probably account for the level
of calcein fluorescence measured in mitochondrial ROI immediately after pinocytic
loading.

Studies of mitochondria, both in intact cells and as isolated organelles in vitro, have
established that MPT pores constitutively undergo rapid transient openings (Petronilli et
al., 1999; Ichas et al., 1997; Huser et al., 1998). The technique described in this chapter
detected constitutive transient MPT as a gradual time-dependent entry of calcein into
mitochondria. Furthermore, these results demonstrate that RA, a known inducer of MPT
(Rigobello et al., 1999), elicited an influx of calcein into the matrix and a loss of
mitochondrial staining with TMRM. Thus, the technique described here can be used to
measure the occurrence of MPT ‘flickering’ and also the bulk entry of calcein into
mitochondria associated with sustained MPT. The latter is most easily detected when
cells are imaged soon after calcein loading.
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Although this new technique has many advantages over previously described methods,
two limitations have been identified. These are: (1) the measurement of sustained MPT
(detected as complete in-filling of mitochondria with calcein) is best performed within
30 minutes of pinocytic loading, and, more importantly, (2) detection of MPT in cells
undergoing apoptosis is not possible. When cells were pinocytically loaded with calcein
several hours after induction of apoptosis, it was not possible to induce release of
calcein from pinocytic vesicles by incubating cells in hypoosmotic media, even when
conditions were varied to increase the osmotic gradient imposed. This result was
obtained when apoptosis was induced in either (1) Jurkat cells with staurosporine or
anti-Fas antibody, or (2) U937 cells with tumour necrosis factor a and cycloheximide
(results not shown). The reason(s) underlying the difference in behaviour between
normal and apoptotic cells is unknown, but it may relate to an increase in the
permeability of the cell membrane that occurs during apoptosis (Zamai et al., 1996).
Unfortunately, due to this latter limitation, this technique would not be appropriate to
determine if novel cancer therapeutics, including that described in section 1.10, induce
apoptosis in intact cells. Despite these limitations, this technique will be valuable in
studies investigating the cellular functions of MPT.
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Apoptosis is a highly regulated form of cell death. Minor changes in the process can
result in diseases, such as cancer. For many years now, clinical treatment of cancer has
involved chemotherapy, radiotherapy and surgery. However, despite the wide use of
these conventional treatments, there are still many disadvantages associated with them.
These disadvantages have led to development of novel cancer therapeutics some of
which are now in stage I and II clinical trials. This thesis describes work directed
towards the development of a novel cancer therapeutic comprised of an endosomaldisruptive polymer conjugated to both a targeting ligand and, via a pH-sensitive linker,
to a pro-apoptotic peptide (Bad(140-165)).

Two different types of synthetic polymer (PAAAs and pDMAEMA) were investigated
for their potential use as endosom al-disruptive agents. PAAAs were found to be
endocytosed into cells and then transported to late endosomes, where acidification of
the lumen by the membrane H+-ATPase triggered polymer-mediated vesicle disruption
and release of endosomal contents to the cytosol. pDMAEMA was also found to be
endocytosed into cells and transported to endosomes where it induced morphological
changes in late endosom es/lysosom es (but did not physically disrupt them ).
pDMEAMA induced rapid necrotic death. PAAAs were chosen as the most appropriate
endosomal-disruptive agents for use in the novel cancer therapeutic because (1) the very
high toxicity of pDMAEMA could pose a significant risk of bystander cell damage in
cancer therapies, and (2) under the conditions tested, pDMAEMA did not have the
ability to disrupt endosomes.

A pH-sensitive hydrazide linker (X) was successfully synthesised and conjugated to
PEAA and PPAA. Whole cell experiments indicated that the pH-sensitive membrane
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disruptive ability of the polymers was retained following conjugation with the hydrazide
linker. The stability of the carboxcyclic-hydrazide bond incorporated into the linker was
then determined. At pH 7, the bond was stable; however, at pH 5, it was very unstable
and the linker was cleaved almost immediately from the polymer. Lastly, Bad( 140-165)
was conjugated to PAAA-X and then introduced into cells by constitutive endocytosis.
Following uptake, in approximately 50% of cells, PAAA-X-Bad(140-165) partially co
localised with early endosomes. Also, uptake of PAAA-X-Bad(140-165) induced a
tim e-dependent release of calcein from endosomes into the cytosol. These results
showed that PAAA-X-Bad(140-165) was internalised by constitutive endocytosis and
retained the ability to disrupt endosomes. Cells were expected to undergo apoptosis
following uptake of PAAA-X-Bad(140-165), however, cell viability was retained. A
number of possibilities (discussed in section 5.4) have been proposed to explain why
apoptosis was not induced. Experimental strategies to investigate these possibilities are
discussed in section 7.1.

Lastly, a new technique was developed to measure MPT in intact cells. Two techniques
of measuring MPT in intact cells have previously been described (Nieminen et al.,
1995; M inam ikaw a et al., 1999). H owever, both these techniques have several
disadvantages. The new technique involves loading cells with calcein using the process
of pinocytic loading. This technique simultaneously loads millions of cells with calcein,
and subsequently visualises m itochondria as darkened voids within a bright green
fluorescent cytosol. MPT is measured as an in-filling of the dark voids. This new
technique has several advantages compared to the other techniques, including (1) it is
applicable to many types of cells, (2) it avoids the use of toxic substances, (3) it avoids
potential artefacts arising from quenching of intra-mitochondrial calcein fluorescence,
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and (4) it unambiguously identifies the physical movement of calcein across the inner
mitochondrial membrane barrier coincident with MPT.

This new technique was initially developed to allow accurate measurement of MPT in
intact cells follow ing uptake of PAA A -X-Bad(140-165). U nfortunately, technical
lim itations prevent the use of this method to measure MPT in cells undergoing
apoptosis (see section 6.4). Despite this limitation, this technique will be useful in
functional studies of MPT.

7.1

Contributions of this Work

We hypothesised that uptake of PAAA-X-Bad(140-165) into cells by constitutive
endocytosis would induce apoptosis, how ever, this was not the case. Further
experim ents will be needed to determ ine why apoptosis was not induced. These
experiments could include:
1. Dual staining of PAAA-X-Bad(140-165). PAAA-X could firstly be conjugated
with a fluorescent molecule that reacts specifically with carboxyl groups (e.g. 5(aminoacetamido) fluorescein). Bad(140-165) could then be conjugated to the
fluorescently labelled PAAA-X and biotinylated (as described in this thesis).
The dual labelled construct could then be introduced into cells by constitutive
endocytosis and the location of PAAA and Bad(140-165) traced using confocal
microscopy. These experiments would indicate if Bad(140-165) is cleaved from
PAAA-X-Bad(140-165) following uptake.
2. Increasing the number of Bad(140-165) molecules released into the cytosol.
A ssuming com plete intracellular cleavage of Bad(140-165) from PAAA-XBad( 140-165), calcu latio n s indicated that the m axim um

in tracellu lar
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concentration of Bad( 140-165) delivered by a 20 minute period of constitutive
endocytosis of PAAA-X-Bad(140-165) from an external concentration of 200
ixg/ml was 4 fold less than the known KD for the in vitro binding of Bad(140165) to Bcl-X L (see D iscussion in Chapter 5). Increasing the number of
hydrazide linkers and/or Bad(140-165) peptides conjugated to PAAA molecules
might overcome this potential problem.
3. Determ ining if Bad(140-165) conjugated to the hydrazide linker alone (XBad(140-165)) induces apoptosis. These experiments would indicate if the linker
conjugated to Bad(140-165) prevents the interaction of Bad(140-165) with BclXL and in turn prevents apoptosis. X-Bad(140-165) could be introduced into
cells by pinocytic loading (as described in section 6.2.2.1) or using PEP 1. PEP
1 is a 21-mer am phipathic peptide. It has the ability to efficiently deliver a
variety of peptides and proteins into several cell types in a fully biological active
form, without the need for prior chemical coupling or denaturing steps (Morris
et al., 2001). Following introduction of X-Bad(140-165), a variety of assays for
apoptosis could be perform ed, including m easurem ents of m itochondrial
depolarisation, MPT, caspase activation, PS exposure and cytochrome c release.

Once the factors(s) responsible for the inability of the initial PAAA-X-Bad(140-165)
constructs to induce apoptosis are identified and resolved, the chosen targeting ligand
could be conjugated to PAAA-X-Bad(140-165) to produce the desired novel cancer
therapeutic (as described in section 1.10). The effects of receptor-mediated endocytosis
of the trimolecular construct on cells could then be established using assays similar to
those described in this thesis.
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At present, cancer is the second most common cause of death in highly developed
countries (Szekeres and Novotny, 2002). The development of new cancer therapeutics,
to be used in conjunction with traditional treatments, will be invaluable in treating
cancer in the future. Hopefully, this thesis will provide information that will aid in the
future development of a new and novel cancer therapeutic.
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